id	sid	tid	token	lemma	pos
work_4fnqcubqirfmrir73ujw47kvna	1	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	1	2	Beauty	Beauty	NNP
work_4fnqcubqirfmrir73ujw47kvna	1	3	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	1	4	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	1	5	Beast	beast	NN
work_4fnqcubqirfmrir73ujw47kvna	1	6	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	1	7	Aspects	aspect	NNS
work_4fnqcubqirfmrir73ujw47kvna	1	8	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	1	9	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	1	10	Autonomic	Autonomic	NNP
work_4fnqcubqirfmrir73ujw47kvna	1	11	Nervous	Nervous	NNP
work_4fnqcubqirfmrir73ujw47kvna	1	12	System	System	NNP
work_4fnqcubqirfmrir73ujw47kvna	1	13	1250886	1250886	CD
work_4fnqcubqirfmrir73ujw47kvna	1	14	-	-	SYM
work_4fnqcubqirfmrir73ujw47kvna	1	15	1714/99	1714/99	CD
work_4fnqcubqirfmrir73ujw47kvna	1	16	5.00	5.00	CD
work_4fnqcubqirfmrir73ujw47kvna	1	17	©	©	CD
work_4fnqcubqirfmrir73ujw47kvna	1	18	2000	2000	CD
work_4fnqcubqirfmrir73ujw47kvna	1	19	Int	Int	NNP
work_4fnqcubqirfmrir73ujw47kvna	1	20	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	2	1	Union	Union	NNP
work_4fnqcubqirfmrir73ujw47kvna	2	2	Physiol	Physiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	2	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	3	1	Sci./Am	Sci./Am	NNP
work_4fnqcubqirfmrir73ujw47kvna	3	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	3	3	Physiol	Physiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	3	4	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	4	1	Soc	Soc	NNP
work_4fnqcubqirfmrir73ujw47kvna	4	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	5	1	News	News	NNP
work_4fnqcubqirfmrir73ujw47kvna	5	2	Physiol	Physiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	5	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	6	1	Sci	Sci	NNP
work_4fnqcubqirfmrir73ujw47kvna	6	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	7	1	•	•	NNP
work_4fnqcubqirfmrir73ujw47kvna	7	2	Volume	volume	NN
work_4fnqcubqirfmrir73ujw47kvna	7	3	15	15	CD
work_4fnqcubqirfmrir73ujw47kvna	7	4	•	•	NN
work_4fnqcubqirfmrir73ujw47kvna	7	5	June	June	NNP
work_4fnqcubqirfmrir73ujw47kvna	7	6	2000	2000	CD
work_4fnqcubqirfmrir73ujw47kvna	7	7	There	there	EX
work_4fnqcubqirfmrir73ujw47kvna	7	8	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	7	9	different	different	JJ
work_4fnqcubqirfmrir73ujw47kvna	7	10	methods	method	NNS
work_4fnqcubqirfmrir73ujw47kvna	7	11	to	to	TO
work_4fnqcubqirfmrir73ujw47kvna	7	12	assess	assess	VB
work_4fnqcubqirfmrir73ujw47kvna	7	13	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	7	14	nervoussystem	nervoussystem	JJ
work_4fnqcubqirfmrir73ujw47kvna	7	15	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	7	16	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	7	17	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	7	18	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	7	19	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	7	20	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	7	21	cardiovascular	cardiovascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	7	22	system	system	NN
work_4fnqcubqirfmrir73ujw47kvna	7	23	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	7	24	humans	human	NNS
work_4fnqcubqirfmrir73ujw47kvna	7	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	8	1	Besides	besides	IN
work_4fnqcubqirfmrir73ujw47kvna	8	2	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	8	3	assessment	assessment	NN
work_4fnqcubqirfmrir73ujw47kvna	8	4	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	8	5	endorgan	endorgan	JJ
work_4fnqcubqirfmrir73ujw47kvna	8	6	responses	response	NNS
work_4fnqcubqirfmrir73ujw47kvna	8	7	such	such	JJ
work_4fnqcubqirfmrir73ujw47kvna	8	8	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	8	9	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	8	10	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	8	11	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	8	12	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	8	13	rate	rate	NN
work_4fnqcubqirfmrir73ujw47kvna	8	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	8	15	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	8	16	most	most	RBS
work_4fnqcubqirfmrir73ujw47kvna	8	17	widely	widely	RB
work_4fnqcubqirfmrir73ujw47kvna	8	18	used	use	VBN
work_4fnqcubqirfmrir73ujw47kvna	8	19	meas-	meas-	NN
work_4fnqcubqirfmrir73ujw47kvna	8	20	urements	urement	NNS
work_4fnqcubqirfmrir73ujw47kvna	8	21	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	8	22	plasma	plasma	NN
work_4fnqcubqirfmrir73ujw47kvna	8	23	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	8	24	norepinephrine	norepinephrine	NN
work_4fnqcubqirfmrir73ujw47kvna	8	25	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	8	26	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	8	27	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	8	28	assay	assay	NNP
work_4fnqcubqirfmrir73ujw47kvna	8	29	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	8	30	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	8	31	spillover	spillover	NN
work_4fnqcubqirfmrir73ujw47kvna	8	32	technique	technique	NN
work_4fnqcubqirfmrir73ujw47kvna	8	33	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	8	34	microneurographic	microneurographic	JJ
work_4fnqcubqirfmrir73ujw47kvna	8	35	recordings	recording	NNS
work_4fnqcubqirfmrir73ujw47kvna	8	36	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	8	37	postganglionic	postganglionic	JJ
work_4fnqcubqirfmrir73ujw47kvna	8	38	muscle	muscle	NN
work_4fnqcubqirfmrir73ujw47kvna	8	39	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	8	40	skin	skin	NN
work_4fnqcubqirfmrir73ujw47kvna	8	41	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	8	42	nerves	nerve	NNS
work_4fnqcubqirfmrir73ujw47kvna	8	43	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	8	44	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	8	45	power	power	NN
work_4fnqcubqirfmrir73ujw47kvna	8	46	spectrum	spectrum	NNP
work_4fnqcubqirfmrir73ujw47kvna	8	47	analysis	analysis	NN
work_4fnqcubqirfmrir73ujw47kvna	8	48	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	8	49	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	8	50	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	8	51	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	8	52	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	8	53	rate	rate	NN
work_4fnqcubqirfmrir73ujw47kvna	8	54	variability	variability	NN
work_4fnqcubqirfmrir73ujw47kvna	8	55	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	9	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	9	2	tech-	tech-	JJ
work_4fnqcubqirfmrir73ujw47kvna	9	3	nique	nique	NN
work_4fnqcubqirfmrir73ujw47kvna	9	4	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	9	5	microneurography	microneurography	NN
work_4fnqcubqirfmrir73ujw47kvna	9	6	allows	allow	VBZ
work_4fnqcubqirfmrir73ujw47kvna	9	7	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	9	8	direct	direct	JJ
work_4fnqcubqirfmrir73ujw47kvna	9	9	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	9	10	continuous	continuous	JJ
work_4fnqcubqirfmrir73ujw47kvna	9	11	assessment	assessment	NN
work_4fnqcubqirfmrir73ujw47kvna	9	12	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	9	13	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	9	14	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	9	15	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	9	16	3	3	CD
work_4fnqcubqirfmrir73ujw47kvna	9	17	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	9	18	13	13	CD
work_4fnqcubqirfmrir73ujw47kvna	9	19	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	9	20	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	9	21	represents	represent	VBZ
work_4fnqcubqirfmrir73ujw47kvna	9	22	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	9	23	only	only	JJ
work_4fnqcubqirfmrir73ujw47kvna	9	24	measure	measure	NN
work_4fnqcubqirfmrir73ujw47kvna	9	25	to	to	TO
work_4fnqcubqirfmrir73ujw47kvna	9	26	detect	detect	VB
work_4fnqcubqirfmrir73ujw47kvna	9	27	small	small	JJ
work_4fnqcubqirfmrir73ujw47kvna	9	28	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	9	29	short	short	RB
work_4fnqcubqirfmrir73ujw47kvna	9	30	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	9	31	lasting	last	VBG
work_4fnqcubqirfmrir73ujw47kvna	9	32	changes	change	NNS
work_4fnqcubqirfmrir73ujw47kvna	9	33	within	within	IN
work_4fnqcubqirfmrir73ujw47kvna	9	34	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	9	35	system	system	NN
work_4fnqcubqirfmrir73ujw47kvna	9	36	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	10	1	Superficial	superficial	JJ
work_4fnqcubqirfmrir73ujw47kvna	10	2	nerves	nerve	NNS
work_4fnqcubqirfmrir73ujw47kvna	10	3	such	such	JJ
work_4fnqcubqirfmrir73ujw47kvna	10	4	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	10	5	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	10	6	peroneal	peroneal	JJ
work_4fnqcubqirfmrir73ujw47kvna	10	7	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	10	8	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	10	9	par-	par-	XX
work_4fnqcubqirfmrir73ujw47kvna	10	10	ticularly	ticularly	RB
work_4fnqcubqirfmrir73ujw47kvna	10	11	suitable	suitable	JJ
work_4fnqcubqirfmrir73ujw47kvna	10	12	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	10	13	microneurography	microneurography	NN
work_4fnqcubqirfmrir73ujw47kvna	10	14	since	since	IN
work_4fnqcubqirfmrir73ujw47kvna	10	15	their	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	10	16	anatomic	anatomic	JJ
work_4fnqcubqirfmrir73ujw47kvna	10	17	location	location	NN
work_4fnqcubqirfmrir73ujw47kvna	10	18	allows	allow	VBZ
work_4fnqcubqirfmrir73ujw47kvna	10	19	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	10	20	placement	placement	NN
work_4fnqcubqirfmrir73ujw47kvna	10	21	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	10	22	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	10	23	recording	recording	NN
work_4fnqcubqirfmrir73ujw47kvna	10	24	microelectrode	microelectrode	NN
work_4fnqcubqirfmrir73ujw47kvna	10	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	11	1	Sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	11	2	outflow	outflow	NN
work_4fnqcubqirfmrir73ujw47kvna	11	3	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	11	4	regulated	regulate	VBN
work_4fnqcubqirfmrir73ujw47kvna	11	5	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	11	6	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	11	7	brain	brain	NN
work_4fnqcubqirfmrir73ujw47kvna	11	8	stem	stem	NN
work_4fnqcubqirfmrir73ujw47kvna	11	9	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	11	10	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	11	11	medulla	medulla	NN
work_4fnqcubqirfmrir73ujw47kvna	11	12	oblongata	oblongata	NN
work_4fnqcubqirfmrir73ujw47kvna	11	13	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	12	1	Sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	12	2	nerves	nerve	NNS
work_4fnqcubqirfmrir73ujw47kvna	12	3	travel	travel	VBP
work_4fnqcubqirfmrir73ujw47kvna	12	4	along	along	IN
work_4fnqcubqirfmrir73ujw47kvna	12	5	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	12	6	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	12	7	column	column	NN
work_4fnqcubqirfmrir73ujw47kvna	12	8	into	into	IN
work_4fnqcubqirfmrir73ujw47kvna	12	9	ganglia	ganglia	NNP
work_4fnqcubqirfmrir73ujw47kvna	12	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	12	11	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	12	12	which	which	WDT
work_4fnqcubqirfmrir73ujw47kvna	12	13	acetylcholine	acetylcholine	NN
work_4fnqcubqirfmrir73ujw47kvna	12	14	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	12	15	respon-	respon-	FW
work_4fnqcubqirfmrir73ujw47kvna	12	16	sible	sible	NNP
work_4fnqcubqirfmrir73ujw47kvna	12	17	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	12	18	transmission	transmission	NN
work_4fnqcubqirfmrir73ujw47kvna	12	19	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	12	20	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	12	21	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	12	22	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	12	23	pre-	pre-	NN
work_4fnqcubqirfmrir73ujw47kvna	12	24	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	12	25	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	12	26	postgan-	postgan-	JJ
work_4fnqcubqirfmrir73ujw47kvna	12	27	glionic	glionic	JJ
work_4fnqcubqirfmrir73ujw47kvna	12	28	adrenergic	adrenergic	JJ
work_4fnqcubqirfmrir73ujw47kvna	12	29	neurons	neuron	NNS
work_4fnqcubqirfmrir73ujw47kvna	12	30	innervating	innervate	VBG
work_4fnqcubqirfmrir73ujw47kvna	12	31	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	12	32	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	12	33	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	12	34	many	many	JJ
work_4fnqcubqirfmrir73ujw47kvna	12	35	other	other	JJ
work_4fnqcubqirfmrir73ujw47kvna	12	36	organs	organ	NNS
work_4fnqcubqirfmrir73ujw47kvna	12	37	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	12	38	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	12	39	body	body	NN
work_4fnqcubqirfmrir73ujw47kvna	12	40	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	13	1	Depolarization	depolarization	NN
work_4fnqcubqirfmrir73ujw47kvna	13	2	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	13	3	postganglionic	postganglionic	JJ
work_4fnqcubqirfmrir73ujw47kvna	13	4	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	13	5	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	13	6	fibers	fiber	NNS
work_4fnqcubqirfmrir73ujw47kvna	13	7	leads	lead	VBZ
work_4fnqcubqirfmrir73ujw47kvna	13	8	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	13	9	increases	increase	NNS
work_4fnqcubqirfmrir73ujw47kvna	13	10	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	13	11	intracellular	intracellular	JJ
work_4fnqcubqirfmrir73ujw47kvna	13	12	calcium	calcium	NN
work_4fnqcubqirfmrir73ujw47kvna	13	13	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	13	14	adrenergic	adrenergic	JJ
work_4fnqcubqirfmrir73ujw47kvna	13	15	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	13	16	endings	ending	NNS
work_4fnqcubqirfmrir73ujw47kvna	13	17	where	where	WRB
work_4fnqcubqirfmrir73ujw47kvna	13	18	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	19	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	13	20	released	release	VBN
work_4fnqcubqirfmrir73ujw47kvna	13	21	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	13	22	Beauty	Beauty	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	23	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	13	24	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	13	25	Beast	beast	NN
work_4fnqcubqirfmrir73ujw47kvna	13	26	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	13	27	Aspects	aspect	NNS
work_4fnqcubqirfmrir73ujw47kvna	13	28	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	13	29	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	13	30	Autonomic	Autonomic	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	31	Nervous	Nervous	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	32	System	System	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	33	Roberto	Roberto	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	34	Corti	Corti	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	35	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	13	36	Christian	Christian	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	37	Binggeli	Binggeli	NNPS
work_4fnqcubqirfmrir73ujw47kvna	13	38	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	13	39	Isabella	Isabella	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	40	Sudano	Sudano	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	41	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	13	42	Lukas	Lukas	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	43	E.	E.	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	44	Spieker	Spieker	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	45	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	13	46	René	René	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	47	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	48	Wenzel	Wenzel	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	49	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	13	50	Thomas	Thomas	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	51	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	52	Lüscher	Lüscher	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	53	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	13	54	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	13	55	Georg	Georg	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	56	Noll	Noll	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	57	Sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	13	58	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	13	59	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	13	60	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	13	61	altered	alter	VBN
work_4fnqcubqirfmrir73ujw47kvna	13	62	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	13	63	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	13	64	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	13	65	prognostic	prognostic	JJ
work_4fnqcubqirfmrir73ujw47kvna	13	66	factor	factor	NN
work_4fnqcubqirfmrir73ujw47kvna	13	67	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	13	68	many	many	JJ
work_4fnqcubqirfmrir73ujw47kvna	13	69	cardiovascular	cardiovascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	13	70	diseases	disease	NNS
work_4fnqcubqirfmrir73ujw47kvna	13	71	such	such	JJ
work_4fnqcubqirfmrir73ujw47kvna	13	72	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	13	73	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	13	74	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	13	75	coronary	coronary	NNP
work_4fnqcubqirfmrir73ujw47kvna	13	76	syndromes	syndrome	VBZ
work_4fnqcubqirfmrir73ujw47kvna	13	77	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	13	78	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	13	79	congestive	congestive	JJ
work_4fnqcubqirfmrir73ujw47kvna	13	80	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	13	81	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	13	82	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	14	1	Therefore	therefore	RB
work_4fnqcubqirfmrir73ujw47kvna	14	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	14	3	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	14	4	selection	selection	NN
work_4fnqcubqirfmrir73ujw47kvna	14	5	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	14	6	vasoactive	vasoactive	JJ
work_4fnqcubqirfmrir73ujw47kvna	14	7	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	14	8	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	14	9	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	14	10	treatment	treatment	NN
work_4fnqcubqirfmrir73ujw47kvna	14	11	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	14	12	these	these	DT
work_4fnqcubqirfmrir73ujw47kvna	14	13	diseases	disease	NNS
work_4fnqcubqirfmrir73ujw47kvna	14	14	should	should	MD
work_4fnqcubqirfmrir73ujw47kvna	14	15	also	also	RB
work_4fnqcubqirfmrir73ujw47kvna	14	16	take	take	VB
work_4fnqcubqirfmrir73ujw47kvna	14	17	into	into	IN
work_4fnqcubqirfmrir73ujw47kvna	14	18	consideration	consideration	NN
work_4fnqcubqirfmrir73ujw47kvna	14	19	their	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	14	20	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	14	21	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	14	22	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	14	23	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	14	24	nervous	nervous	JJ
work_4fnqcubqirfmrir73ujw47kvna	14	25	system	system	NN
work_4fnqcubqirfmrir73ujw47kvna	14	26	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	15	1	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	2	Corti	Corti	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	3	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	15	4	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	5	Binggeli	Binggeli	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	6	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	15	7	I.	I.	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	8	Sudano	Sudano	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	9	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	15	10	L.	L.	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	11	E.	E.	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	12	Spieker	Spieker	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	13	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	15	14	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	15	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	16	Wenzel	Wenzel	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	17	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	15	18	T.	T.	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	19	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	20	Lüscher	Lüscher	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	21	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	15	22	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	15	23	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	24	Noll	Noll	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	25	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	15	26	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	15	27	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	15	28	Department	Department	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	29	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	15	30	Cardiology	Cardiology	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	31	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	15	32	University	University	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	33	Hospital	Hospital	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	34	Zurich	Zurich	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	35	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	15	36	Switzerland	Switzerland	NNP
work_4fnqcubqirfmrir73ujw47kvna	15	37	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	16	1	within	within	IN
work_4fnqcubqirfmrir73ujw47kvna	16	2	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	16	3	next	next	JJ
work_4fnqcubqirfmrir73ujw47kvna	16	4	decade	decade	NN
work_4fnqcubqirfmrir73ujw47kvna	16	5	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	17	1	However	however	RB
work_4fnqcubqirfmrir73ujw47kvna	17	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	17	3	it	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	17	4	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	17	5	equally	equally	RB
work_4fnqcubqirfmrir73ujw47kvna	17	6	true	true	JJ
work_4fnqcubqirfmrir73ujw47kvna	17	7	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	17	8	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	17	9	enormous	enormous	JJ
work_4fnqcubqirfmrir73ujw47kvna	17	10	amount	amount	NN
work_4fnqcubqirfmrir73ujw47kvna	17	11	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	17	12	research	research	NN
work_4fnqcubqirfmrir73ujw47kvna	17	13	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	17	14	still	still	RB
work_4fnqcubqirfmrir73ujw47kvna	17	15	to	to	TO
work_4fnqcubqirfmrir73ujw47kvna	17	16	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	17	17	done	do	VBN
work_4fnqcubqirfmrir73ujw47kvna	17	18	before	before	IN
work_4fnqcubqirfmrir73ujw47kvna	17	19	human	human	JJ
work_4fnqcubqirfmrir73ujw47kvna	17	20	therapy	therapy	NN
work_4fnqcubqirfmrir73ujw47kvna	17	21	can	can	MD
work_4fnqcubqirfmrir73ujw47kvna	17	22	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	17	23	attempted	attempt	VBN
work_4fnqcubqirfmrir73ujw47kvna	17	24	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	18	1	An	an	DT
work_4fnqcubqirfmrir73ujw47kvna	18	2	essential	essential	JJ
work_4fnqcubqirfmrir73ujw47kvna	18	3	side	side	NN
work_4fnqcubqirfmrir73ujw47kvna	18	4	effect	effect	NN
work_4fnqcubqirfmrir73ujw47kvna	18	5	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	18	6	develop-	develop-	NNP
work_4fnqcubqirfmrir73ujw47kvna	18	7	ing	ing	NNP
work_4fnqcubqirfmrir73ujw47kvna	18	8	therapies	therapy	NNS
work_4fnqcubqirfmrir73ujw47kvna	18	9	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	18	10	animal	animal	NN
work_4fnqcubqirfmrir73ujw47kvna	18	11	models	model	NNS
work_4fnqcubqirfmrir73ujw47kvna	18	12	will	will	MD
work_4fnqcubqirfmrir73ujw47kvna	18	13	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	18	14	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	18	15	further	further	JJ
work_4fnqcubqirfmrir73ujw47kvna	18	16	understand-	understand-	JJ
work_4fnqcubqirfmrir73ujw47kvna	18	17	ing	ing	NN
work_4fnqcubqirfmrir73ujw47kvna	18	18	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	18	19	retinal	retinal	JJ
work_4fnqcubqirfmrir73ujw47kvna	18	20	cell	cell	NN
work_4fnqcubqirfmrir73ujw47kvna	18	21	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	18	22	molecular	molecular	JJ
work_4fnqcubqirfmrir73ujw47kvna	18	23	biology	biology	NN
work_4fnqcubqirfmrir73ujw47kvna	18	24	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	19	1	For	for	IN
work_4fnqcubqirfmrir73ujw47kvna	19	2	example	example	NN
work_4fnqcubqirfmrir73ujw47kvna	19	3	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	19	4	what	what	WP
work_4fnqcubqirfmrir73ujw47kvna	19	5	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	19	6	/	/	,
work_4fnqcubqirfmrir73ujw47kvna	19	7	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	19	8	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	19	9	role(s	role(s	NNP
work_4fnqcubqirfmrir73ujw47kvna	19	10	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	19	11	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	19	12	c	c	NN
work_4fnqcubqirfmrir73ujw47kvna	19	13	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	19	14	fos	fos	NNP
work_4fnqcubqirfmrir73ujw47kvna	19	15	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	19	16	does	do	VBZ
work_4fnqcubqirfmrir73ujw47kvna	19	17	photoregeneration	photoregeneration	NN
work_4fnqcubqirfmrir73ujw47kvna	19	18	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	19	19	rhodopsin	rhodopsin	NN
work_4fnqcubqirfmrir73ujw47kvna	19	20	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	19	21	blue	blue	JJ
work_4fnqcubqirfmrir73ujw47kvna	19	22	light	light	NN
work_4fnqcubqirfmrir73ujw47kvna	19	23	occur	occur	VBP
work_4fnqcubqirfmrir73ujw47kvna	19	24	under	under	IN
work_4fnqcubqirfmrir73ujw47kvna	19	25	natural	natural	JJ
work_4fnqcubqirfmrir73ujw47kvna	19	26	conditions	condition	NNS
work_4fnqcubqirfmrir73ujw47kvna	19	27	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	19	28	mammals	mammal	NNS
work_4fnqcubqirfmrir73ujw47kvna	19	29	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	19	30	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	19	31	do	do	VBP
work_4fnqcubqirfmrir73ujw47kvna	19	32	autophagy	autophagy	NNP
work_4fnqcubqirfmrir73ujw47kvna	19	33	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	19	34	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	19	35	proteasome	proteasome	NN
work_4fnqcubqirfmrir73ujw47kvna	19	36	system	system	NN
work_4fnqcubqirfmrir73ujw47kvna	19	37	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	19	38	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	19	39	apoptosis	apoptosis	NN
work_4fnqcubqirfmrir73ujw47kvna	19	40	repre-	repre-	NN
work_4fnqcubqirfmrir73ujw47kvna	19	41	sent	send	VBD
work_4fnqcubqirfmrir73ujw47kvna	19	42	means	mean	NNS
work_4fnqcubqirfmrir73ujw47kvna	19	43	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	19	44	adaptation	adaptation	NN
work_4fnqcubqirfmrir73ujw47kvna	19	45	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	19	46	changing	change	VBG
work_4fnqcubqirfmrir73ujw47kvna	19	47	metabolic	metabolic	NN
work_4fnqcubqirfmrir73ujw47kvna	19	48	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	19	49	environ-	environ-	NN
work_4fnqcubqirfmrir73ujw47kvna	19	50	mental	mental	JJ
work_4fnqcubqirfmrir73ujw47kvna	19	51	conditions	condition	NNS
work_4fnqcubqirfmrir73ujw47kvna	19	52	?	?	.
work_4fnqcubqirfmrir73ujw47kvna	20	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	20	2	this	this	DT
work_4fnqcubqirfmrir73ujw47kvna	20	3	latter	latter	JJ
work_4fnqcubqirfmrir73ujw47kvna	20	4	context	context	NN
work_4fnqcubqirfmrir73ujw47kvna	20	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	20	6	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	20	7	apparent	apparent	JJ
work_4fnqcubqirfmrir73ujw47kvna	20	8	paradox	paradox	NN
work_4fnqcubqirfmrir73ujw47kvna	20	9	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	20	10	light	light	NN
work_4fnqcubqirfmrir73ujw47kvna	20	11	eliminating	eliminate	VBG
work_4fnqcubqirfmrir73ujw47kvna	20	12	photoreceptors	photoreceptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	20	13	might	may	MD
work_4fnqcubqirfmrir73ujw47kvna	20	14	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	20	15	resolved	resolve	VBN
work_4fnqcubqirfmrir73ujw47kvna	20	16	into	into	IN
work_4fnqcubqirfmrir73ujw47kvna	20	17	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	20	18	meaningful	meaningful	JJ
work_4fnqcubqirfmrir73ujw47kvna	20	19	measure	measure	NN
work_4fnqcubqirfmrir73ujw47kvna	20	20	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	20	21	those	those	DT
work_4fnqcubqirfmrir73ujw47kvna	20	22	cases	case	NNS
work_4fnqcubqirfmrir73ujw47kvna	20	23	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	20	24	which	which	WDT
work_4fnqcubqirfmrir73ujw47kvna	20	25	adaptation	adaptation	NN
work_4fnqcubqirfmrir73ujw47kvna	20	26	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	20	27	bright	bright	JJ
work_4fnqcubqirfmrir73ujw47kvna	20	28	light	light	NN
work_4fnqcubqirfmrir73ujw47kvna	20	29	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	20	30	required	require	VBN
work_4fnqcubqirfmrir73ujw47kvna	20	31	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	21	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	21	2	death	death	NN
work_4fnqcubqirfmrir73ujw47kvna	21	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	21	4	single	single	JJ
work_4fnqcubqirfmrir73ujw47kvna	21	5	cells	cell	NNS
work_4fnqcubqirfmrir73ujw47kvna	21	6	might	may	MD
work_4fnqcubqirfmrir73ujw47kvna	21	7	help	help	VB
work_4fnqcubqirfmrir73ujw47kvna	21	8	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	21	9	remaining	remain	VBG
work_4fnqcubqirfmrir73ujw47kvna	21	10	ones	one	NNS
work_4fnqcubqirfmrir73ujw47kvna	21	11	to	to	TO
work_4fnqcubqirfmrir73ujw47kvna	21	12	survive	survive	VB
work_4fnqcubqirfmrir73ujw47kvna	21	13	through	through	IN
work_4fnqcubqirfmrir73ujw47kvna	21	14	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	21	15	reduction	reduction	NN
work_4fnqcubqirfmrir73ujw47kvna	21	16	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	21	17	overall	overall	JJ
work_4fnqcubqirfmrir73ujw47kvna	21	18	light	light	JJ
work_4fnqcubqirfmrir73ujw47kvna	21	19	sensitivity	sensitivity	NN
work_4fnqcubqirfmrir73ujw47kvna	21	20	or	or	CC
work_4fnqcubqirfmrir73ujw47kvna	21	21	photon	photon	NN
work_4fnqcubqirfmrir73ujw47kvna	21	22	absorption	absorption	NN
work_4fnqcubqirfmrir73ujw47kvna	21	23	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	21	24	respectively	respectively	RB
work_4fnqcubqirfmrir73ujw47kvna	21	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	22	1	We	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	22	2	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	22	3	supported	support	VBN
work_4fnqcubqirfmrir73ujw47kvna	22	4	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	22	5	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	22	6	Swiss	Swiss	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	7	National	National	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	8	Science	Science	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	9	Foundation	Foundation	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	22	11	Brupbacher	Brupbacher	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	12	Foundation	Foundation	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	13	Zürich	Zürich	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	22	15	EMDO-	EMDO-	NNPS
work_4fnqcubqirfmrir73ujw47kvna	22	16	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	22	17	Hartmann	Hartmann	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	18	Müller	Müller	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	19	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	22	20	Foundation	Foundation	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	21	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	22	22	Zürich	Zürich	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	23	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	22	24	SUVA	SUVA	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	25	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	22	26	Research	Research	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	27	Foundation	Foundation	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	28	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	22	29	Luzern	Luzern	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	30	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	22	31	Switzerland	Switzerland	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	32	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	22	33	Grimmke	Grimmke	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	34	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	22	35	Foundation	Foundation	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	36	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	22	37	Düsseldorf	Düsseldorf	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	38	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	22	39	Germany	Germany	NNP
work_4fnqcubqirfmrir73ujw47kvna	22	40	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	22	41	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	22	42	others	other	NNS
work_4fnqcubqirfmrir73ujw47kvna	22	43	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	23	1	References	reference	NNS
work_4fnqcubqirfmrir73ujw47kvna	23	2	1	1	CD
work_4fnqcubqirfmrir73ujw47kvna	23	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	24	1	Enari	Enari	NNP
work_4fnqcubqirfmrir73ujw47kvna	24	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	24	3	M.	M.	NNP
work_4fnqcubqirfmrir73ujw47kvna	24	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	24	5	H.	H.	NNP
work_4fnqcubqirfmrir73ujw47kvna	24	6	Sakahira	Sakahira	NNP
work_4fnqcubqirfmrir73ujw47kvna	24	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	24	8	H.	H.	NNP
work_4fnqcubqirfmrir73ujw47kvna	24	9	Yokoyama	Yokoyama	NNP
work_4fnqcubqirfmrir73ujw47kvna	24	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	24	11	K.	K.	NNP
work_4fnqcubqirfmrir73ujw47kvna	24	12	Okawa	Okawa	NNP
work_4fnqcubqirfmrir73ujw47kvna	24	13	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	24	14	A.	a.	NN
work_4fnqcubqirfmrir73ujw47kvna	24	15	Iwamatsu	Iwamatsu	NNP
work_4fnqcubqirfmrir73ujw47kvna	24	16	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	24	17	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	24	18	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	24	19	Nagata	Nagata	NNP
work_4fnqcubqirfmrir73ujw47kvna	24	20	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	25	1	A	a	DT
work_4fnqcubqirfmrir73ujw47kvna	25	2	caspase	caspase	NN
work_4fnqcubqirfmrir73ujw47kvna	25	3	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	25	4	activated	activate	VBN
work_4fnqcubqirfmrir73ujw47kvna	25	5	DNase	DNase	NNP
work_4fnqcubqirfmrir73ujw47kvna	25	6	that	that	WDT
work_4fnqcubqirfmrir73ujw47kvna	25	7	degrades	degrade	VBZ
work_4fnqcubqirfmrir73ujw47kvna	25	8	DNA	dna	NN
work_4fnqcubqirfmrir73ujw47kvna	25	9	during	during	IN
work_4fnqcubqirfmrir73ujw47kvna	25	10	apoptosis	apoptosis	NN
work_4fnqcubqirfmrir73ujw47kvna	25	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	25	12	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	25	13	its	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	25	14	inhibitor	inhibitor	NN
work_4fnqcubqirfmrir73ujw47kvna	25	15	ICAD	icad	NN
work_4fnqcubqirfmrir73ujw47kvna	25	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	26	1	Nature	nature	NN
work_4fnqcubqirfmrir73ujw47kvna	26	2	391	391	CD
work_4fnqcubqirfmrir73ujw47kvna	26	3	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	26	4	43–50	43–50	CD
work_4fnqcubqirfmrir73ujw47kvna	26	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	26	6	1998	1998	CD
work_4fnqcubqirfmrir73ujw47kvna	26	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	27	1	2	2	LS
work_4fnqcubqirfmrir73ujw47kvna	27	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	28	1	Häcker	Häcker	NNP
work_4fnqcubqirfmrir73ujw47kvna	28	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	28	3	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	28	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	28	5	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	28	6	D.	D.	NNP
work_4fnqcubqirfmrir73ujw47kvna	28	7	L.	L.	NNP
work_4fnqcubqirfmrir73ujw47kvna	28	8	Vaux	Vaux	NNP
work_4fnqcubqirfmrir73ujw47kvna	28	9	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	29	1	A	a	DT
work_4fnqcubqirfmrir73ujw47kvna	29	2	chronology	chronology	NN
work_4fnqcubqirfmrir73ujw47kvna	29	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	29	4	cell	cell	NN
work_4fnqcubqirfmrir73ujw47kvna	29	5	death	death	NN
work_4fnqcubqirfmrir73ujw47kvna	29	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	30	1	Apoptosis	apoptosis	NN
work_4fnqcubqirfmrir73ujw47kvna	30	2	2	2	CD
work_4fnqcubqirfmrir73ujw47kvna	30	3	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	30	4	247–256	247–256	CD
work_4fnqcubqirfmrir73ujw47kvna	30	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	30	6	1997	1997	CD
work_4fnqcubqirfmrir73ujw47kvna	30	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	31	1	3	3	LS
work_4fnqcubqirfmrir73ujw47kvna	31	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	32	1	Hafezi	Hafezi	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	32	3	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	32	5	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	6	P.	P.	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	7	Steinbach	Steinbach	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	32	9	A.	a.	NN
work_4fnqcubqirfmrir73ujw47kvna	32	10	Marti	Marti	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	32	12	K.	K.	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	13	Munz	Munz	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	32	15	Z.	Z.	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	16	Q.Wang	Q.Wang	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	17	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	32	18	E.	E.	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	19	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	20	Wagner	Wagner	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	21	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	32	22	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	23	Aguzzi	Aguzzi	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	24	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	32	25	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	32	26	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	27	E.	E.	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	28	Remé	Remé	NNP
work_4fnqcubqirfmrir73ujw47kvna	32	29	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	33	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	33	2	absence	absence	NN
work_4fnqcubqirfmrir73ujw47kvna	33	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	33	4	c	c	NN
work_4fnqcubqirfmrir73ujw47kvna	33	5	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	33	6	fos	fos	NN
work_4fnqcubqirfmrir73ujw47kvna	33	7	prevents	prevent	NNS
work_4fnqcubqirfmrir73ujw47kvna	33	8	light	light	RB
work_4fnqcubqirfmrir73ujw47kvna	33	9	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	33	10	induced	induce	VBN
work_4fnqcubqirfmrir73ujw47kvna	33	11	apop-	apop-	JJ
work_4fnqcubqirfmrir73ujw47kvna	33	12	totic	totic	JJ
work_4fnqcubqirfmrir73ujw47kvna	33	13	cell	cell	NN
work_4fnqcubqirfmrir73ujw47kvna	33	14	death	death	NN
work_4fnqcubqirfmrir73ujw47kvna	33	15	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	33	16	photoreceptors	photoreceptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	33	17	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	33	18	retinal	retinal	JJ
work_4fnqcubqirfmrir73ujw47kvna	33	19	degeneration	degeneration	NN
work_4fnqcubqirfmrir73ujw47kvna	33	20	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	33	21	vivo	vivo	NNP
work_4fnqcubqirfmrir73ujw47kvna	33	22	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	34	1	Nat	Nat	NNP
work_4fnqcubqirfmrir73ujw47kvna	34	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	35	1	Med	Med	NNP
work_4fnqcubqirfmrir73ujw47kvna	35	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	36	1	3	3	LS
work_4fnqcubqirfmrir73ujw47kvna	36	2	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	36	3	346–349	346–349	CD
work_4fnqcubqirfmrir73ujw47kvna	36	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	36	5	1997	1997	CD
work_4fnqcubqirfmrir73ujw47kvna	36	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	37	1	4	4	LS
work_4fnqcubqirfmrir73ujw47kvna	37	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	38	1	Hafezi	Hafezi	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	38	3	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	38	5	M.	M.	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	6	Abegg	Abegg	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	38	8	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	9	Grimm	Grimm	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	38	11	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	12	Wenzel	Wenzel	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	13	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	38	14	K.	K.	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	15	Munz	Munz	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	16	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	38	17	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	18	Stürmer	Stürmer	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	19	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	38	20	D.	D.	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	21	B.	B.	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	22	Far-	Far-	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	23	ber	ber	NN
work_4fnqcubqirfmrir73ujw47kvna	38	24	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	38	25	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	38	26	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	27	E.	E.	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	28	Remé	Remé	NNP
work_4fnqcubqirfmrir73ujw47kvna	38	29	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	39	1	Retinal	retinal	JJ
work_4fnqcubqirfmrir73ujw47kvna	39	2	degeneration	degeneration	NN
work_4fnqcubqirfmrir73ujw47kvna	39	3	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	39	4	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	39	5	rd	rd	NNP
work_4fnqcubqirfmrir73ujw47kvna	39	6	mouse	mouse	NN
work_4fnqcubqirfmrir73ujw47kvna	39	7	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	39	8	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	39	9	absence	absence	NN
work_4fnqcubqirfmrir73ujw47kvna	39	10	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	39	11	c	c	NN
work_4fnqcubqirfmrir73ujw47kvna	39	12	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	39	13	fos	fos	NNP
work_4fnqcubqirfmrir73ujw47kvna	39	14	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	40	1	Invest	invest	VB
work_4fnqcubqirfmrir73ujw47kvna	40	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	41	1	Ophthalmol	Ophthalmol	NNP
work_4fnqcubqirfmrir73ujw47kvna	41	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	42	1	Vis	Vis	NNP
work_4fnqcubqirfmrir73ujw47kvna	42	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	43	1	Sci	Sci	NNP
work_4fnqcubqirfmrir73ujw47kvna	43	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	44	1	39	39	CD
work_4fnqcubqirfmrir73ujw47kvna	44	2	:	:	SYM
work_4fnqcubqirfmrir73ujw47kvna	44	3	2239–2244	2239–2244	CD
work_4fnqcubqirfmrir73ujw47kvna	44	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	44	5	1998	1998	CD
work_4fnqcubqirfmrir73ujw47kvna	44	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	45	1	5	5	CD
work_4fnqcubqirfmrir73ujw47kvna	45	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	46	1	Mancini	Mancini	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	46	3	M.	M.	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	46	5	D.	D.	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	6	W.	W.	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	7	Nicholson	Nicholson	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	46	9	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	10	Roy	Roy	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	46	12	N.	N.	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	13	A.	a.	NN
work_4fnqcubqirfmrir73ujw47kvna	46	14	Thornberry	Thornberry	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	15	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	46	16	E.	E.	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	17	P.	P.	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	18	Peterson	Peterson	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	19	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	46	20	L.	L.	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	21	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	22	Casciola	Casciola	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	23	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	46	24	Rosen	Rosen	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	25	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	46	26	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	46	27	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	28	Rosen	Rosen	NNP
work_4fnqcubqirfmrir73ujw47kvna	46	29	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	47	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	47	2	caspase-3	caspase-3	NNP
work_4fnqcubqirfmrir73ujw47kvna	47	3	precursor	precursor	NN
work_4fnqcubqirfmrir73ujw47kvna	47	4	has	have	VBZ
work_4fnqcubqirfmrir73ujw47kvna	47	5	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	47	6	cytosolic	cytosolic	JJ
work_4fnqcubqirfmrir73ujw47kvna	47	7	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	47	8	mitochondrial	mitochondrial	NN
work_4fnqcubqirfmrir73ujw47kvna	47	9	distribution	distribution	NN
work_4fnqcubqirfmrir73ujw47kvna	47	10	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	47	11	implications	implication	NNS
work_4fnqcubqirfmrir73ujw47kvna	47	12	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	47	13	apoptotic	apoptotic	JJ
work_4fnqcubqirfmrir73ujw47kvna	47	14	signaling	signaling	NN
work_4fnqcubqirfmrir73ujw47kvna	47	15	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	48	1	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	49	1	Cell	cell	NN
work_4fnqcubqirfmrir73ujw47kvna	49	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	50	1	Biol	Biol	NNP
work_4fnqcubqirfmrir73ujw47kvna	50	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	51	1	140	140	CD
work_4fnqcubqirfmrir73ujw47kvna	51	2	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	51	3	1485–1495	1485–1495	CD
work_4fnqcubqirfmrir73ujw47kvna	51	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	51	5	1998	1998	CD
work_4fnqcubqirfmrir73ujw47kvna	51	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	52	1	6	6	CD
work_4fnqcubqirfmrir73ujw47kvna	52	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	53	1	Miller	Miller	NNP
work_4fnqcubqirfmrir73ujw47kvna	53	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	53	3	L.	L.	NNP
work_4fnqcubqirfmrir73ujw47kvna	53	4	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	53	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	53	6	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	53	7	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	53	8	Marx	Marx	NNP
work_4fnqcubqirfmrir73ujw47kvna	53	9	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	54	1	Apoptosis	apoptosis	NN
work_4fnqcubqirfmrir73ujw47kvna	54	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	55	1	Science	science	NN
work_4fnqcubqirfmrir73ujw47kvna	55	2	281	281	CD
work_4fnqcubqirfmrir73ujw47kvna	55	3	:	:	SYM
work_4fnqcubqirfmrir73ujw47kvna	55	4	1301–1326	1301–1326	CD
work_4fnqcubqirfmrir73ujw47kvna	55	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	55	6	1998	1998	CD
work_4fnqcubqirfmrir73ujw47kvna	55	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	56	1	7	7	LS
work_4fnqcubqirfmrir73ujw47kvna	56	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	57	1	Nir	Nir	NNP
work_4fnqcubqirfmrir73ujw47kvna	57	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	57	3	I.	I.	NNP
work_4fnqcubqirfmrir73ujw47kvna	57	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	57	5	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	57	6	N.	N.	NNP
work_4fnqcubqirfmrir73ujw47kvna	57	7	Agarwal	Agarwal	NNP
work_4fnqcubqirfmrir73ujw47kvna	57	8	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	58	1	Diurnal	diurnal	JJ
work_4fnqcubqirfmrir73ujw47kvna	58	2	expression	expression	NN
work_4fnqcubqirfmrir73ujw47kvna	58	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	58	4	c	c	NN
work_4fnqcubqirfmrir73ujw47kvna	58	5	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	58	6	fos	fos	NNP
work_4fnqcubqirfmrir73ujw47kvna	58	7	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	58	8	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	58	9	mouse	mouse	NN
work_4fnqcubqirfmrir73ujw47kvna	58	10	retina	retina	NNP
work_4fnqcubqirfmrir73ujw47kvna	58	11	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	59	1	Brain	Brain	NNP
work_4fnqcubqirfmrir73ujw47kvna	59	2	Res	Res	NNP
work_4fnqcubqirfmrir73ujw47kvna	59	3	Mol	Mol	NNP
work_4fnqcubqirfmrir73ujw47kvna	59	4	Brain	Brain	NNP
work_4fnqcubqirfmrir73ujw47kvna	59	5	Res	Res	NNP
work_4fnqcubqirfmrir73ujw47kvna	59	6	19	19	CD
work_4fnqcubqirfmrir73ujw47kvna	59	7	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	59	8	47–54	47–54	CD
work_4fnqcubqirfmrir73ujw47kvna	59	9	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	59	10	1993	1993	CD
work_4fnqcubqirfmrir73ujw47kvna	59	11	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	60	1	8	8	LS
work_4fnqcubqirfmrir73ujw47kvna	60	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	61	1	Portera	Portera	NNP
work_4fnqcubqirfmrir73ujw47kvna	61	2	Cailliau	Cailliau	NNP
work_4fnqcubqirfmrir73ujw47kvna	61	3	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	61	4	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	61	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	61	6	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	61	7	H.	H.	NNP
work_4fnqcubqirfmrir73ujw47kvna	61	8	Sung	Sung	NNP
work_4fnqcubqirfmrir73ujw47kvna	61	9	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	61	10	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	61	11	Nathans	Nathans	NNP
work_4fnqcubqirfmrir73ujw47kvna	61	12	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	61	13	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	61	14	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	61	15	Adler	Adler	NNP
work_4fnqcubqirfmrir73ujw47kvna	61	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	62	1	Apoptotic	apoptotic	JJ
work_4fnqcubqirfmrir73ujw47kvna	62	2	pho-	pho-	NN
work_4fnqcubqirfmrir73ujw47kvna	62	3	toreceptor	toreceptor	VBP
work_4fnqcubqirfmrir73ujw47kvna	62	4	cell	cell	NN
work_4fnqcubqirfmrir73ujw47kvna	62	5	death	death	NN
work_4fnqcubqirfmrir73ujw47kvna	62	6	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	62	7	mouse	mouse	NN
work_4fnqcubqirfmrir73ujw47kvna	62	8	models	model	NNS
work_4fnqcubqirfmrir73ujw47kvna	62	9	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	62	10	retinitis	retinitis	NNP
work_4fnqcubqirfmrir73ujw47kvna	62	11	pigmentosa	pigmentosa	NNP
work_4fnqcubqirfmrir73ujw47kvna	62	12	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	63	1	Proc	Proc	NNP
work_4fnqcubqirfmrir73ujw47kvna	63	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	64	1	Natl	Natl	NNP
work_4fnqcubqirfmrir73ujw47kvna	64	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	65	1	Acad	Acad	NNS
work_4fnqcubqirfmrir73ujw47kvna	65	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	66	1	Sci	Sci	NNP
work_4fnqcubqirfmrir73ujw47kvna	66	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	67	1	USA	USA	NNP
work_4fnqcubqirfmrir73ujw47kvna	67	2	91	91	CD
work_4fnqcubqirfmrir73ujw47kvna	67	3	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	67	4	974–978	974–978	CD
work_4fnqcubqirfmrir73ujw47kvna	67	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	67	6	1994	1994	CD
work_4fnqcubqirfmrir73ujw47kvna	67	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	68	1	9	9	CD
work_4fnqcubqirfmrir73ujw47kvna	68	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	69	1	Raff	Raff	NNP
work_4fnqcubqirfmrir73ujw47kvna	69	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	69	3	M.	M.	NNP
work_4fnqcubqirfmrir73ujw47kvna	69	4	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	69	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	69	6	B.	B.	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	1	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	2	Barres	Barres	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	3	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	70	4	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	5	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	6	Burne	Burne	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	70	8	H.	H.	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	9	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	10	Coles	Coles	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	70	12	Y.	Y.	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	13	Ishizaki	Ishizaki	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	70	15	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	70	16	M.	M.	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	17	D.	D.	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	18	Jacobson	Jacobson	NNP
work_4fnqcubqirfmrir73ujw47kvna	70	19	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	71	1	Programmed	program	VBN
work_4fnqcubqirfmrir73ujw47kvna	71	2	cell	cell	NN
work_4fnqcubqirfmrir73ujw47kvna	71	3	death	death	NN
work_4fnqcubqirfmrir73ujw47kvna	71	4	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	71	5	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	71	6	control	control	NN
work_4fnqcubqirfmrir73ujw47kvna	71	7	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	71	8	cell	cell	NN
work_4fnqcubqirfmrir73ujw47kvna	71	9	survival	survival	NN
work_4fnqcubqirfmrir73ujw47kvna	71	10	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	71	11	lessons	lesson	NNS
work_4fnqcubqirfmrir73ujw47kvna	71	12	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	71	13	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	71	14	nervous	nervous	JJ
work_4fnqcubqirfmrir73ujw47kvna	71	15	system	system	NN
work_4fnqcubqirfmrir73ujw47kvna	71	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	72	1	Science	science	NN
work_4fnqcubqirfmrir73ujw47kvna	72	2	262	262	CD
work_4fnqcubqirfmrir73ujw47kvna	72	3	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	72	4	695–700	695–700	CD
work_4fnqcubqirfmrir73ujw47kvna	72	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	72	6	1993	1993	CD
work_4fnqcubqirfmrir73ujw47kvna	72	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	73	1	10	10	CD
work_4fnqcubqirfmrir73ujw47kvna	73	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	74	1	Remé	Remé	NNP
work_4fnqcubqirfmrir73ujw47kvna	74	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	74	3	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	74	4	E.	E.	NNP
work_4fnqcubqirfmrir73ujw47kvna	74	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	74	6	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	74	7	Grimm	Grimm	NNP
work_4fnqcubqirfmrir73ujw47kvna	74	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	74	9	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	74	10	Hafezi	Hafezi	NNP
work_4fnqcubqirfmrir73ujw47kvna	74	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	74	12	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	74	13	Marti	Marti	NNP
work_4fnqcubqirfmrir73ujw47kvna	74	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	74	15	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	74	16	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	74	17	Wenzel	Wenzel	NNP
work_4fnqcubqirfmrir73ujw47kvna	74	18	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	75	1	Apoptotic	apoptotic	JJ
work_4fnqcubqirfmrir73ujw47kvna	75	2	cell	cell	NN
work_4fnqcubqirfmrir73ujw47kvna	75	3	death	death	NN
work_4fnqcubqirfmrir73ujw47kvna	75	4	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	75	5	retinal	retinal	JJ
work_4fnqcubqirfmrir73ujw47kvna	75	6	degenerations	degeneration	NNS
work_4fnqcubqirfmrir73ujw47kvna	75	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	76	1	Prog	Prog	NNS
work_4fnqcubqirfmrir73ujw47kvna	76	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	77	1	Retin	Retin	NNP
work_4fnqcubqirfmrir73ujw47kvna	77	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	78	1	Eye	Eye	NNP
work_4fnqcubqirfmrir73ujw47kvna	78	2	Res	Res	NNP
work_4fnqcubqirfmrir73ujw47kvna	78	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	79	1	17	17	CD
work_4fnqcubqirfmrir73ujw47kvna	79	2	:	:	SYM
work_4fnqcubqirfmrir73ujw47kvna	79	3	443–463	443–463	CD
work_4fnqcubqirfmrir73ujw47kvna	79	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	79	5	1998	1998	CD
work_4fnqcubqirfmrir73ujw47kvna	79	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	80	1	11	11	CD
work_4fnqcubqirfmrir73ujw47kvna	80	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	81	1	Remé	Remé	NNP
work_4fnqcubqirfmrir73ujw47kvna	81	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	81	3	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	81	4	E.	E.	NNP
work_4fnqcubqirfmrir73ujw47kvna	81	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	81	6	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	81	7	Hafezi	Hafezi	NNP
work_4fnqcubqirfmrir73ujw47kvna	81	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	81	9	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	81	10	Marti	Marti	NNP
work_4fnqcubqirfmrir73ujw47kvna	81	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	81	12	K.	K.	NNP
work_4fnqcubqirfmrir73ujw47kvna	81	13	Munz	Munz	NNP
work_4fnqcubqirfmrir73ujw47kvna	81	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	81	15	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	81	16	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	81	17	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	81	18	Reinboth	Reinboth	NNP
work_4fnqcubqirfmrir73ujw47kvna	81	19	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	82	1	Light	light	NN
work_4fnqcubqirfmrir73ujw47kvna	82	2	dam-	dam-	XX
work_4fnqcubqirfmrir73ujw47kvna	82	3	age	age	NN
work_4fnqcubqirfmrir73ujw47kvna	82	4	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	82	5	retina	retina	NNP
work_4fnqcubqirfmrir73ujw47kvna	82	6	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	82	7	pigment	pigment	NN
work_4fnqcubqirfmrir73ujw47kvna	82	8	epithelium	epithelium	NN
work_4fnqcubqirfmrir73ujw47kvna	82	9	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	83	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	83	2	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	83	3	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	83	4	Retinal	Retinal	NNP
work_4fnqcubqirfmrir73ujw47kvna	83	5	Pigment	Pigment	NNP
work_4fnqcubqirfmrir73ujw47kvna	83	6	Epithelium	Epithelium	NNP
work_4fnqcubqirfmrir73ujw47kvna	83	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	83	8	Current	Current	NNP
work_4fnqcubqirfmrir73ujw47kvna	83	9	Aspects	Aspects	NNPS
work_4fnqcubqirfmrir73ujw47kvna	83	10	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	83	11	Function	Function	NNP
work_4fnqcubqirfmrir73ujw47kvna	83	12	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	83	13	Disease	Disease	NNP
work_4fnqcubqirfmrir73ujw47kvna	83	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	83	15	edited	edit	VBN
work_4fnqcubqirfmrir73ujw47kvna	83	16	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	83	17	M.	M.	NNP
work_4fnqcubqirfmrir73ujw47kvna	83	18	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	83	19	Marmor	Marmor	NNP
work_4fnqcubqirfmrir73ujw47kvna	83	20	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	83	21	T.	T.	NNP
work_4fnqcubqirfmrir73ujw47kvna	83	22	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	83	23	Wolfensberger	Wolfensberger	NNP
work_4fnqcubqirfmrir73ujw47kvna	83	24	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	84	1	Oxford	Oxford	NNP
work_4fnqcubqirfmrir73ujw47kvna	84	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	84	3	UK	UK	NNP
work_4fnqcubqirfmrir73ujw47kvna	84	4	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	84	5	Oxford	Oxford	NNP
work_4fnqcubqirfmrir73ujw47kvna	84	6	University	University	NNP
work_4fnqcubqirfmrir73ujw47kvna	84	7	Press	Press	NNP
work_4fnqcubqirfmrir73ujw47kvna	84	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	84	9	1998	1998	CD
work_4fnqcubqirfmrir73ujw47kvna	84	10	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	85	1	12	12	CD
work_4fnqcubqirfmrir73ujw47kvna	85	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	86	1	Rich	Rich	NNP
work_4fnqcubqirfmrir73ujw47kvna	86	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	86	3	K.	K.	NNP
work_4fnqcubqirfmrir73ujw47kvna	86	4	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	86	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	86	6	Y.	Y.	NNP
work_4fnqcubqirfmrir73ujw47kvna	86	7	Zhan	Zhan	NNP
work_4fnqcubqirfmrir73ujw47kvna	86	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	86	9	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	86	10	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	86	11	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	86	12	Blanks	Blanks	NNP
work_4fnqcubqirfmrir73ujw47kvna	86	13	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	87	1	Aberrant	aberrant	JJ
work_4fnqcubqirfmrir73ujw47kvna	87	2	expression	expression	NN
work_4fnqcubqirfmrir73ujw47kvna	87	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	87	4	c	c	NN
work_4fnqcubqirfmrir73ujw47kvna	87	5	-	-	:
work_4fnqcubqirfmrir73ujw47kvna	87	6	Fos	fos	NN
work_4fnqcubqirfmrir73ujw47kvna	87	7	accom-	accom-	JJ
work_4fnqcubqirfmrir73ujw47kvna	87	8	panies	panie	NNS
work_4fnqcubqirfmrir73ujw47kvna	87	9	photoreceptor	photoreceptor	NN
work_4fnqcubqirfmrir73ujw47kvna	87	10	cell	cell	NN
work_4fnqcubqirfmrir73ujw47kvna	87	11	death	death	NN
work_4fnqcubqirfmrir73ujw47kvna	87	12	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	87	13	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	87	14	rd	rd	NNP
work_4fnqcubqirfmrir73ujw47kvna	87	15	Mouse	Mouse	NNP
work_4fnqcubqirfmrir73ujw47kvna	87	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	88	1	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	88	2	Neurobiol	Neurobiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	88	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	89	1	32	32	CD
work_4fnqcubqirfmrir73ujw47kvna	89	2	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	89	3	593–612	593–612	CD
work_4fnqcubqirfmrir73ujw47kvna	89	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	89	5	1997	1997	CD
work_4fnqcubqirfmrir73ujw47kvna	89	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	90	1	13	13	CD
work_4fnqcubqirfmrir73ujw47kvna	90	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	91	1	Susin	Susin	NNP
work_4fnqcubqirfmrir73ujw47kvna	91	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	91	3	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	91	4	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	91	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	91	6	N.	N.	NNP
work_4fnqcubqirfmrir73ujw47kvna	91	7	Zamzami	Zamzami	NNP
work_4fnqcubqirfmrir73ujw47kvna	91	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	91	9	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	91	10	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	91	11	Kroemer	Kroemer	NNP
work_4fnqcubqirfmrir73ujw47kvna	91	12	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	92	1	Mitochondria	Mitochondria	NNP
work_4fnqcubqirfmrir73ujw47kvna	92	2	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	92	3	regulators	regulator	NNS
work_4fnqcubqirfmrir73ujw47kvna	92	4	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	92	5	apoptosis	apoptosis	NN
work_4fnqcubqirfmrir73ujw47kvna	92	6	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	92	7	doubt	doubt	NN
work_4fnqcubqirfmrir73ujw47kvna	92	8	no	no	RB
work_4fnqcubqirfmrir73ujw47kvna	92	9	more	more	JJR
work_4fnqcubqirfmrir73ujw47kvna	92	10	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	93	1	Biochim	Biochim	NNP
work_4fnqcubqirfmrir73ujw47kvna	93	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	94	1	Biophys	Biophys	NNP
work_4fnqcubqirfmrir73ujw47kvna	94	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	95	1	Acta	Acta	NNP
work_4fnqcubqirfmrir73ujw47kvna	95	2	1366	1366	CD
work_4fnqcubqirfmrir73ujw47kvna	95	3	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	95	4	151–165	151–165	CD
work_4fnqcubqirfmrir73ujw47kvna	95	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	95	6	1998	1998	CD
work_4fnqcubqirfmrir73ujw47kvna	95	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	96	1	14	14	CD
work_4fnqcubqirfmrir73ujw47kvna	96	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	97	1	Yoshida	Yoshida	NNP
work_4fnqcubqirfmrir73ujw47kvna	97	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	97	3	K.	K.	NNP
work_4fnqcubqirfmrir73ujw47kvna	97	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	97	5	K.	K.	NNP
work_4fnqcubqirfmrir73ujw47kvna	97	6	Kawamura	Kawamura	NNP
work_4fnqcubqirfmrir73ujw47kvna	97	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	97	8	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	97	9	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	97	10	Imaki	Imaki	NNP
work_4fnqcubqirfmrir73ujw47kvna	97	11	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	98	1	Differential	differential	JJ
work_4fnqcubqirfmrir73ujw47kvna	98	2	expression	expression	NN
work_4fnqcubqirfmrir73ujw47kvna	98	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	98	4	c	c	NN
work_4fnqcubqirfmrir73ujw47kvna	98	5	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	98	6	fos	fos	NN
work_4fnqcubqirfmrir73ujw47kvna	98	7	mRNA	mrna	NN
work_4fnqcubqirfmrir73ujw47kvna	98	8	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	98	9	rat	rat	NNP
work_4fnqcubqirfmrir73ujw47kvna	98	10	retinal	retinal	JJ
work_4fnqcubqirfmrir73ujw47kvna	98	11	cells	cell	NNS
work_4fnqcubqirfmrir73ujw47kvna	98	12	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	98	13	regulation	regulation	NN
work_4fnqcubqirfmrir73ujw47kvna	98	14	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	98	15	light	light	JJ
work_4fnqcubqirfmrir73ujw47kvna	98	16	/	/	SYM
work_4fnqcubqirfmrir73ujw47kvna	98	17	dark	dark	JJ
work_4fnqcubqirfmrir73ujw47kvna	98	18	cycle	cycle	NN
work_4fnqcubqirfmrir73ujw47kvna	98	19	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	99	1	Neuron	Neuron	NNP
work_4fnqcubqirfmrir73ujw47kvna	99	2	10	10	CD
work_4fnqcubqirfmrir73ujw47kvna	99	3	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	99	4	1049–1054	1049–1054	CD
work_4fnqcubqirfmrir73ujw47kvna	99	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	99	6	1993	1993	CD
work_4fnqcubqirfmrir73ujw47kvna	99	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	100	1	15	15	CD
work_4fnqcubqirfmrir73ujw47kvna	100	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	101	1	Zhao	Zhao	NNP
work_4fnqcubqirfmrir73ujw47kvna	101	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	101	3	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	101	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	101	5	Q.	Q.	NNP
work_4fnqcubqirfmrir73ujw47kvna	101	6	Zhou	Zhou	NNP
work_4fnqcubqirfmrir73ujw47kvna	101	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	101	8	T.	T.	NNP
work_4fnqcubqirfmrir73ujw47kvna	101	9	Wiedmer	Wiedmer	NNP
work_4fnqcubqirfmrir73ujw47kvna	101	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	101	11	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	101	12	P.	P.	NNP
work_4fnqcubqirfmrir73ujw47kvna	101	13	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	101	14	Sims	Sims	NNP
work_4fnqcubqirfmrir73ujw47kvna	101	15	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	102	1	Level	level	NN
work_4fnqcubqirfmrir73ujw47kvna	102	2	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	102	3	expression	expression	NN
work_4fnqcubqirfmrir73ujw47kvna	102	4	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	102	5	phos-	phos-	NNP
work_4fnqcubqirfmrir73ujw47kvna	102	6	pholipid	pholipid	NNP
work_4fnqcubqirfmrir73ujw47kvna	102	7	scramblase	scramblase	NNP
work_4fnqcubqirfmrir73ujw47kvna	102	8	regulates	regulate	VBZ
work_4fnqcubqirfmrir73ujw47kvna	102	9	movement	movement	NN
work_4fnqcubqirfmrir73ujw47kvna	102	10	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	102	11	phosphatidylserine	phosphatidylserine	NN
work_4fnqcubqirfmrir73ujw47kvna	102	12	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	102	13	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	102	14	cell	cell	NN
work_4fnqcubqirfmrir73ujw47kvna	102	15	surface	surface	NN
work_4fnqcubqirfmrir73ujw47kvna	102	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	103	1	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	103	2	Biol	Biol	NNP
work_4fnqcubqirfmrir73ujw47kvna	103	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	104	1	Chem	Chem	NNP
work_4fnqcubqirfmrir73ujw47kvna	104	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	105	1	273	273	CD
work_4fnqcubqirfmrir73ujw47kvna	105	2	:	:	SYM
work_4fnqcubqirfmrir73ujw47kvna	105	3	6603–6606	6603–6606	CD
work_4fnqcubqirfmrir73ujw47kvna	105	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	105	5	1998	1998	CD
work_4fnqcubqirfmrir73ujw47kvna	105	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	106	1	Downloaded	download	VBN
work_4fnqcubqirfmrir73ujw47kvna	106	2	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	106	3	journals.physiology.org/journal/physiologyonline	journals.physiology.org/journal/physiologyonline	NN
work_4fnqcubqirfmrir73ujw47kvna	106	4	at	at	IN
work_4fnqcubqirfmrir73ujw47kvna	106	5	Carnegie	Carnegie	NNP
work_4fnqcubqirfmrir73ujw47kvna	106	6	Mellon	Mellon	NNP
work_4fnqcubqirfmrir73ujw47kvna	106	7	Univ	Univ	NNP
work_4fnqcubqirfmrir73ujw47kvna	106	8	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	106	9	128.182.081.034	128.182.081.034	CD
work_4fnqcubqirfmrir73ujw47kvna	106	10	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	106	11	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	106	12	April	April	NNP
work_4fnqcubqirfmrir73ujw47kvna	106	13	5	5	CD
work_4fnqcubqirfmrir73ujw47kvna	106	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	106	15	2021	2021	CD
work_4fnqcubqirfmrir73ujw47kvna	106	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	106	17	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	106	18	vesicles	vesicle	NNS
work_4fnqcubqirfmrir73ujw47kvna	106	19	located	locate	VBN
work_4fnqcubqirfmrir73ujw47kvna	106	20	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	106	21	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	106	22	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	106	23	terminals	terminal	NNS
work_4fnqcubqirfmrir73ujw47kvna	106	24	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	107	1	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	107	2	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	107	3	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	107	4	main	main	JJ
work_4fnqcubqirfmrir73ujw47kvna	107	5	neurotransmitter	neurotransmitter	NN
work_4fnqcubqirfmrir73ujw47kvna	107	6	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	107	7	although	although	IN
work_4fnqcubqirfmrir73ujw47kvna	107	8	neuropeptide	neuropeptide	NNP
work_4fnqcubqirfmrir73ujw47kvna	107	9	Y	Y	NNP
work_4fnqcubqirfmrir73ujw47kvna	107	10	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	107	11	ATP	ATP	NNP
work_4fnqcubqirfmrir73ujw47kvna	107	12	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	107	13	also	also	RB
work_4fnqcubqirfmrir73ujw47kvna	107	14	participate	participate	VB
work_4fnqcubqirfmrir73ujw47kvna	107	15	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	108	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	108	2	amount	amount	NN
work_4fnqcubqirfmrir73ujw47kvna	108	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	108	4	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	108	5	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	108	6	other	other	JJ
work_4fnqcubqirfmrir73ujw47kvna	108	7	neurotransmitters	neurotransmitter	NNS
work_4fnqcubqirfmrir73ujw47kvna	108	8	released	release	VBN
work_4fnqcubqirfmrir73ujw47kvna	108	9	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	108	10	tightly	tightly	RB
work_4fnqcubqirfmrir73ujw47kvna	108	11	regulated	regulate	VBN
work_4fnqcubqirfmrir73ujw47kvna	108	12	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	108	13	negative	negative	JJ
work_4fnqcubqirfmrir73ujw47kvna	108	14	feedback	feedback	NN
work_4fnqcubqirfmrir73ujw47kvna	108	15	mecha-	mecha-	NNP
work_4fnqcubqirfmrir73ujw47kvna	108	16	nisms	nisms	NNP
work_4fnqcubqirfmrir73ujw47kvna	108	17	involving	involve	VBG
work_4fnqcubqirfmrir73ujw47kvna	108	18	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	108	19	neurotransmitter	neurotransmitter	NN
work_4fnqcubqirfmrir73ujw47kvna	108	20	itself	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	108	21	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	108	22	via	via	IN
work_4fnqcubqirfmrir73ujw47kvna	108	23	presynaptic	presynaptic	JJ
work_4fnqcubqirfmrir73ujw47kvna	108	24	α2-adrenergic	α2-adrenergic	NNP
work_4fnqcubqirfmrir73ujw47kvna	108	25	receptors	receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	108	26	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	108	27	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	108	28	but	but	CC
work_4fnqcubqirfmrir73ujw47kvna	108	29	also	also	RB
work_4fnqcubqirfmrir73ujw47kvna	108	30	other	other	JJ
work_4fnqcubqirfmrir73ujw47kvna	108	31	mediators	mediator	NNS
work_4fnqcubqirfmrir73ujw47kvna	108	32	such	such	JJ
work_4fnqcubqirfmrir73ujw47kvna	108	33	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	108	34	adrenaline	adrenaline	NN
work_4fnqcubqirfmrir73ujw47kvna	108	35	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	108	36	serotonin	serotonin	NN
work_4fnqcubqirfmrir73ujw47kvna	108	37	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	108	38	histamine	histamine	NN
work_4fnqcubqirfmrir73ujw47kvna	108	39	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	108	40	acetylcholine	acetylcholine	NN
work_4fnqcubqirfmrir73ujw47kvna	108	41	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	108	42	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	108	43	many	many	JJ
work_4fnqcubqirfmrir73ujw47kvna	108	44	others	other	NNS
work_4fnqcubqirfmrir73ujw47kvna	108	45	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	108	46	Fig	fig	NN
work_4fnqcubqirfmrir73ujw47kvna	108	47	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	109	1	1	1	LS
work_4fnqcubqirfmrir73ujw47kvna	109	2	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	109	3	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	109	4	12	12	CD
work_4fnqcubqirfmrir73ujw47kvna	109	5	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	109	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	110	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	110	2	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	110	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	110	4	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	110	5	at	at	IN
work_4fnqcubqirfmrir73ujw47kvna	110	6	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	110	7	postjunctional	postjunctional	JJ
work_4fnqcubqirfmrir73ujw47kvna	110	8	level	level	NN
work_4fnqcubqirfmrir73ujw47kvna	110	9	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	110	10	i.e.	i.e.	FW
work_4fnqcubqirfmrir73ujw47kvna	110	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	110	12	vascular	vascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	110	13	smooth	smooth	JJ
work_4fnqcubqirfmrir73ujw47kvna	110	14	muscle	muscle	NN
work_4fnqcubqirfmrir73ujw47kvna	110	15	cells	cell	NNS
work_4fnqcubqirfmrir73ujw47kvna	110	16	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	110	17	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	110	18	vessels	vessel	NNS
work_4fnqcubqirfmrir73ujw47kvna	110	19	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	110	20	myocytes	myocyte	NNS
work_4fnqcubqirfmrir73ujw47kvna	110	21	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	110	22	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	110	23	myocardium	myocardium	NN
work_4fnqcubqirfmrir73ujw47kvna	110	24	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	110	25	involve	involve	VBP
work_4fnqcubqirfmrir73ujw47kvna	110	26	β	β	NNP
work_4fnqcubqirfmrir73ujw47kvna	110	27	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	110	28	adrenergic	adrenergic	JJ
work_4fnqcubqirfmrir73ujw47kvna	110	29	receptors	receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	110	30	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	110	31	as	as	RB
work_4fnqcubqirfmrir73ujw47kvna	110	32	well	well	RB
work_4fnqcubqirfmrir73ujw47kvna	110	33	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	110	34	α1-	α1-	NNP
work_4fnqcubqirfmrir73ujw47kvna	110	35	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	110	36	α2-adrenergic	α2-adrenergic	NNP
work_4fnqcubqirfmrir73ujw47kvna	110	37	receptors	receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	110	38	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	111	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	111	2	former	former	JJ
work_4fnqcubqirfmrir73ujw47kvna	111	3	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	111	4	involved	involve	VBN
work_4fnqcubqirfmrir73ujw47kvna	111	5	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	111	6	vasodi-	vasodi-	FW
work_4fnqcubqirfmrir73ujw47kvna	111	7	latation	latation	NN
work_4fnqcubqirfmrir73ujw47kvna	111	8	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	111	9	β2-adrenergic	β2-adrenergic	NNP
work_4fnqcubqirfmrir73ujw47kvna	111	10	receptors	receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	111	11	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	111	12	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	111	13	inotropy	inotropy	NN
work_4fnqcubqirfmrir73ujw47kvna	111	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	111	15	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	111	16	chronotropy	chronotropy	NN
work_4fnqcubqirfmrir73ujw47kvna	111	17	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	111	18	β1-adrenergic	β1-adrenergic	NNP
work_4fnqcubqirfmrir73ujw47kvna	111	19	receptors	receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	111	20	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	111	21	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	111	22	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	111	23	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	111	24	latter	latter	JJ
work_4fnqcubqirfmrir73ujw47kvna	111	25	mediate	mediate	NNP
work_4fnqcubqirfmrir73ujw47kvna	111	26	vasocon-	vasocon-	NNP
work_4fnqcubqirfmrir73ujw47kvna	111	27	striction	striction	NN
work_4fnqcubqirfmrir73ujw47kvna	111	28	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	111	29	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	111	30	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	111	31	vessel	vessel	NN
work_4fnqcubqirfmrir73ujw47kvna	111	32	wall	wall	NNP
work_4fnqcubqirfmrir73ujw47kvna	111	33	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	112	1	Of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	112	2	particular	particular	JJ
work_4fnqcubqirfmrir73ujw47kvna	112	3	interest	interest	NN
work_4fnqcubqirfmrir73ujw47kvna	112	4	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	112	5	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	112	6	fact	fact	NN
work_4fnqcubqirfmrir73ujw47kvna	112	7	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	112	8	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	112	9	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	112	10	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	112	11	very	very	RB
work_4fnqcubqirfmrir73ujw47kvna	112	12	heterogeneous	heterogeneous	JJ
work_4fnqcubqirfmrir73ujw47kvna	112	13	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	112	14	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	112	15	body	body	NN
work_4fnqcubqirfmrir73ujw47kvna	112	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	113	1	Indeed	indeed	RB
work_4fnqcubqirfmrir73ujw47kvna	113	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	113	3	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	113	4	system	system	NN
work_4fnqcubqirfmrir73ujw47kvna	113	5	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	113	6	capable	capable	JJ
work_4fnqcubqirfmrir73ujw47kvna	113	7	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	113	8	activating	activate	VBG
work_4fnqcubqirfmrir73ujw47kvna	113	9	certain	certain	JJ
work_4fnqcubqirfmrir73ujw47kvna	113	10	organs	organ	NNS
work_4fnqcubqirfmrir73ujw47kvna	113	11	but	but	CC
work_4fnqcubqirfmrir73ujw47kvna	113	12	not	not	RB
work_4fnqcubqirfmrir73ujw47kvna	113	13	others	other	NNS
work_4fnqcubqirfmrir73ujw47kvna	113	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	113	15	depending	depend	VBG
work_4fnqcubqirfmrir73ujw47kvna	113	16	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	113	17	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	113	18	pattern	pattern	NN
work_4fnqcubqirfmrir73ujw47kvna	113	19	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	113	20	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	113	21	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	113	22	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	113	23	physiological	physiological	JJ
work_4fnqcubqirfmrir73ujw47kvna	113	24	stimulus	stimulus	NN
work_4fnqcubqirfmrir73ujw47kvna	113	25	involved	involve	VBN
work_4fnqcubqirfmrir73ujw47kvna	113	26	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	114	1	Sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	114	2	fibers	fiber	NNS
work_4fnqcubqirfmrir73ujw47kvna	114	3	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	114	4	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	114	5	peroneal	peroneal	JJ
work_4fnqcubqirfmrir73ujw47kvna	114	6	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	114	7	innervate	innervate	JJ
work_4fnqcubqirfmrir73ujw47kvna	114	8	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	114	9	ves-	ves-	NNS
work_4fnqcubqirfmrir73ujw47kvna	114	10	sels	sel	NNS
work_4fnqcubqirfmrir73ujw47kvna	114	11	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	114	12	muscle	muscle	NN
work_4fnqcubqirfmrir73ujw47kvna	114	13	tissue	tissue	NN
work_4fnqcubqirfmrir73ujw47kvna	114	14	or	or	CC
work_4fnqcubqirfmrir73ujw47kvna	114	15	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	114	16	skin	skin	NN
work_4fnqcubqirfmrir73ujw47kvna	114	17	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	114	18	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	114	19	leg	leg	NN
work_4fnqcubqirfmrir73ujw47kvna	114	20	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	115	1	Electrical	electrical	JJ
work_4fnqcubqirfmrir73ujw47kvna	115	2	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	115	3	within	within	IN
work_4fnqcubqirfmrir73ujw47kvna	115	4	muscle	muscle	NN
work_4fnqcubqirfmrir73ujw47kvna	115	5	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	115	6	skin	skin	NN
work_4fnqcubqirfmrir73ujw47kvna	115	7	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	115	8	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	115	9	fibers	fiber	NNS
work_4fnqcubqirfmrir73ujw47kvna	115	10	can	can	MD
work_4fnqcubqirfmrir73ujw47kvna	115	11	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	115	12	iden-	iden-	NNP
work_4fnqcubqirfmrir73ujw47kvna	115	13	tified	tifie	VBN
work_4fnqcubqirfmrir73ujw47kvna	115	14	according	accord	VBG
work_4fnqcubqirfmrir73ujw47kvna	115	15	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	115	16	its	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	115	17	characteristic	characteristic	JJ
work_4fnqcubqirfmrir73ujw47kvna	115	18	pattern	pattern	NN
work_4fnqcubqirfmrir73ujw47kvna	115	19	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	116	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	116	2	neurogram	neurogram	NN
work_4fnqcubqirfmrir73ujw47kvna	116	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	116	4	muscle	muscle	NN
work_4fnqcubqirfmrir73ujw47kvna	116	5	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	116	6	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	116	7	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	116	8	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	116	9	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	116	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	116	11	which	which	WDT
work_4fnqcubqirfmrir73ujw47kvna	116	12	significantly	significantly	RB
work_4fnqcubqirfmrir73ujw47kvna	116	13	con-	con-	VBP
work_4fnqcubqirfmrir73ujw47kvna	116	14	tributes	tribute	VBZ
work_4fnqcubqirfmrir73ujw47kvna	116	15	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	116	16	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	116	17	regulation	regulation	NN
work_4fnqcubqirfmrir73ujw47kvna	116	18	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	116	19	peripheral	peripheral	JJ
work_4fnqcubqirfmrir73ujw47kvna	116	20	vascular	vascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	116	21	resistance	resistance	NN
work_4fnqcubqirfmrir73ujw47kvna	116	22	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	116	23	reveals	reveal	VBZ
work_4fnqcubqirfmrir73ujw47kvna	116	24	spontaneous	spontaneous	JJ
work_4fnqcubqirfmrir73ujw47kvna	116	25	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	116	26	intermittent	intermittent	JJ
work_4fnqcubqirfmrir73ujw47kvna	116	27	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	116	28	pulse	pulse	NN
work_4fnqcubqirfmrir73ujw47kvna	116	29	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	116	30	synchronous	synchronous	JJ
work_4fnqcubqirfmrir73ujw47kvna	116	31	sympa-	sympa-	NN
work_4fnqcubqirfmrir73ujw47kvna	116	32	thetic	thetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	116	33	bursts	burst	NNS
work_4fnqcubqirfmrir73ujw47kvna	116	34	that	that	WDT
work_4fnqcubqirfmrir73ujw47kvna	116	35	increase	increase	VBP
work_4fnqcubqirfmrir73ujw47kvna	116	36	during	during	IN
work_4fnqcubqirfmrir73ujw47kvna	116	37	apnea	apnea	NNP
work_4fnqcubqirfmrir73ujw47kvna	116	38	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	117	1	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	117	2	can	can	MD
work_4fnqcubqirfmrir73ujw47kvna	117	3	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	117	4	stimu-	stimu-	NN
work_4fnqcubqirfmrir73ujw47kvna	117	5	lated	late	VBN
work_4fnqcubqirfmrir73ujw47kvna	117	6	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	117	7	different	different	JJ
work_4fnqcubqirfmrir73ujw47kvna	117	8	maneuvers	maneuver	NNS
work_4fnqcubqirfmrir73ujw47kvna	117	9	such	such	JJ
work_4fnqcubqirfmrir73ujw47kvna	117	10	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	117	11	physical	physical	JJ
work_4fnqcubqirfmrir73ujw47kvna	117	12	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	117	13	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	117	14	mental	mental	JJ
work_4fnqcubqirfmrir73ujw47kvna	117	15	stress	stress	NN
work_4fnqcubqirfmrir73ujw47kvna	117	16	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	117	17	hypoxia	hypoxia	NNP
work_4fnqcubqirfmrir73ujw47kvna	117	18	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	117	19	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	117	20	unloading	unloading	NN
work_4fnqcubqirfmrir73ujw47kvna	117	21	baroreceptors	baroreceptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	117	22	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	118	1	During	during	IN
work_4fnqcubqirfmrir73ujw47kvna	118	2	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	118	3	cold	cold	JJ
work_4fnqcubqirfmrir73ujw47kvna	118	4	pressor	pressor	NN
work_4fnqcubqirfmrir73ujw47kvna	118	5	test	test	NN
work_4fnqcubqirfmrir73ujw47kvna	118	6	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	118	7	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	118	8	massive	massive	JJ
work_4fnqcubqirfmrir73ujw47kvna	118	9	increase	increase	NN
work_4fnqcubqirfmrir73ujw47kvna	118	10	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	118	11	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	118	12	occurs	occur	VBZ
work_4fnqcubqirfmrir73ujw47kvna	118	13	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	118	14	3	3	CD
work_4fnqcubqirfmrir73ujw47kvna	118	15	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	118	16	13	13	CD
work_4fnqcubqirfmrir73ujw47kvna	118	17	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	118	18	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	119	1	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	119	2	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	119	3	cardiovascular	cardiovascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	119	4	disease	disease	NN
work_4fnqcubqirfmrir73ujw47kvna	119	5	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	119	6	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	119	7	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	119	8	fibers	fiber	NNS
work_4fnqcubqirfmrir73ujw47kvna	119	9	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	119	10	ubiquitously	ubiquitously	RB
work_4fnqcubqirfmrir73ujw47kvna	119	11	distributed	distribute	VBN
work_4fnqcubqirfmrir73ujw47kvna	119	12	within	within	IN
work_4fnqcubqirfmrir73ujw47kvna	119	13	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	119	14	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	119	15	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	119	16	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	119	17	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	119	18	vessels	vessel	NNS
work_4fnqcubqirfmrir73ujw47kvna	119	19	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	119	20	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	119	21	kidney	kidney	NN
work_4fnqcubqirfmrir73ujw47kvna	119	22	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	119	23	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	119	24	major	major	JJ
work_4fnqcubqirfmrir73ujw47kvna	119	25	peripheral	peripheral	JJ
work_4fnqcubqirfmrir73ujw47kvna	119	26	baroreceptor	baroreceptor	NN
work_4fnqcubqirfmrir73ujw47kvna	119	27	sites	site	NNS
work_4fnqcubqirfmrir73ujw47kvna	119	28	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	119	29	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	119	30	finding	finding	NN
work_4fnqcubqirfmrir73ujw47kvna	119	31	that	that	WDT
work_4fnqcubqirfmrir73ujw47kvna	119	32	suggests	suggest	VBZ
work_4fnqcubqirfmrir73ujw47kvna	119	33	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	119	34	direct	direct	JJ
work_4fnqcubqirfmrir73ujw47kvna	119	35	effect	effect	NN
work_4fnqcubqirfmrir73ujw47kvna	119	36	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	119	37	fluid	fluid	JJ
work_4fnqcubqirfmrir73ujw47kvna	119	38	control	control	NN
work_4fnqcubqirfmrir73ujw47kvna	119	39	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	119	40	cardiac	cardiac	JJ
work_4fnqcubqirfmrir73ujw47kvna	119	41	output	output	NN
work_4fnqcubqirfmrir73ujw47kvna	119	42	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	119	43	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	119	44	peripheral	peripheral	JJ
work_4fnqcubqirfmrir73ujw47kvna	119	45	vascu-	vascu-	NN
work_4fnqcubqirfmrir73ujw47kvna	119	46	lar	lar	NN
work_4fnqcubqirfmrir73ujw47kvna	119	47	resistances	resistance	NNS
work_4fnqcubqirfmrir73ujw47kvna	119	48	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	120	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	120	2	fact	fact	NN
work_4fnqcubqirfmrir73ujw47kvna	120	3	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	120	4	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	120	5	significantly	significantly	RB
work_4fnqcubqirfmrir73ujw47kvna	120	6	regulates	regulate	VBZ
work_4fnqcubqirfmrir73ujw47kvna	120	7	cardiovas-	cardiovas-	NNP
work_4fnqcubqirfmrir73ujw47kvna	120	8	cular	cular	JJ
work_4fnqcubqirfmrir73ujw47kvna	120	9	homeostasis	homeostasis	NN
work_4fnqcubqirfmrir73ujw47kvna	120	10	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	120	11	11	11	CD
work_4fnqcubqirfmrir73ujw47kvna	120	12	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	120	13	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	120	14	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	120	15	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	120	16	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	120	17	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	120	18	altered	alter	VBN
work_4fnqcubqirfmrir73ujw47kvna	120	19	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	120	20	various	various	JJ
work_4fnqcubqirfmrir73ujw47kvna	120	21	forms	form	NNS
work_4fnqcubqirfmrir73ujw47kvna	120	22	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	120	23	cardiovascular	cardiovascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	120	24	disease	disease	NN
work_4fnqcubqirfmrir73ujw47kvna	120	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	121	1	Activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	121	2	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	121	3	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	121	4	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	121	5	plays	play	VBZ
work_4fnqcubqirfmrir73ujw47kvna	121	6	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	121	7	important	important	JJ
work_4fnqcubqirfmrir73ujw47kvna	121	8	role	role	NN
work_4fnqcubqirfmrir73ujw47kvna	121	9	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	121	10	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	121	11	pathophysiology	pathophysiology	NN
work_4fnqcubqirfmrir73ujw47kvna	121	12	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	121	13	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	121	14	prognosis	prognosis	NN
work_4fnqcubqirfmrir73ujw47kvna	121	15	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	121	16	cardiovascular	cardiovascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	121	17	disease	disease	NN
work_4fnqcubqirfmrir73ujw47kvna	121	18	such	such	JJ
work_4fnqcubqirfmrir73ujw47kvna	121	19	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	121	20	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	121	21	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	121	22	ischemic	ischemic	JJ
work_4fnqcubqirfmrir73ujw47kvna	121	23	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	121	24	disease	disease	NN
work_4fnqcubqirfmrir73ujw47kvna	121	25	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	121	26	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	121	27	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	121	28	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	121	29	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	122	1	Hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	122	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	123	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	123	2	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	123	3	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	123	4	hyperactivity	hyperactivity	NN
work_4fnqcubqirfmrir73ujw47kvna	123	5	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	123	6	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	123	7	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	123	8	was	be	VBD
work_4fnqcubqirfmrir73ujw47kvna	123	9	postulated	postulate	VBN
work_4fnqcubqirfmrir73ujw47kvna	123	10	decades	decade	NNS
work_4fnqcubqirfmrir73ujw47kvna	123	11	ago	ago	RB
work_4fnqcubqirfmrir73ujw47kvna	123	12	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	124	1	It	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	124	2	has	have	VBZ
work_4fnqcubqirfmrir73ujw47kvna	124	3	been	be	VBN
work_4fnqcubqirfmrir73ujw47kvna	124	4	demonstrated	demonstrate	VBN
work_4fnqcubqirfmrir73ujw47kvna	124	5	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	124	6	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	124	7	partic-	partic-	NN
work_4fnqcubqirfmrir73ujw47kvna	124	8	ularly	ularly	RB
work_4fnqcubqirfmrir73ujw47kvna	124	9	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	124	10	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	124	11	early	early	JJ
work_4fnqcubqirfmrir73ujw47kvna	124	12	phases	phase	NNS
work_4fnqcubqirfmrir73ujw47kvna	124	13	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	124	14	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	124	15	hypertensive	hypertensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	124	16	process	process	NN
work_4fnqcubqirfmrir73ujw47kvna	124	17	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	124	18	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	124	19	sym-	sym-	JJ
work_4fnqcubqirfmrir73ujw47kvna	124	20	pathetic	pathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	124	21	drive	drive	NN
work_4fnqcubqirfmrir73ujw47kvna	124	22	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	124	23	increased	increase	VBN
work_4fnqcubqirfmrir73ujw47kvna	124	24	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	125	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	125	2	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	125	3	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	125	4	borderline	borderline	NN
work_4fnqcubqirfmrir73ujw47kvna	125	5	or	or	CC
work_4fnqcubqirfmrir73ujw47kvna	125	6	mild	mild	JJ
work_4fnqcubqirfmrir73ujw47kvna	125	7	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	125	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	125	9	increased	increase	VBD
work_4fnqcubqirfmrir73ujw47kvna	125	10	cardiac	cardiac	JJ
work_4fnqcubqirfmrir73ujw47kvna	125	11	β	β	NN
work_4fnqcubqirfmrir73ujw47kvna	125	12	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	125	13	adrenergic	adrenergic	NNP
work_4fnqcubqirfmrir73ujw47kvna	125	14	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	125	15	vascular	vascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	125	16	α-	α-	XX
work_4fnqcubqirfmrir73ujw47kvna	125	17	adrenergic	adrenergic	JJ
work_4fnqcubqirfmrir73ujw47kvna	125	18	drive	drive	NN
work_4fnqcubqirfmrir73ujw47kvna	125	19	has	have	VBZ
work_4fnqcubqirfmrir73ujw47kvna	125	20	been	be	VBN
work_4fnqcubqirfmrir73ujw47kvna	125	21	documented	document	VBN
work_4fnqcubqirfmrir73ujw47kvna	125	22	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	125	23	selective	selective	JJ
work_4fnqcubqirfmrir73ujw47kvna	125	24	receptor	receptor	NN
work_4fnqcubqirfmrir73ujw47kvna	125	25	blockade	blockade	NN
work_4fnqcubqirfmrir73ujw47kvna	125	26	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	126	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	126	2	evidence	evidence	NN
work_4fnqcubqirfmrir73ujw47kvna	126	3	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	126	4	pharmacological	pharmacological	JJ
work_4fnqcubqirfmrir73ujw47kvna	126	5	studies	study	NNS
work_4fnqcubqirfmrir73ujw47kvna	126	6	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	126	7	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	126	8	line	line	NN
work_4fnqcubqirfmrir73ujw47kvna	126	9	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	126	10	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	126	11	slightly	slightly	RB
work_4fnqcubqirfmrir73ujw47kvna	126	12	increased	increase	VBN
work_4fnqcubqirfmrir73ujw47kvna	126	13	plasma	plasma	NN
work_4fnqcubqirfmrir73ujw47kvna	126	14	levels	level	NNS
work_4fnqcubqirfmrir73ujw47kvna	126	15	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	126	16	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	126	17	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	126	18	young	young	JJ
work_4fnqcubqirfmrir73ujw47kvna	126	19	sub-	sub-	JJ
work_4fnqcubqirfmrir73ujw47kvna	126	20	jects	ject	NNS
work_4fnqcubqirfmrir73ujw47kvna	126	21	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	126	22	mild	mild	JJ
work_4fnqcubqirfmrir73ujw47kvna	126	23	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	126	24	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	127	1	These	these	DT
work_4fnqcubqirfmrir73ujw47kvna	127	2	findings	finding	NNS
work_4fnqcubqirfmrir73ujw47kvna	127	3	were	be	VBD
work_4fnqcubqirfmrir73ujw47kvna	127	4	confirmed	confirm	VBN
work_4fnqcubqirfmrir73ujw47kvna	127	5	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	127	6	experiments	experiment	NNS
work_4fnqcubqirfmrir73ujw47kvna	127	7	that	that	WDT
work_4fnqcubqirfmrir73ujw47kvna	127	8	showed	show	VBD
work_4fnqcubqirfmrir73ujw47kvna	127	9	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	127	10	increase	increase	NN
work_4fnqcubqirfmrir73ujw47kvna	127	11	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	127	12	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	127	13	spillover	spillover	NN
work_4fnqcubqirfmrir73ujw47kvna	127	14	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	127	15	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	127	16	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	127	17	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	127	18	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	127	19	kidney	kidney	NN
work_4fnqcubqirfmrir73ujw47kvna	127	20	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	127	21	hypertensives	hypertensive	NNS
work_4fnqcubqirfmrir73ujw47kvna	127	22	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	127	23	particular	particular	JJ
work_4fnqcubqirfmrir73ujw47kvna	127	24	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	128	1	Further-	Further-	NNP
work_4fnqcubqirfmrir73ujw47kvna	128	2	more	more	RBR
work_4fnqcubqirfmrir73ujw47kvna	128	3	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	128	4	using	use	VBG
work_4fnqcubqirfmrir73ujw47kvna	128	5	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	128	6	technique	technique	NN
work_4fnqcubqirfmrir73ujw47kvna	128	7	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	128	8	microneurography	microneurography	NN
work_4fnqcubqirfmrir73ujw47kvna	128	9	it	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	128	10	has	have	VBZ
work_4fnqcubqirfmrir73ujw47kvna	128	11	been	be	VBN
work_4fnqcubqirfmrir73ujw47kvna	128	12	clearly	clearly	RB
work_4fnqcubqirfmrir73ujw47kvna	128	13	demonstrated	demonstrate	VBN
work_4fnqcubqirfmrir73ujw47kvna	128	14	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	128	15	resting	rest	VBG
work_4fnqcubqirfmrir73ujw47kvna	128	16	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	128	17	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	128	18	increased	increase	VBN
work_4fnqcubqirfmrir73ujw47kvna	128	19	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	128	20	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	128	21	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	128	22	borderline	borderline	NN
work_4fnqcubqirfmrir73ujw47kvna	128	23	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	128	24	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	128	25	1	1	CD
work_4fnqcubqirfmrir73ujw47kvna	128	26	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	128	27	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	129	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	129	2	addition	addition	NN
work_4fnqcubqirfmrir73ujw47kvna	129	3	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	129	4	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	129	5	exaggerated	exaggerated	JJ
work_4fnqcubqirfmrir73ujw47kvna	129	6	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	129	7	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	129	8	response	response	NN
work_4fnqcubqirfmrir73ujw47kvna	129	9	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	129	10	mental	mental	JJ
work_4fnqcubqirfmrir73ujw47kvna	129	11	stress	stress	NN
work_4fnqcubqirfmrir73ujw47kvna	129	12	has	have	VBZ
work_4fnqcubqirfmrir73ujw47kvna	129	13	been	be	VBN
work_4fnqcubqirfmrir73ujw47kvna	129	14	demon-	demon-	NN
work_4fnqcubqirfmrir73ujw47kvna	129	15	strated	strate	VBN
work_4fnqcubqirfmrir73ujw47kvna	129	16	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	129	17	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	129	18	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	129	19	essential	essential	JJ
work_4fnqcubqirfmrir73ujw47kvna	129	20	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	129	21	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	130	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	130	2	normotensive	normotensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	130	3	offspring	offspring	NN
work_4fnqcubqirfmrir73ujw47kvna	130	4	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	130	5	hypertensive	hypertensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	130	6	parents	parent	NNS
work_4fnqcubqirfmrir73ujw47kvna	130	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	130	8	we	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	130	9	found	find	VBD
work_4fnqcubqirfmrir73ujw47kvna	130	10	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	130	11	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	130	12	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	130	13	response	response	NN
work_4fnqcubqirfmrir73ujw47kvna	130	14	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	130	15	mental	mental	JJ
work_4fnqcubqirfmrir73ujw47kvna	130	16	stress	stress	NN
work_4fnqcubqirfmrir73ujw47kvna	130	17	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	130	18	more	more	RBR
work_4fnqcubqirfmrir73ujw47kvna	130	19	pronounced	pronounced	JJ
work_4fnqcubqirfmrir73ujw47kvna	130	20	than	than	IN
work_4fnqcubqirfmrir73ujw47kvna	130	21	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	130	22	offspring	offspre	VBG
work_4fnqcubqirfmrir73ujw47kvna	130	23	News	News	NNP
work_4fnqcubqirfmrir73ujw47kvna	130	24	Physiol	Physiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	130	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	131	1	Sci	Sci	NNP
work_4fnqcubqirfmrir73ujw47kvna	131	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	132	1	•	•	NNP
work_4fnqcubqirfmrir73ujw47kvna	132	2	Volume	volume	NN
work_4fnqcubqirfmrir73ujw47kvna	132	3	15	15	CD
work_4fnqcubqirfmrir73ujw47kvna	132	4	•	•	NNP
work_4fnqcubqirfmrir73ujw47kvna	132	5	June	June	NNP
work_4fnqcubqirfmrir73ujw47kvna	132	6	2000126	2000126	CD
work_4fnqcubqirfmrir73ujw47kvna	132	7	FIGURE	FIGURE	NNP
work_4fnqcubqirfmrir73ujw47kvna	132	8	1	1	CD
work_4fnqcubqirfmrir73ujw47kvna	132	9	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	133	1	Regulation	regulation	NN
work_4fnqcubqirfmrir73ujw47kvna	133	2	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	133	3	vascular	vascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	133	4	smooth	smooth	JJ
work_4fnqcubqirfmrir73ujw47kvna	133	5	muscle	muscle	NN
work_4fnqcubqirfmrir73ujw47kvna	133	6	cell	cell	NN
work_4fnqcubqirfmrir73ujw47kvna	133	7	tone	tone	NN
work_4fnqcubqirfmrir73ujw47kvna	133	8	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	133	9	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	133	10	nervous	nervous	JJ
work_4fnqcubqirfmrir73ujw47kvna	133	11	system	system	NN
work_4fnqcubqirfmrir73ujw47kvna	133	12	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	133	13	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	133	14	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	133	15	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	134	1	Release	release	NN
work_4fnqcubqirfmrir73ujw47kvna	134	2	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	134	3	neurotransmitters	neurotransmitter	NNS
work_4fnqcubqirfmrir73ujw47kvna	134	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	134	5	norepinephrine	norepinephrine	NN
work_4fnqcubqirfmrir73ujw47kvna	134	6	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	134	7	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	134	8	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	134	9	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	134	10	neuropep-	neuropep-	CC
work_4fnqcubqirfmrir73ujw47kvna	134	11	tide	tide	NNP
work_4fnqcubqirfmrir73ujw47kvna	134	12	Y	Y	NNP
work_4fnqcubqirfmrir73ujw47kvna	134	13	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	134	14	NPY	NPY	NNP
work_4fnqcubqirfmrir73ujw47kvna	134	15	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	134	16	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	134	17	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	134	18	ATP	atp	NN
work_4fnqcubqirfmrir73ujw47kvna	134	19	at	at	IN
work_4fnqcubqirfmrir73ujw47kvna	134	20	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	134	21	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	134	22	endings	ending	NNS
work_4fnqcubqirfmrir73ujw47kvna	134	23	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	134	24	influenced	influence	VBN
work_4fnqcubqirfmrir73ujw47kvna	134	25	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	134	26	several	several	JJ
work_4fnqcubqirfmrir73ujw47kvna	134	27	substances	substance	NNS
work_4fnqcubqirfmrir73ujw47kvna	134	28	acting	act	VBG
work_4fnqcubqirfmrir73ujw47kvna	134	29	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	134	30	presynaptic	presynaptic	JJ
work_4fnqcubqirfmrir73ujw47kvna	134	31	receptors	receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	134	32	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	135	1	Thus	thus	RB
work_4fnqcubqirfmrir73ujw47kvna	135	2	acetylcholine	acetylcholine	VB
work_4fnqcubqirfmrir73ujw47kvna	135	3	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	135	4	ACh	ACh	NNP
work_4fnqcubqirfmrir73ujw47kvna	135	5	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	135	6	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	135	7	histamine	histamine	NN
work_4fnqcubqirfmrir73ujw47kvna	135	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	135	9	sero-	sero-	NN
work_4fnqcubqirfmrir73ujw47kvna	135	10	tonin	tonin	NN
work_4fnqcubqirfmrir73ujw47kvna	135	11	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	135	12	5-HT	5-ht	CD
work_4fnqcubqirfmrir73ujw47kvna	135	13	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	135	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	135	15	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	135	16	dopamine	dopamine	NN
work_4fnqcubqirfmrir73ujw47kvna	135	17	can	can	MD
work_4fnqcubqirfmrir73ujw47kvna	135	18	inhibit	inhibit	VB
work_4fnqcubqirfmrir73ujw47kvna	135	19	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	135	20	–	–	:
work_4fnqcubqirfmrir73ujw47kvna	135	21	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	135	22	release	release	NN
work_4fnqcubqirfmrir73ujw47kvna	135	23	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	135	24	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	135	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	136	1	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	136	2	itself	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	136	3	can	can	MD
work_4fnqcubqirfmrir73ujw47kvna	136	4	inhibit	inhibit	VB
work_4fnqcubqirfmrir73ujw47kvna	136	5	its	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	136	6	release	release	NN
work_4fnqcubqirfmrir73ujw47kvna	136	7	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	136	8	acting	act	VBG
work_4fnqcubqirfmrir73ujw47kvna	136	9	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	136	10	presynaptic	presynaptic	JJ
work_4fnqcubqirfmrir73ujw47kvna	136	11	α2-receptors	α2-receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	136	12	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	137	1	Vasoactive	vasoactive	JJ
work_4fnqcubqirfmrir73ujw47kvna	137	2	substances	substance	NNS
work_4fnqcubqirfmrir73ujw47kvna	137	3	such	such	JJ
work_4fnqcubqirfmrir73ujw47kvna	137	4	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	137	5	epi-	epi-	IN
work_4fnqcubqirfmrir73ujw47kvna	137	6	nephrine	nephrine	NNP
work_4fnqcubqirfmrir73ujw47kvna	137	7	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	137	8	angiotensin	angiotensin	NNP
work_4fnqcubqirfmrir73ujw47kvna	137	9	II	II	NNP
work_4fnqcubqirfmrir73ujw47kvna	137	10	can	can	MD
work_4fnqcubqirfmrir73ujw47kvna	137	11	increase	increase	VB
work_4fnqcubqirfmrir73ujw47kvna	137	12	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	137	13	+	+	NFP
work_4fnqcubqirfmrir73ujw47kvna	137	14	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	137	15	release	release	NN
work_4fnqcubqirfmrir73ujw47kvna	137	16	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	137	17	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	137	18	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	137	19	activating	activate	VBG
work_4fnqcubqirfmrir73ujw47kvna	137	20	presynaptic	presynaptic	JJ
work_4fnqcubqirfmrir73ujw47kvna	137	21	receptors	receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	137	22	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	138	1	On	on	IN
work_4fnqcubqirfmrir73ujw47kvna	138	2	smooth	smooth	JJ
work_4fnqcubqirfmrir73ujw47kvna	138	3	muscle	muscle	NN
work_4fnqcubqirfmrir73ujw47kvna	138	4	cells	cell	NNS
work_4fnqcubqirfmrir73ujw47kvna	138	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	138	6	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	138	7	can	can	MD
work_4fnqcubqirfmrir73ujw47kvna	138	8	stimulate	stimulate	VB
work_4fnqcubqirfmrir73ujw47kvna	138	9	α1-receptors	α1-receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	138	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	138	11	causing	cause	VBG
work_4fnqcubqirfmrir73ujw47kvna	138	12	contraction	contraction	NN
work_4fnqcubqirfmrir73ujw47kvna	138	13	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	138	14	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	138	15	α2-receptors	α2-receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	138	16	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	138	17	causing	cause	VBG
work_4fnqcubqirfmrir73ujw47kvna	138	18	relaxation	relaxation	NN
work_4fnqcubqirfmrir73ujw47kvna	138	19	;	;	:
work_4fnqcubqirfmrir73ujw47kvna	138	20	ATP	atp	NN
work_4fnqcubqirfmrir73ujw47kvna	138	21	acting	act	VBG
work_4fnqcubqirfmrir73ujw47kvna	138	22	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	138	23	P	p	NN
work_4fnqcubqirfmrir73ujw47kvna	138	24	receptors	receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	138	25	induces	induce	NNS
work_4fnqcubqirfmrir73ujw47kvna	138	26	relaxation	relaxation	NN
work_4fnqcubqirfmrir73ujw47kvna	138	27	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	138	28	whereas	whereas	IN
work_4fnqcubqirfmrir73ujw47kvna	138	29	NPY	NPY	NNP
work_4fnqcubqirfmrir73ujw47kvna	138	30	can	can	MD
work_4fnqcubqirfmrir73ujw47kvna	138	31	induce	induce	VB
work_4fnqcubqirfmrir73ujw47kvna	138	32	constriction	constriction	NN
work_4fnqcubqirfmrir73ujw47kvna	138	33	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	139	1	Downloaded	download	VBN
work_4fnqcubqirfmrir73ujw47kvna	139	2	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	139	3	journals.physiology.org/journal/physiologyonline	journals.physiology.org/journal/physiologyonline	NN
work_4fnqcubqirfmrir73ujw47kvna	139	4	at	at	IN
work_4fnqcubqirfmrir73ujw47kvna	139	5	Carnegie	Carnegie	NNP
work_4fnqcubqirfmrir73ujw47kvna	139	6	Mellon	Mellon	NNP
work_4fnqcubqirfmrir73ujw47kvna	139	7	Univ	Univ	NNP
work_4fnqcubqirfmrir73ujw47kvna	139	8	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	139	9	128.182.081.034	128.182.081.034	CD
work_4fnqcubqirfmrir73ujw47kvna	139	10	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	139	11	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	139	12	April	April	NNP
work_4fnqcubqirfmrir73ujw47kvna	139	13	5	5	CD
work_4fnqcubqirfmrir73ujw47kvna	139	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	139	15	2021	2021	CD
work_4fnqcubqirfmrir73ujw47kvna	139	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	139	17	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	139	18	normotensive	normotensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	139	19	parents	parent	NNS
work_4fnqcubqirfmrir73ujw47kvna	139	20	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	139	21	but	but	CC
work_4fnqcubqirfmrir73ujw47kvna	139	22	resting	rest	VBG
work_4fnqcubqirfmrir73ujw47kvna	139	23	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	139	24	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	139	25	comparable	comparable	JJ
work_4fnqcubqirfmrir73ujw47kvna	139	26	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	139	27	Fig	fig	NN
work_4fnqcubqirfmrir73ujw47kvna	139	28	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	140	1	2	2	LS
work_4fnqcubqirfmrir73ujw47kvna	140	2	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	140	3	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	140	4	9	9	CD
work_4fnqcubqirfmrir73ujw47kvna	140	5	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	140	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	141	1	Thus	thus	RB
work_4fnqcubqirfmrir73ujw47kvna	141	2	it	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	141	3	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	141	4	now	now	RB
work_4fnqcubqirfmrir73ujw47kvna	141	5	clear	clear	JJ
work_4fnqcubqirfmrir73ujw47kvna	141	6	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	141	7	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	141	8	offspring	offspring	NN
work_4fnqcubqirfmrir73ujw47kvna	141	9	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	141	10	hypertensive	hypertensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	141	11	par-	par-	NN
work_4fnqcubqirfmrir73ujw47kvna	141	12	ents	ent	NNS
work_4fnqcubqirfmrir73ujw47kvna	141	13	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	141	14	which	which	WDT
work_4fnqcubqirfmrir73ujw47kvna	141	15	resting	rest	VBG
work_4fnqcubqirfmrir73ujw47kvna	141	16	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	141	17	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	141	18	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	141	19	still	still	RB
work_4fnqcubqirfmrir73ujw47kvna	141	20	normal	normal	JJ
work_4fnqcubqirfmrir73ujw47kvna	141	21	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	141	22	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	141	23	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	141	24	abnormally	abnormally	RB
work_4fnqcubqirfmrir73ujw47kvna	141	25	stimulated	stimulate	VBN
work_4fnqcubqirfmrir73ujw47kvna	141	26	during	during	IN
work_4fnqcubqirfmrir73ujw47kvna	141	27	mental	mental	JJ
work_4fnqcubqirfmrir73ujw47kvna	141	28	stress	stress	NN
work_4fnqcubqirfmrir73ujw47kvna	141	29	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	141	30	9	9	CD
work_4fnqcubqirfmrir73ujw47kvna	141	31	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	141	32	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	142	1	It	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	142	2	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	142	3	possible	possible	JJ
work_4fnqcubqirfmrir73ujw47kvna	142	4	that	that	RB
work_4fnqcubqirfmrir73ujw47kvna	142	5	early	early	RB
work_4fnqcubqirfmrir73ujw47kvna	142	6	on	on	RB
work_4fnqcubqirfmrir73ujw47kvna	142	7	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	142	8	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	142	9	disease	disease	NN
work_4fnqcubqirfmrir73ujw47kvna	142	10	process	process	NN
work_4fnqcubqirfmrir73ujw47kvna	142	11	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	142	12	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	142	13	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	142	14	only	only	RB
work_4fnqcubqirfmrir73ujw47kvna	142	15	activated	activate	VBN
work_4fnqcubqirfmrir73ujw47kvna	142	16	abnormally	abnormally	RB
work_4fnqcubqirfmrir73ujw47kvna	142	17	during	during	IN
work_4fnqcubqirfmrir73ujw47kvna	142	18	episodes	episode	NNS
work_4fnqcubqirfmrir73ujw47kvna	142	19	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	142	20	increased	increase	VBN
work_4fnqcubqirfmrir73ujw47kvna	142	21	stress	stress	NN
work_4fnqcubqirfmrir73ujw47kvna	142	22	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	142	23	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	142	24	resting	rest	VBG
work_4fnqcubqirfmrir73ujw47kvna	142	25	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	142	26	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	142	27	increased	increase	VBN
work_4fnqcubqirfmrir73ujw47kvna	142	28	during	during	IN
work_4fnqcubqirfmrir73ujw47kvna	142	29	development	development	NN
work_4fnqcubqirfmrir73ujw47kvna	142	30	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	142	31	high	high	JJ
work_4fnqcubqirfmrir73ujw47kvna	142	32	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	142	33	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	142	34	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	142	35	whereas	whereas	IN
work_4fnqcubqirfmrir73ujw47kvna	142	36	at	at	IN
work_4fnqcubqirfmrir73ujw47kvna	142	37	later	later	JJ
work_4fnqcubqirfmrir73ujw47kvna	142	38	stages	stage	NNS
work_4fnqcubqirfmrir73ujw47kvna	142	39	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	142	40	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	142	41	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	142	42	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	142	43	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	142	44	again	again	RB
work_4fnqcubqirfmrir73ujw47kvna	142	45	become	become	VB
work_4fnqcubqirfmrir73ujw47kvna	142	46	normal	normal	JJ
work_4fnqcubqirfmrir73ujw47kvna	142	47	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	142	48	although	although	IN
work_4fnqcubqirfmrir73ujw47kvna	142	49	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	142	50	values	value	NNS
work_4fnqcubqirfmrir73ujw47kvna	142	51	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	142	52	still	still	RB
work_4fnqcubqirfmrir73ujw47kvna	142	53	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	142	54	too	too	RB
work_4fnqcubqirfmrir73ujw47kvna	142	55	high	high	JJ
work_4fnqcubqirfmrir73ujw47kvna	142	56	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	142	57	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	142	58	level	level	NN
work_4fnqcubqirfmrir73ujw47kvna	142	59	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	142	60	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	142	61	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	142	62	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	142	63	these	these	DT
work_4fnqcubqirfmrir73ujw47kvna	142	64	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	142	65	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	143	1	Coronary	coronary	JJ
work_4fnqcubqirfmrir73ujw47kvna	143	2	artery	artery	NN
work_4fnqcubqirfmrir73ujw47kvna	143	3	disease	disease	NN
work_4fnqcubqirfmrir73ujw47kvna	143	4	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	144	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	144	2	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	144	3	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	144	4	coronary	coronary	JJ
work_4fnqcubqirfmrir73ujw47kvna	144	5	artery	artery	NN
work_4fnqcubqirfmrir73ujw47kvna	144	6	disease	disease	NN
work_4fnqcubqirfmrir73ujw47kvna	144	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	144	8	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	144	9	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	144	10	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	144	11	its	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	144	12	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	144	13	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	144	14	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	144	15	important	important	JJ
work_4fnqcubqirfmrir73ujw47kvna	144	16	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	144	17	triggers	trigger	NNS
work_4fnqcubqirfmrir73ujw47kvna	144	18	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	144	19	acute	acute	JJ
work_4fnqcubqirfmrir73ujw47kvna	144	20	coronary	coronary	NNP
work_4fnqcubqirfmrir73ujw47kvna	144	21	syndromes	syndrome	VBZ
work_4fnqcubqirfmrir73ujw47kvna	144	22	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	144	23	general	general	JJ
work_4fnqcubqirfmrir73ujw47kvna	144	24	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	144	25	sudden	sudden	JJ
work_4fnqcubqirfmrir73ujw47kvna	144	26	death	death	NN
work_4fnqcubqirfmrir73ujw47kvna	144	27	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	144	28	particular	particular	JJ
work_4fnqcubqirfmrir73ujw47kvna	144	29	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	145	1	Indeed	indeed	RB
work_4fnqcubqirfmrir73ujw47kvna	145	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	145	3	abnormal	abnormal	JJ
work_4fnqcubqirfmrir73ujw47kvna	145	4	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	145	5	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	145	6	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	145	7	assessed	assess	VBN
work_4fnqcubqirfmrir73ujw47kvna	145	8	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	145	9	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	145	10	rate	rate	NN
work_4fnqcubqirfmrir73ujw47kvna	145	11	variability	variability	NN
work_4fnqcubqirfmrir73ujw47kvna	145	12	greatly	greatly	RB
work_4fnqcubqirfmrir73ujw47kvna	145	13	determines	determine	VBZ
work_4fnqcubqirfmrir73ujw47kvna	145	14	prognosis	prognosis	NN
work_4fnqcubqirfmrir73ujw47kvna	145	15	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	145	16	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	145	17	after	after	IN
work_4fnqcubqirfmrir73ujw47kvna	145	18	myocardial	myocardial	JJ
work_4fnqcubqirfmrir73ujw47kvna	145	19	infarction	infarction	NN
work_4fnqcubqirfmrir73ujw47kvna	145	20	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	145	21	5	5	CD
work_4fnqcubqirfmrir73ujw47kvna	145	22	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	145	23	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	146	1	Heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	146	2	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	146	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	147	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	147	2	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	147	3	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	147	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	147	5	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	147	6	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	147	7	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	147	8	markedly	markedly	RB
work_4fnqcubqirfmrir73ujw47kvna	147	9	activated	activate	VBN
work_4fnqcubqirfmrir73ujw47kvna	147	10	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	147	11	4	4	CD
work_4fnqcubqirfmrir73ujw47kvna	147	12	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	147	13	6	6	CD
work_4fnqcubqirfmrir73ujw47kvna	147	14	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	147	15	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	147	16	probably	probably	RB
work_4fnqcubqirfmrir73ujw47kvna	147	17	because	because	IN
work_4fnqcubqirfmrir73ujw47kvna	147	18	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	147	19	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	147	20	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	147	21	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	147	22	baroreflex	baroreflex	JJ
work_4fnqcubqirfmrir73ujw47kvna	147	23	mech-	mech-	JJ
work_4fnqcubqirfmrir73ujw47kvna	147	24	anisms	anism	NNS
work_4fnqcubqirfmrir73ujw47kvna	147	25	to	to	TO
work_4fnqcubqirfmrir73ujw47kvna	147	26	compensate	compensate	VB
work_4fnqcubqirfmrir73ujw47kvna	147	27	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	147	28	low	low	JJ
work_4fnqcubqirfmrir73ujw47kvna	147	29	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	147	30	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	147	31	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	147	32	decreased	decrease	VBD
work_4fnqcubqirfmrir73ujw47kvna	147	33	perfusion	perfusion	NN
work_4fnqcubqirfmrir73ujw47kvna	147	34	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	147	35	vital	vital	JJ
work_4fnqcubqirfmrir73ujw47kvna	147	36	organs	organ	NNS
work_4fnqcubqirfmrir73ujw47kvna	147	37	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	147	38	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	147	39	consequence	consequence	NN
work_4fnqcubqirfmrir73ujw47kvna	147	40	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	147	41	abnormal	abnormal	JJ
work_4fnqcubqirfmrir73ujw47kvna	147	42	left	leave	VBD
work_4fnqcubqirfmrir73ujw47kvna	147	43	ventricular	ventricular	JJ
work_4fnqcubqirfmrir73ujw47kvna	147	44	function	function	NN
work_4fnqcubqirfmrir73ujw47kvna	147	45	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	148	1	This	this	DT
work_4fnqcubqirfmrir73ujw47kvna	148	2	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	148	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	148	4	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	148	5	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	148	6	initially	initially	RB
work_4fnqcubqirfmrir73ujw47kvna	148	7	lead	lead	VB
work_4fnqcubqirfmrir73ujw47kvna	148	8	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	148	9	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	148	10	increase	increase	NN
work_4fnqcubqirfmrir73ujw47kvna	148	11	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	148	12	cardiac	cardiac	JJ
work_4fnqcubqirfmrir73ujw47kvna	148	13	output	output	NN
work_4fnqcubqirfmrir73ujw47kvna	148	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	148	15	but	but	CC
work_4fnqcubqirfmrir73ujw47kvna	148	16	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	148	17	severe	severe	JJ
work_4fnqcubqirfmrir73ujw47kvna	148	18	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	148	19	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	148	20	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	148	21	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	148	22	mediated	mediate	VBN
work_4fnqcubqirfmrir73ujw47kvna	148	23	increase	increase	NN
work_4fnqcubqirfmrir73ujw47kvna	148	24	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	148	25	peripheral	peripheral	JJ
work_4fnqcubqirfmrir73ujw47kvna	148	26	vascular	vascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	148	27	resistance	resistance	NN
work_4fnqcubqirfmrir73ujw47kvna	148	28	fur-	fur-	NN
work_4fnqcubqirfmrir73ujw47kvna	148	29	ther	ther	NN
work_4fnqcubqirfmrir73ujw47kvna	148	30	deteriorates	deteriorate	VBZ
work_4fnqcubqirfmrir73ujw47kvna	148	31	cardiac	cardiac	JJ
work_4fnqcubqirfmrir73ujw47kvna	148	32	function	function	NN
work_4fnqcubqirfmrir73ujw47kvna	148	33	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	148	34	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	148	35	actually	actually	RB
work_4fnqcubqirfmrir73ujw47kvna	148	36	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	148	37	harm-	harm-	RB
work_4fnqcubqirfmrir73ujw47kvna	148	38	ful	ful	JJ
work_4fnqcubqirfmrir73ujw47kvna	148	39	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	149	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	149	2	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	149	3	vasodialator	vasodialator	NN
work_4fnqcubqirfmrir73ujw47kvna	149	4	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	149	5	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	149	6	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	149	7	trial	trial	NN
work_4fnqcubqirfmrir73ujw47kvna	149	8	study	study	NN
work_4fnqcubqirfmrir73ujw47kvna	149	9	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	149	10	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	149	11	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	149	12	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	149	13	highest	high	JJS
work_4fnqcubqirfmrir73ujw47kvna	149	14	levels	level	NNS
work_4fnqcubqirfmrir73ujw47kvna	149	15	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	149	16	plasma	plasma	NN
work_4fnqcubqirfmrir73ujw47kvna	149	17	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	149	18	had	have	VBD
work_4fnqcubqirfmrir73ujw47kvna	149	19	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	149	20	poorest	poor	JJS
work_4fnqcubqirfmrir73ujw47kvna	149	21	prognosis	prognosis	NN
work_4fnqcubqirfmrir73ujw47kvna	149	22	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	149	23	2	2	CD
work_4fnqcubqirfmrir73ujw47kvna	149	24	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	149	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	150	1	This	this	DT
work_4fnqcubqirfmrir73ujw47kvna	150	2	suggests	suggest	VBZ
work_4fnqcubqirfmrir73ujw47kvna	150	3	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	150	4	indeed	indeed	RB
work_4fnqcubqirfmrir73ujw47kvna	150	5	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	150	6	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	150	7	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	150	8	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	150	9	degree	degree	NN
work_4fnqcubqirfmrir73ujw47kvna	150	10	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	150	11	acti-	acti-	NN
work_4fnqcubqirfmrir73ujw47kvna	150	12	vation	vation	NN
work_4fnqcubqirfmrir73ujw47kvna	150	13	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	150	14	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	150	15	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	150	16	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	150	17	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	150	18	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	150	19	important	important	JJ
work_4fnqcubqirfmrir73ujw47kvna	150	20	prognostic	prognostic	JJ
work_4fnqcubqirfmrir73ujw47kvna	150	21	variable	variable	NN
work_4fnqcubqirfmrir73ujw47kvna	150	22	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	151	1	Modulation	Modulation	NNP
work_4fnqcubqirfmrir73ujw47kvna	151	2	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	151	3	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	151	4	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	151	5	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	151	6	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	151	7	cardiovascular	cardiovascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	151	8	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	151	9	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	151	10	efficacy	efficacy	NN
work_4fnqcubqirfmrir73ujw47kvna	151	11	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	151	12	cardiovascular	cardiovascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	151	13	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	151	14	primarily	primarily	RB
work_4fnqcubqirfmrir73ujw47kvna	151	15	depends	depend	VBZ
work_4fnqcubqirfmrir73ujw47kvna	151	16	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	151	17	their	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	151	18	action	action	NN
work_4fnqcubqirfmrir73ujw47kvna	151	19	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	151	20	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	151	21	vessel	vessel	NN
work_4fnqcubqirfmrir73ujw47kvna	151	22	wall	wall	NNP
work_4fnqcubqirfmrir73ujw47kvna	151	23	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	151	24	myocardium	myocardium	NN
work_4fnqcubqirfmrir73ujw47kvna	151	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	152	1	However	however	RB
work_4fnqcubqirfmrir73ujw47kvna	152	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	152	3	some	some	DT
work_4fnqcubqirfmrir73ujw47kvna	152	4	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	152	5	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	152	6	beneficial	beneficial	JJ
work_4fnqcubqirfmrir73ujw47kvna	152	7	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	152	8	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	152	9	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	152	10	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	152	11	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	152	12	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	152	13	circulation	circulation	NN
work_4fnqcubqirfmrir73ujw47kvna	152	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	152	15	i.e.	i.e.	FW
work_4fnqcubqirfmrir73ujw47kvna	152	16	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	152	17	vasodilatation	vasodilatation	NN
work_4fnqcubqirfmrir73ujw47kvna	152	18	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	152	19	stimulation	stimulation	NN
work_4fnqcubqirfmrir73ujw47kvna	152	20	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	152	21	myocardial	myocardial	JJ
work_4fnqcubqirfmrir73ujw47kvna	152	22	contractil-	contractil-	NNP
work_4fnqcubqirfmrir73ujw47kvna	152	23	ity	ity	NNP
work_4fnqcubqirfmrir73ujw47kvna	152	24	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	152	25	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	152	26	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	152	27	overcome	overcome	VBN
work_4fnqcubqirfmrir73ujw47kvna	152	28	at	at	IN
work_4fnqcubqirfmrir73ujw47kvna	152	29	least	least	JJS
work_4fnqcubqirfmrir73ujw47kvna	152	30	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	152	31	part	part	NN
work_4fnqcubqirfmrir73ujw47kvna	152	32	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	152	33	their	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	152	34	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	152	35	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	152	36	neu-	neu-	RB
work_4fnqcubqirfmrir73ujw47kvna	152	37	rohumoral	rohumoral	JJ
work_4fnqcubqirfmrir73ujw47kvna	152	38	regulators	regulator	NNS
work_4fnqcubqirfmrir73ujw47kvna	152	39	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	153	1	Various	various	JJ
work_4fnqcubqirfmrir73ujw47kvna	153	2	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	153	3	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	153	4	used	use	VBN
work_4fnqcubqirfmrir73ujw47kvna	153	5	to	to	TO
work_4fnqcubqirfmrir73ujw47kvna	153	6	treat	treat	VB
work_4fnqcubqirfmrir73ujw47kvna	153	7	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	153	8	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	153	9	cardiovascu-	cardiovascu-	NNP
work_4fnqcubqirfmrir73ujw47kvna	153	10	lar	lar	NNP
work_4fnqcubqirfmrir73ujw47kvna	153	11	disease	disease	NNP
work_4fnqcubqirfmrir73ujw47kvna	153	12	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	153	13	e.g.	e.g.	RB
work_4fnqcubqirfmrir73ujw47kvna	154	1	β	β	LS
work_4fnqcubqirfmrir73ujw47kvna	154	2	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	154	3	blockers	blocker	NNS
work_4fnqcubqirfmrir73ujw47kvna	154	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	154	5	calcium	calcium	NN
work_4fnqcubqirfmrir73ujw47kvna	154	6	antagonists	antagonist	NNS
work_4fnqcubqirfmrir73ujw47kvna	154	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	154	8	ACE-	ACE-	NNP
work_4fnqcubqirfmrir73ujw47kvna	154	9	inhibitors	inhibitor	NNS
work_4fnqcubqirfmrir73ujw47kvna	154	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	154	11	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	154	12	nitrates	nitrate	NNS
work_4fnqcubqirfmrir73ujw47kvna	154	13	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	155	1	Indeed	indeed	RB
work_4fnqcubqirfmrir73ujw47kvna	155	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	155	3	certain	certain	JJ
work_4fnqcubqirfmrir73ujw47kvna	155	4	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	155	5	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	155	6	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	155	7	very	very	RB
work_4fnqcubqirfmrir73ujw47kvna	155	8	efficacious	efficacious	JJ
work_4fnqcubqirfmrir73ujw47kvna	155	9	antihypertensive	antihypertensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	155	10	or	or	CC
work_4fnqcubqirfmrir73ujw47kvna	155	11	vasodilator	vasodilator	JJ
work_4fnqcubqirfmrir73ujw47kvna	155	12	agents	agent	NNS
work_4fnqcubqirfmrir73ujw47kvna	155	13	yet	yet	RB
work_4fnqcubqirfmrir73ujw47kvna	155	14	activate	activate	VBP
work_4fnqcubqirfmrir73ujw47kvna	155	15	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	155	16	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	155	17	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	155	18	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	155	19	others	other	NNS
work_4fnqcubqirfmrir73ujw47kvna	155	20	inhibit	inhibit	VBP
work_4fnqcubqirfmrir73ujw47kvna	155	21	it	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	155	22	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	155	23	7	7	CD
work_4fnqcubqirfmrir73ujw47kvna	155	24	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	155	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	156	1	Given	give	VBN
work_4fnqcubqirfmrir73ujw47kvna	156	2	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	156	3	important	important	JJ
work_4fnqcubqirfmrir73ujw47kvna	156	4	prog-	prog-	JJ
work_4fnqcubqirfmrir73ujw47kvna	156	5	nostic	nostic	JJ
work_4fnqcubqirfmrir73ujw47kvna	156	6	relevance	relevance	NN
work_4fnqcubqirfmrir73ujw47kvna	156	7	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	156	8	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	156	9	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	156	10	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	156	11	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	156	12	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	156	13	cardiovascu-	cardiovascu-	NNP
work_4fnqcubqirfmrir73ujw47kvna	156	14	lar	lar	NNP
work_4fnqcubqirfmrir73ujw47kvna	156	15	disease	disease	NNP
work_4fnqcubqirfmrir73ujw47kvna	156	16	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	156	17	understanding	understand	VBG
work_4fnqcubqirfmrir73ujw47kvna	156	18	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	156	19	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	156	20	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	156	21	these	these	DT
work_4fnqcubqirfmrir73ujw47kvna	156	22	vasoactive	vasoactive	JJ
work_4fnqcubqirfmrir73ujw47kvna	156	23	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	156	24	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	156	25	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	156	26	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	156	27	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	156	28	have	have	VB
work_4fnqcubqirfmrir73ujw47kvna	156	29	great	great	JJ
work_4fnqcubqirfmrir73ujw47kvna	156	30	clinical	clinical	JJ
work_4fnqcubqirfmrir73ujw47kvna	156	31	relevance	relevance	NN
work_4fnqcubqirfmrir73ujw47kvna	156	32	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	157	1	Calcium	calcium	NN
work_4fnqcubqirfmrir73ujw47kvna	157	2	channel	channel	NN
work_4fnqcubqirfmrir73ujw47kvna	157	3	blockers	blocker	NNS
work_4fnqcubqirfmrir73ujw47kvna	157	4	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	157	5	potent	potent	JJ
work_4fnqcubqirfmrir73ujw47kvna	157	6	vasodilators	vasodilator	NNS
work_4fnqcubqirfmrir73ujw47kvna	157	7	acting	act	VBG
work_4fnqcubqirfmrir73ujw47kvna	157	8	directly	directly	RB
work_4fnqcubqirfmrir73ujw47kvna	157	9	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	157	10	vascular	vascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	157	11	smooth	smooth	JJ
work_4fnqcubqirfmrir73ujw47kvna	157	12	muscle	muscle	NN
work_4fnqcubqirfmrir73ujw47kvna	157	13	cells	cell	NNS
work_4fnqcubqirfmrir73ujw47kvna	157	14	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	158	1	These	these	DT
work_4fnqcubqirfmrir73ujw47kvna	158	2	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	158	3	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	158	4	widely	widely	RB
work_4fnqcubqirfmrir73ujw47kvna	158	5	used	use	VBN
work_4fnqcubqirfmrir73ujw47kvna	158	6	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	158	7	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	158	8	treatment	treatment	NN
work_4fnqcubqirfmrir73ujw47kvna	158	9	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	158	10	hypertension	hypertension	NNP
work_4fnqcubqirfmrir73ujw47kvna	158	11	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	158	12	angina	angina	NNP
work_4fnqcubqirfmrir73ujw47kvna	158	13	pectoris	pectoris	NNP
work_4fnqcubqirfmrir73ujw47kvna	158	14	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	159	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	159	2	secondary	secondary	JJ
work_4fnqcubqirfmrir73ujw47kvna	159	3	prevention	prevention	NN
work_4fnqcubqirfmrir73ujw47kvna	159	4	after	after	IN
work_4fnqcubqirfmrir73ujw47kvna	159	5	myocardial	myocardial	JJ
work_4fnqcubqirfmrir73ujw47kvna	159	6	infarction	infarction	NN
work_4fnqcubqirfmrir73ujw47kvna	159	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	159	8	calcium	calcium	NN
work_4fnqcubqirfmrir73ujw47kvna	159	9	antagonists	antagonist	NNS
work_4fnqcubqirfmrir73ujw47kvna	159	10	did	do	VBD
work_4fnqcubqirfmrir73ujw47kvna	159	11	not	not	RB
work_4fnqcubqirfmrir73ujw47kvna	159	12	have	have	VB
work_4fnqcubqirfmrir73ujw47kvna	159	13	beneficial	beneficial	JJ
work_4fnqcubqirfmrir73ujw47kvna	159	14	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	159	15	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	159	16	car-	car-	JJ
work_4fnqcubqirfmrir73ujw47kvna	159	17	diovascular	diovascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	159	18	events	event	NNS
work_4fnqcubqirfmrir73ujw47kvna	159	19	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	159	20	survival	survival	NN
work_4fnqcubqirfmrir73ujw47kvna	159	21	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	159	22	particularly	particularly	RB
work_4fnqcubqirfmrir73ujw47kvna	159	23	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	159	24	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	159	25	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	159	26	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	159	27	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	159	28	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	160	1	This	this	DT
work_4fnqcubqirfmrir73ujw47kvna	160	2	could	could	MD
work_4fnqcubqirfmrir73ujw47kvna	160	3	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	160	4	due	due	IN
work_4fnqcubqirfmrir73ujw47kvna	160	5	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	160	6	either	either	DT
work_4fnqcubqirfmrir73ujw47kvna	160	7	negative	negative	JJ
work_4fnqcubqirfmrir73ujw47kvna	160	8	inotropic	inotropic	JJ
work_4fnqcubqirfmrir73ujw47kvna	160	9	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	160	10	or	or	CC
work_4fnqcubqirfmrir73ujw47kvna	160	11	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	160	12	baroreceptor	baroreceptor	NN
work_4fnqcubqirfmrir73ujw47kvna	160	13	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	160	14	mediated	mediate	VBN
work_4fnqcubqirfmrir73ujw47kvna	160	15	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	160	16	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	160	17	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	160	18	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	160	19	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	160	20	2	2	CD
work_4fnqcubqirfmrir73ujw47kvna	160	21	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	160	22	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	161	1	Dihydropyridines	dihydropyridine	NNS
work_4fnqcubqirfmrir73ujw47kvna	161	2	such	such	JJ
work_4fnqcubqirfmrir73ujw47kvna	161	3	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	161	4	nifedipine	nifedipine	NN
work_4fnqcubqirfmrir73ujw47kvna	161	5	also	also	RB
work_4fnqcubqirfmrir73ujw47kvna	161	6	have	have	VBP
work_4fnqcubqirfmrir73ujw47kvna	161	7	important	important	JJ
work_4fnqcubqirfmrir73ujw47kvna	161	8	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	161	9	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	161	10	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	161	11	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	161	12	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	161	13	healthy	healthy	JJ
work_4fnqcubqirfmrir73ujw47kvna	161	14	human	human	JJ
work_4fnqcubqirfmrir73ujw47kvna	161	15	subjects	subject	NNS
work_4fnqcubqirfmrir73ujw47kvna	161	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	162	1	Oral	oral	JJ
work_4fnqcubqirfmrir73ujw47kvna	162	2	adminis-	adminis-	NN
work_4fnqcubqirfmrir73ujw47kvna	162	3	tration	tration	NN
work_4fnqcubqirfmrir73ujw47kvna	162	4	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	162	5	short	short	JJ
work_4fnqcubqirfmrir73ujw47kvna	162	6	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	162	7	acting	act	VBG
work_4fnqcubqirfmrir73ujw47kvna	162	8	nifedipine	nifedipine	NN
work_4fnqcubqirfmrir73ujw47kvna	162	9	leads	lead	VBZ
work_4fnqcubqirfmrir73ujw47kvna	162	10	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	162	11	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	162	12	marked	marked	JJ
work_4fnqcubqirfmrir73ujw47kvna	162	13	increase	increase	NN
work_4fnqcubqirfmrir73ujw47kvna	162	14	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	162	15	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	162	16	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	162	17	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	162	18	plasma	plasma	NN
work_4fnqcubqirfmrir73ujw47kvna	162	19	levels	level	NNS
work_4fnqcubqirfmrir73ujw47kvna	162	20	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	162	21	Fig	fig	NN
work_4fnqcubqirfmrir73ujw47kvna	162	22	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	163	1	3	3	LS
work_4fnqcubqirfmrir73ujw47kvna	163	2	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	163	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	164	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	164	2	degree	degree	NN
work_4fnqcubqirfmrir73ujw47kvna	164	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	164	4	activa-	activa-	JJ
work_4fnqcubqirfmrir73ujw47kvna	164	5	tion	tion	NN
work_4fnqcubqirfmrir73ujw47kvna	164	6	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	164	7	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	164	8	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	164	9	comparable	comparable	JJ
work_4fnqcubqirfmrir73ujw47kvna	164	10	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	164	11	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	164	12	cold	cold	JJ
work_4fnqcubqirfmrir73ujw47kvna	164	13	pressor	pressor	NN
work_4fnqcubqirfmrir73ujw47kvna	164	14	test	test	NN
work_4fnqcubqirfmrir73ujw47kvna	164	15	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	164	16	which	which	WDT
work_4fnqcubqirfmrir73ujw47kvna	164	17	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	164	18	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	164	19	most	most	RBS
work_4fnqcubqirfmrir73ujw47kvna	164	20	potent	potent	JJ
work_4fnqcubqirfmrir73ujw47kvna	164	21	stimulus	stimulus	NN
work_4fnqcubqirfmrir73ujw47kvna	164	22	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	164	23	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	164	24	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	164	25	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	164	26	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	164	27	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	165	1	Most	most	RBS
work_4fnqcubqirfmrir73ujw47kvna	165	2	interestingly	interestingly	RB
work_4fnqcubqirfmrir73ujw47kvna	165	3	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	165	4	nifedipine	nifedipine	NNP
work_4fnqcubqirfmrir73ujw47kvna	165	5	remains	remain	VBZ
work_4fnqcubqirfmrir73ujw47kvna	165	6	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	165	7	very	very	RB
work_4fnqcubqirfmrir73ujw47kvna	165	8	important	important	JJ
work_4fnqcubqirfmrir73ujw47kvna	165	9	stimulus	stimulus	NN
work_4fnqcubqirfmrir73ujw47kvna	165	10	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	165	11	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	165	12	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	165	13	even	even	RB
work_4fnqcubqirfmrir73ujw47kvna	165	14	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	165	15	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	165	16	presence	presence	NN
work_4fnqcubqirfmrir73ujw47kvna	165	17	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	165	18	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	165	19	cold	cold	JJ
work_4fnqcubqirfmrir73ujw47kvna	165	20	pressor	pressor	NN
work_4fnqcubqirfmrir73ujw47kvna	165	21	test	test	NN
work_4fnqcubqirfmrir73ujw47kvna	165	22	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	165	23	14	14	CD
work_4fnqcubqirfmrir73ujw47kvna	165	24	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	165	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	166	1	This	this	DT
work_4fnqcubqirfmrir73ujw47kvna	166	2	finding	finding	NN
work_4fnqcubqirfmrir73ujw47kvna	166	3	indicates	indicate	VBZ
work_4fnqcubqirfmrir73ujw47kvna	166	4	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	166	5	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	166	6	short	short	RB
work_4fnqcubqirfmrir73ujw47kvna	166	7	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	166	8	acting	act	VBG
work_4fnqcubqirfmrir73ujw47kvna	166	9	dihydropy-	dihydropy-	NN
work_4fnqcubqirfmrir73ujw47kvna	166	10	ridines	ridine	NNS
work_4fnqcubqirfmrir73ujw47kvna	166	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	166	12	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	166	13	peripheral	peripheral	JJ
work_4fnqcubqirfmrir73ujw47kvna	166	14	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	166	15	cardiac	cardiac	JJ
work_4fnqcubqirfmrir73ujw47kvna	166	16	portions	portion	NNS
work_4fnqcubqirfmrir73ujw47kvna	166	17	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	166	18	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	166	19	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	166	20	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	166	21	highly	highly	RB
work_4fnqcubqirfmrir73ujw47kvna	166	22	activated	activate	VBN
work_4fnqcubqirfmrir73ujw47kvna	166	23	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	166	24	remain	remain	VBP
work_4fnqcubqirfmrir73ujw47kvna	166	25	responsive	responsive	JJ
work_4fnqcubqirfmrir73ujw47kvna	166	26	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	166	27	these	these	DT
work_4fnqcubqirfmrir73ujw47kvna	166	28	stimulatory	stimulatory	JJ
work_4fnqcubqirfmrir73ujw47kvna	166	29	maneuvers	maneuver	NNS
work_4fnqcubqirfmrir73ujw47kvna	166	30	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	167	1	Indeed	indeed	RB
work_4fnqcubqirfmrir73ujw47kvna	167	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	167	3	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	167	4	potent	potent	JJ
work_4fnqcubqirfmrir73ujw47kvna	167	5	vasodilator	vasodilator	NN
work_4fnqcubqirfmrir73ujw47kvna	167	6	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	167	7	under	under	IN
work_4fnqcubqirfmrir73ujw47kvna	167	8	acute	acute	JJ
work_4fnqcubqirfmrir73ujw47kvna	167	9	conditions	condition	NNS
work_4fnqcubqirfmrir73ujw47kvna	167	10	together	together	RB
work_4fnqcubqirfmrir73ujw47kvna	167	11	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	167	12	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	167	13	negative	negative	JJ
work_4fnqcubqirfmrir73ujw47kvna	167	14	inotropic	inotropic	JJ
work_4fnqcubqirfmrir73ujw47kvna	167	15	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	167	16	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	167	17	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	167	18	drug	drug	NN
work_4fnqcubqirfmrir73ujw47kvna	167	19	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	167	20	lead	lead	VB
work_4fnqcubqirfmrir73ujw47kvna	167	21	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	167	22	marked	mark	VBN
work_4fnqcubqirfmrir73ujw47kvna	167	23	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	167	24	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	167	25	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	167	26	baroreflex	baroreflex	NNP
work_4fnqcubqirfmrir73ujw47kvna	167	27	News	News	NNP
work_4fnqcubqirfmrir73ujw47kvna	167	28	Physiol	Physiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	167	29	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	168	1	Sci	Sci	NNP
work_4fnqcubqirfmrir73ujw47kvna	168	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	169	1	•	•	NNP
work_4fnqcubqirfmrir73ujw47kvna	169	2	Volume	volume	NN
work_4fnqcubqirfmrir73ujw47kvna	169	3	15	15	CD
work_4fnqcubqirfmrir73ujw47kvna	169	4	•	•	NN
work_4fnqcubqirfmrir73ujw47kvna	169	5	June	June	NNP
work_4fnqcubqirfmrir73ujw47kvna	169	6	2000	2000	CD
work_4fnqcubqirfmrir73ujw47kvna	169	7	127	127	CD
work_4fnqcubqirfmrir73ujw47kvna	169	8	FIGURE	figure	NN
work_4fnqcubqirfmrir73ujw47kvna	169	9	2	2	CD
work_4fnqcubqirfmrir73ujw47kvna	169	10	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	170	1	Muscle	muscle	NN
work_4fnqcubqirfmrir73ujw47kvna	170	2	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	170	3	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	170	4	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	170	5	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	170	6	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	170	7	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	170	8	peroneal	peroneal	NN
work_4fnqcubqirfmrir73ujw47kvna	170	9	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	170	10	at	at	IN
work_4fnqcubqirfmrir73ujw47kvna	170	11	rest	rest	NN
work_4fnqcubqirfmrir73ujw47kvna	170	12	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	170	13	during	during	IN
work_4fnqcubqirfmrir73ujw47kvna	170	14	mental	mental	JJ
work_4fnqcubqirfmrir73ujw47kvna	170	15	stress	stress	NN
work_4fnqcubqirfmrir73ujw47kvna	170	16	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	170	17	normotensive	normotensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	170	18	offspring	offspring	NN
work_4fnqcubqirfmrir73ujw47kvna	170	19	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	170	20	normotensive	normotensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	170	21	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	170	22	left	left	RB
work_4fnqcubqirfmrir73ujw47kvna	170	23	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	170	24	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	170	25	hypertensive	hypertensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	170	26	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	170	27	right	right	JJ
work_4fnqcubqirfmrir73ujw47kvna	170	28	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	170	29	parents	parent	NNS
work_4fnqcubqirfmrir73ujw47kvna	170	30	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	171	1	Increase	increase	NN
work_4fnqcubqirfmrir73ujw47kvna	171	2	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	171	3	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	171	4	during	during	IN
work_4fnqcubqirfmrir73ujw47kvna	171	5	mental	mental	JJ
work_4fnqcubqirfmrir73ujw47kvna	171	6	stress	stress	NN
work_4fnqcubqirfmrir73ujw47kvna	171	7	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	171	8	more	more	RBR
work_4fnqcubqirfmrir73ujw47kvna	171	9	pronounced	pronounced	JJ
work_4fnqcubqirfmrir73ujw47kvna	171	10	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	171	11	offspring	offspring	NN
work_4fnqcubqirfmrir73ujw47kvna	171	12	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	171	13	hypertensive	hypertensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	171	14	parents	parent	NNS
work_4fnqcubqirfmrir73ujw47kvna	171	15	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	172	1	BP	BP	NNP
work_4fnqcubqirfmrir73ujw47kvna	172	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	172	3	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	172	4	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	172	5	;	;	:
work_4fnqcubqirfmrir73ujw47kvna	172	6	HR	hr	NN
work_4fnqcubqirfmrir73ujw47kvna	172	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	172	8	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	172	9	rate	rate	NN
work_4fnqcubqirfmrir73ujw47kvna	172	10	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	173	1	Modified	modify	VBN
work_4fnqcubqirfmrir73ujw47kvna	173	2	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	173	3	Ref	Ref	NNP
work_4fnqcubqirfmrir73ujw47kvna	173	4	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	174	1	9	9	CD
work_4fnqcubqirfmrir73ujw47kvna	174	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	175	1	Downloaded	download	VBN
work_4fnqcubqirfmrir73ujw47kvna	175	2	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	175	3	journals.physiology.org/journal/physiologyonline	journals.physiology.org/journal/physiologyonline	NN
work_4fnqcubqirfmrir73ujw47kvna	175	4	at	at	IN
work_4fnqcubqirfmrir73ujw47kvna	175	5	Carnegie	Carnegie	NNP
work_4fnqcubqirfmrir73ujw47kvna	175	6	Mellon	Mellon	NNP
work_4fnqcubqirfmrir73ujw47kvna	175	7	Univ	Univ	NNP
work_4fnqcubqirfmrir73ujw47kvna	175	8	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	175	9	128.182.081.034	128.182.081.034	CD
work_4fnqcubqirfmrir73ujw47kvna	175	10	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	175	11	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	175	12	April	April	NNP
work_4fnqcubqirfmrir73ujw47kvna	175	13	5	5	CD
work_4fnqcubqirfmrir73ujw47kvna	175	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	175	15	2021	2021	CD
work_4fnqcubqirfmrir73ujw47kvna	175	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	175	17	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	175	18	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	175	19	turn	turn	NN
work_4fnqcubqirfmrir73ujw47kvna	175	20	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	175	21	increase	increase	NN
work_4fnqcubqirfmrir73ujw47kvna	175	22	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	175	23	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	175	24	rate	rate	NN
work_4fnqcubqirfmrir73ujw47kvna	175	25	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	175	26	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	175	27	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	175	28	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	176	1	It	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	176	2	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	176	3	conceivable	conceivable	JJ
work_4fnqcubqirfmrir73ujw47kvna	176	4	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	176	5	such	such	JJ
work_4fnqcubqirfmrir73ujw47kvna	176	6	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	176	7	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	176	8	less	less	RBR
work_4fnqcubqirfmrir73ujw47kvna	176	9	pronounced	pronounced	JJ
work_4fnqcubqirfmrir73ujw47kvna	176	10	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	176	11	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	176	12	more	more	RBR
work_4fnqcubqirfmrir73ujw47kvna	176	13	slowly	slowly	RB
work_4fnqcubqirfmrir73ujw47kvna	176	14	acting	act	VBG
work_4fnqcubqirfmrir73ujw47kvna	176	15	form	form	NN
work_4fnqcubqirfmrir73ujw47kvna	176	16	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	176	17	nifedipine	nifedipine	NN
work_4fnqcubqirfmrir73ujw47kvna	176	18	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	177	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	177	2	nifedipine	nifedipine	NN
work_4fnqcubqirfmrir73ujw47kvna	177	3	gas-	gas-	NN
work_4fnqcubqirfmrir73ujw47kvna	177	4	trointestinal	trointestinal	JJ
work_4fnqcubqirfmrir73ujw47kvna	177	5	therapeutic	therapeutic	JJ
work_4fnqcubqirfmrir73ujw47kvna	177	6	system	system	NN
work_4fnqcubqirfmrir73ujw47kvna	177	7	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	177	8	GITS	GITS	NNP
work_4fnqcubqirfmrir73ujw47kvna	177	9	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	177	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	177	11	which	which	WDT
work_4fnqcubqirfmrir73ujw47kvna	177	12	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	177	13	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	177	14	slow-	slow-	JJ
work_4fnqcubqirfmrir73ujw47kvna	177	15	release	release	NN
work_4fnqcubqirfmrir73ujw47kvna	177	16	form	form	NN
work_4fnqcubqirfmrir73ujw47kvna	177	17	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	177	18	nifedipine	nifedipine	NN
work_4fnqcubqirfmrir73ujw47kvna	177	19	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	177	20	indeed	indeed	RB
work_4fnqcubqirfmrir73ujw47kvna	177	21	does	do	VBZ
work_4fnqcubqirfmrir73ujw47kvna	177	22	not	not	RB
work_4fnqcubqirfmrir73ujw47kvna	177	23	significantly	significantly	RB
work_4fnqcubqirfmrir73ujw47kvna	177	24	change	change	VB
work_4fnqcubqirfmrir73ujw47kvna	177	25	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	177	26	rate	rate	NN
work_4fnqcubqirfmrir73ujw47kvna	177	27	even	even	RB
work_4fnqcubqirfmrir73ujw47kvna	177	28	under	under	IN
work_4fnqcubqirfmrir73ujw47kvna	177	29	acute	acute	JJ
work_4fnqcubqirfmrir73ujw47kvna	177	30	conditions	condition	NNS
work_4fnqcubqirfmrir73ujw47kvna	177	31	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	177	32	suggesting	suggest	VBG
work_4fnqcubqirfmrir73ujw47kvna	177	33	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	177	34	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	177	35	baroreflex	baroreflex	NN
work_4fnqcubqirfmrir73ujw47kvna	177	36	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	177	37	less	less	RBR
work_4fnqcubqirfmrir73ujw47kvna	177	38	activated	activate	VBN
work_4fnqcubqirfmrir73ujw47kvna	177	39	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	178	1	However	however	RB
work_4fnqcubqirfmrir73ujw47kvna	178	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	178	3	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	178	4	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	178	5	per-	per-	NN
work_4fnqcubqirfmrir73ujw47kvna	178	6	oneal	oneal	JJ
work_4fnqcubqirfmrir73ujw47kvna	178	7	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	178	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	178	9	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	178	10	marked	mark	VBN
work_4fnqcubqirfmrir73ujw47kvna	178	11	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	178	12	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	178	13	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	178	14	can	can	MD
work_4fnqcubqirfmrir73ujw47kvna	178	15	still	still	RB
work_4fnqcubqirfmrir73ujw47kvna	178	16	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	178	17	docu-	docu-	NN
work_4fnqcubqirfmrir73ujw47kvna	178	18	mented	mente	VBN
work_4fnqcubqirfmrir73ujw47kvna	178	19	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	178	20	Fig	fig	NN
work_4fnqcubqirfmrir73ujw47kvna	178	21	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	179	1	3	3	LS
work_4fnqcubqirfmrir73ujw47kvna	179	2	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	179	3	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	179	4	14	14	CD
work_4fnqcubqirfmrir73ujw47kvna	179	5	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	179	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	180	1	This	this	DT
work_4fnqcubqirfmrir73ujw47kvna	180	2	suggests	suggest	VBZ
work_4fnqcubqirfmrir73ujw47kvna	180	3	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	180	4	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	180	5	slower	slow	JJR
work_4fnqcubqirfmrir73ujw47kvna	180	6	onset	onset	NN
work_4fnqcubqirfmrir73ujw47kvna	180	7	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	180	8	vasodilatation	vasodilatation	NN
work_4fnqcubqirfmrir73ujw47kvna	180	9	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	180	10	it	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	180	11	occurs	occur	VBZ
work_4fnqcubqirfmrir73ujw47kvna	180	12	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	180	13	slow	slow	JJ
work_4fnqcubqirfmrir73ujw47kvna	180	14	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	180	15	release	release	NN
work_4fnqcubqirfmrir73ujw47kvna	180	16	nifedipine	nifedipine	NN
work_4fnqcubqirfmrir73ujw47kvna	180	17	does	do	VBZ
work_4fnqcubqirfmrir73ujw47kvna	180	18	not	not	RB
work_4fnqcubqirfmrir73ujw47kvna	180	19	lead	lead	VB
work_4fnqcubqirfmrir73ujw47kvna	180	20	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	180	21	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	180	22	generalized	generalize	VBN
work_4fnqcubqirfmrir73ujw47kvna	180	23	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	180	24	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	180	25	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	180	26	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	180	27	does	do	VBZ
work_4fnqcubqirfmrir73ujw47kvna	180	28	not	not	RB
work_4fnqcubqirfmrir73ujw47kvna	180	29	significantly	significantly	RB
work_4fnqcubqirfmrir73ujw47kvna	180	30	increase	increase	VB
work_4fnqcubqirfmrir73ujw47kvna	180	31	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	180	32	outflow	outflow	NN
work_4fnqcubqirfmrir73ujw47kvna	180	33	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	180	34	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	180	35	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	180	36	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	181	1	Nevertheless	nevertheless	RB
work_4fnqcubqirfmrir73ujw47kvna	181	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	181	3	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	181	4	outflow	outflow	NN
work_4fnqcubqirfmrir73ujw47kvna	181	5	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	181	6	peripheral	peripheral	JJ
work_4fnqcubqirfmrir73ujw47kvna	181	7	mus-	mus-	NN
work_4fnqcubqirfmrir73ujw47kvna	181	8	cles	cles	NNP
work_4fnqcubqirfmrir73ujw47kvna	181	9	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	181	10	still	still	RB
work_4fnqcubqirfmrir73ujw47kvna	181	11	activated	activate	VBN
work_4fnqcubqirfmrir73ujw47kvna	181	12	under	under	IN
work_4fnqcubqirfmrir73ujw47kvna	181	13	these	these	DT
work_4fnqcubqirfmrir73ujw47kvna	181	14	conditions	condition	NNS
work_4fnqcubqirfmrir73ujw47kvna	181	15	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	182	1	Whether	whether	IN
work_4fnqcubqirfmrir73ujw47kvna	182	2	such	such	JJ
work_4fnqcubqirfmrir73ujw47kvna	182	3	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	182	4	also	also	RB
work_4fnqcubqirfmrir73ujw47kvna	182	5	occur	occur	VBP
work_4fnqcubqirfmrir73ujw47kvna	182	6	during	during	IN
work_4fnqcubqirfmrir73ujw47kvna	182	7	chronic	chronic	JJ
work_4fnqcubqirfmrir73ujw47kvna	182	8	treatment	treatment	NN
work_4fnqcubqirfmrir73ujw47kvna	182	9	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	182	10	nifedipine	nifedipine	NN
work_4fnqcubqirfmrir73ujw47kvna	182	11	remains	remain	VBZ
work_4fnqcubqirfmrir73ujw47kvna	182	12	to	to	TO
work_4fnqcubqirfmrir73ujw47kvna	182	13	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	182	14	demonstrated	demonstrate	VBN
work_4fnqcubqirfmrir73ujw47kvna	182	15	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	183	1	Due	due	IN
work_4fnqcubqirfmrir73ujw47kvna	183	2	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	183	3	its	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	183	4	different	different	JJ
work_4fnqcubqirfmrir73ujw47kvna	183	5	pharmacological	pharmacological	JJ
work_4fnqcubqirfmrir73ujw47kvna	183	6	profile	profile	NN
work_4fnqcubqirfmrir73ujw47kvna	183	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	183	8	verapamil	verapamil	NN
work_4fnqcubqirfmrir73ujw47kvna	183	9	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	183	10	associated	associate	VBN
work_4fnqcubqirfmrir73ujw47kvna	183	11	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	183	12	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	183	13	decrease	decrease	NN
work_4fnqcubqirfmrir73ujw47kvna	183	14	rather	rather	RB
work_4fnqcubqirfmrir73ujw47kvna	183	15	than	than	IN
work_4fnqcubqirfmrir73ujw47kvna	183	16	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	183	17	increase	increase	NN
work_4fnqcubqirfmrir73ujw47kvna	183	18	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	183	19	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	183	20	rate	rate	NN
work_4fnqcubqirfmrir73ujw47kvna	183	21	even	even	RB
work_4fnqcubqirfmrir73ujw47kvna	183	22	under	under	IN
work_4fnqcubqirfmrir73ujw47kvna	183	23	acute	acute	JJ
work_4fnqcubqirfmrir73ujw47kvna	183	24	conditions	condition	NNS
work_4fnqcubqirfmrir73ujw47kvna	183	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	184	1	During	during	IN
work_4fnqcubqirfmrir73ujw47kvna	184	2	chronic	chronic	JJ
work_4fnqcubqirfmrir73ujw47kvna	184	3	therapy	therapy	NN
work_4fnqcubqirfmrir73ujw47kvna	184	4	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	184	5	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	184	6	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	184	7	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	184	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	184	9	verapamil	verapamil	NN
work_4fnqcubqirfmrir73ujw47kvna	184	10	lowers	lower	VBZ
work_4fnqcubqirfmrir73ujw47kvna	184	11	rather	rather	RB
work_4fnqcubqirfmrir73ujw47kvna	184	12	than	than	IN
work_4fnqcubqirfmrir73ujw47kvna	184	13	increases	increase	VBZ
work_4fnqcubqirfmrir73ujw47kvna	184	14	plasma	plasma	NN
work_4fnqcubqirfmrir73ujw47kvna	184	15	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	184	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	185	1	Although	although	IN
work_4fnqcubqirfmrir73ujw47kvna	185	2	studies	study	NNS
work_4fnqcubqirfmrir73ujw47kvna	185	3	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	185	4	microneurography	microneurography	NN
work_4fnqcubqirfmrir73ujw47kvna	185	5	have	have	VBP
work_4fnqcubqirfmrir73ujw47kvna	185	6	not	not	RB
work_4fnqcubqirfmrir73ujw47kvna	185	7	been	be	VBN
work_4fnqcubqirfmrir73ujw47kvna	185	8	performed	perform	VBN
work_4fnqcubqirfmrir73ujw47kvna	185	9	yet	yet	RB
work_4fnqcubqirfmrir73ujw47kvna	185	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	185	11	there	there	EX
work_4fnqcubqirfmrir73ujw47kvna	185	12	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	185	13	indirect	indirect	JJ
work_4fnqcubqirfmrir73ujw47kvna	185	14	evidence	evidence	NN
work_4fnqcubqirfmrir73ujw47kvna	185	15	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	185	16	verapamil	verapamil	NN
work_4fnqcubqirfmrir73ujw47kvna	185	17	affects	affect	VBZ
work_4fnqcubqirfmrir73ujw47kvna	185	18	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	185	19	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	185	20	differently	differently	RB
work_4fnqcubqirfmrir73ujw47kvna	185	21	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	185	22	dihydropyridines	dihydropyridine	NNS
work_4fnqcubqirfmrir73ujw47kvna	185	23	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	185	24	10	10	CD
work_4fnqcubqirfmrir73ujw47kvna	185	25	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	185	26	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	186	1	Angiotensin	Angiotensin	NNP
work_4fnqcubqirfmrir73ujw47kvna	186	2	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	186	3	converting	convert	VBG
work_4fnqcubqirfmrir73ujw47kvna	186	4	enzyme	enzyme	NNS
work_4fnqcubqirfmrir73ujw47kvna	186	5	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	186	6	ACE	ACE	NNP
work_4fnqcubqirfmrir73ujw47kvna	186	7	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	186	8	inhibitors	inhibitor	NNS
work_4fnqcubqirfmrir73ujw47kvna	186	9	also	also	RB
work_4fnqcubqirfmrir73ujw47kvna	186	10	act	act	VBP
work_4fnqcubqirfmrir73ujw47kvna	186	11	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	186	12	vasodilators	vasodilator	NNS
work_4fnqcubqirfmrir73ujw47kvna	186	13	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	186	14	inhibiting	inhibit	VBG
work_4fnqcubqirfmrir73ujw47kvna	186	15	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	186	16	formation	formation	NN
work_4fnqcubqirfmrir73ujw47kvna	186	17	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	186	18	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	186	19	vasoconstrictor	vasoconstrictor	NN
work_4fnqcubqirfmrir73ujw47kvna	186	20	peptide	peptide	NNP
work_4fnqcubqirfmrir73ujw47kvna	186	21	angiotensin	angiotensin	NNP
work_4fnqcubqirfmrir73ujw47kvna	186	22	II	II	NNP
work_4fnqcubqirfmrir73ujw47kvna	186	23	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	187	1	ACE	ACE	NNP
work_4fnqcubqirfmrir73ujw47kvna	187	2	inhibitors	inhibitor	NNS
work_4fnqcubqirfmrir73ujw47kvna	187	3	tend	tend	VBP
work_4fnqcubqirfmrir73ujw47kvna	187	4	to	to	TO
work_4fnqcubqirfmrir73ujw47kvna	187	5	lower	lower	VB
work_4fnqcubqirfmrir73ujw47kvna	187	6	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	187	7	rate	rate	NN
work_4fnqcubqirfmrir73ujw47kvna	187	8	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	187	9	normotensive	normotensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	187	10	subjects	subject	NNS
work_4fnqcubqirfmrir73ujw47kvna	187	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	187	12	although	although	IN
work_4fnqcubqirfmrir73ujw47kvna	187	13	they	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	187	14	do	do	VBP
work_4fnqcubqirfmrir73ujw47kvna	187	15	slightly	slightly	RB
work_4fnqcubqirfmrir73ujw47kvna	187	16	decrease	decrease	VB
work_4fnqcubqirfmrir73ujw47kvna	187	17	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	187	18	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	187	19	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	188	1	These	these	DT
work_4fnqcubqirfmrir73ujw47kvna	188	2	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	188	3	not	not	RB
work_4fnqcubqirfmrir73ujw47kvna	188	4	only	only	RB
work_4fnqcubqirfmrir73ujw47kvna	188	5	improve	improve	VBP
work_4fnqcubqirfmrir73ujw47kvna	188	6	symptoms	symptom	NNS
work_4fnqcubqirfmrir73ujw47kvna	188	7	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	188	8	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	188	9	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	188	10	left	left	JJ
work_4fnqcubqirfmrir73ujw47kvna	188	11	ventricular	ventricular	JJ
work_4fnqcubqirfmrir73ujw47kvna	188	12	dysfunction	dysfunction	NN
work_4fnqcubqirfmrir73ujw47kvna	188	13	and/or	and/or	CC
work_4fnqcubqirfmrir73ujw47kvna	188	14	congestive	congestive	JJ
work_4fnqcubqirfmrir73ujw47kvna	188	15	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	188	16	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	188	17	but	but	CC
work_4fnqcubqirfmrir73ujw47kvna	188	18	also	also	RB
work_4fnqcubqirfmrir73ujw47kvna	188	19	reduce	reduce	VB
work_4fnqcubqirfmrir73ujw47kvna	188	20	acute	acute	JJ
work_4fnqcubqirfmrir73ujw47kvna	188	21	coronary	coronary	JJ
work_4fnqcubqirfmrir73ujw47kvna	188	22	events	event	NNS
work_4fnqcubqirfmrir73ujw47kvna	188	23	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	188	24	death	death	NN
work_4fnqcubqirfmrir73ujw47kvna	188	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	189	1	Experimentally	experimentally	RB
work_4fnqcubqirfmrir73ujw47kvna	189	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	189	3	angiotensin	angiotensin	NNP
work_4fnqcubqirfmrir73ujw47kvna	189	4	II	II	NNP
work_4fnqcubqirfmrir73ujw47kvna	189	5	stimulates	stimulate	VBZ
work_4fnqcubqirfmrir73ujw47kvna	189	6	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	189	7	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	189	8	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	189	9	activating	activate	VBG
work_4fnqcubqirfmrir73ujw47kvna	189	10	specific	specific	JJ
work_4fnqcubqirfmrir73ujw47kvna	189	11	binding	bind	VBG
work_4fnqcubqirfmrir73ujw47kvna	189	12	sites	site	NNS
work_4fnqcubqirfmrir73ujw47kvna	189	13	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	189	14	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	189	15	brainstem	brainstem	NN
work_4fnqcubqirfmrir73ujw47kvna	189	16	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	189	17	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	189	18	at	at	IN
work_4fnqcubqirfmrir73ujw47kvna	189	19	presynaptic	presynaptic	JJ
work_4fnqcubqirfmrir73ujw47kvna	189	20	levels	level	NNS
work_4fnqcubqirfmrir73ujw47kvna	189	21	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	189	22	it	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	189	23	increases	increase	VBZ
work_4fnqcubqirfmrir73ujw47kvna	189	24	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	189	25	release	release	NN
work_4fnqcubqirfmrir73ujw47kvna	189	26	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	189	27	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	189	28	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	189	29	sym-	sym-	JJ
work_4fnqcubqirfmrir73ujw47kvna	189	30	pathetic	pathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	189	31	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	189	32	endings	ending	NNS
work_4fnqcubqirfmrir73ujw47kvna	189	33	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	189	34	Fig	fig	NN
work_4fnqcubqirfmrir73ujw47kvna	189	35	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	190	1	1	1	LS
work_4fnqcubqirfmrir73ujw47kvna	190	2	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	190	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	191	1	These	these	DT
work_4fnqcubqirfmrir73ujw47kvna	191	2	mechanisms	mechanism	NNS
work_4fnqcubqirfmrir73ujw47kvna	191	3	could	could	MD
work_4fnqcubqirfmrir73ujw47kvna	191	4	explain	explain	VB
work_4fnqcubqirfmrir73ujw47kvna	191	5	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	191	6	increased	increased	JJ
work_4fnqcubqirfmrir73ujw47kvna	191	7	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	191	8	observed	observe	VBD
work_4fnqcubqirfmrir73ujw47kvna	191	9	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	191	10	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	191	11	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	191	12	reno-	reno-	JJ
work_4fnqcubqirfmrir73ujw47kvna	191	13	vascular	vascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	191	14	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	191	15	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	191	16	characterized	characterize	VBN
work_4fnqcubqirfmrir73ujw47kvna	191	17	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	191	18	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	191	19	high	high	JJ
work_4fnqcubqirfmrir73ujw47kvna	191	20	plasma	plasma	NN
work_4fnqcubqirfmrir73ujw47kvna	191	21	level	level	NN
work_4fnqcubqirfmrir73ujw47kvna	191	22	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	191	23	angiotensin	angiotensin	NNP
work_4fnqcubqirfmrir73ujw47kvna	191	24	II	II	NNP
work_4fnqcubqirfmrir73ujw47kvna	191	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	192	1	After	after	IN
work_4fnqcubqirfmrir73ujw47kvna	192	2	administration	administration	NN
work_4fnqcubqirfmrir73ujw47kvna	192	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	192	4	captopril	captopril	NNP
work_4fnqcubqirfmrir73ujw47kvna	192	5	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	192	6	healthy	healthy	JJ
work_4fnqcubqirfmrir73ujw47kvna	192	7	volunteers	volunteer	NNS
work_4fnqcubqirfmrir73ujw47kvna	192	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	192	9	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	192	10	remained	remain	VBD
work_4fnqcubqirfmrir73ujw47kvna	192	11	constant	constant	JJ
work_4fnqcubqirfmrir73ujw47kvna	192	12	despite	despite	IN
work_4fnqcubqirfmrir73ujw47kvna	192	13	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	192	14	significant	significant	JJ
work_4fnqcubqirfmrir73ujw47kvna	192	15	decrease	decrease	NN
work_4fnqcubqirfmrir73ujw47kvna	192	16	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	192	17	diastolic	diastolic	JJ
work_4fnqcubqirfmrir73ujw47kvna	192	18	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	192	19	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	192	20	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	192	21	Fig	fig	NN
work_4fnqcubqirfmrir73ujw47kvna	192	22	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	193	1	4	4	LS
work_4fnqcubqirfmrir73ujw47kvna	193	2	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	193	3	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	193	4	8)	8)	CD
work_4fnqcubqirfmrir73ujw47kvna	193	5	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	194	1	These	these	DT
work_4fnqcubqirfmrir73ujw47kvna	194	2	find-	find-	JJ
work_4fnqcubqirfmrir73ujw47kvna	194	3	ings	ing	NNS
work_4fnqcubqirfmrir73ujw47kvna	194	4	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	194	5	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	194	6	line	line	NN
work_4fnqcubqirfmrir73ujw47kvna	194	7	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	194	8	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	194	9	observation	observation	NN
work_4fnqcubqirfmrir73ujw47kvna	194	10	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	194	11	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	194	12	rat	rat	NN
work_4fnqcubqirfmrir73ujw47kvna	194	13	model	model	NN
work_4fnqcubqirfmrir73ujw47kvna	194	14	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	194	15	renal	renal	NNP
work_4fnqcubqirfmrir73ujw47kvna	194	16	hypertension	hypertension	NNP
work_4fnqcubqirfmrir73ujw47kvna	194	17	lisinopril	lisinopril	NNP
work_4fnqcubqirfmrir73ujw47kvna	194	18	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	194	19	losartan	losartan	NNP
work_4fnqcubqirfmrir73ujw47kvna	194	20	had	have	VBD
work_4fnqcubqirfmrir73ujw47kvna	194	21	no	no	DT
work_4fnqcubqirfmrir73ujw47kvna	194	22	influence	influence	NN
work_4fnqcubqirfmrir73ujw47kvna	194	23	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	194	24	splanchnic	splanchnic	JJ
work_4fnqcubqirfmrir73ujw47kvna	194	25	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	194	26	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	194	27	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	194	28	despite	despite	IN
work_4fnqcubqirfmrir73ujw47kvna	194	29	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	194	30	reduction	reduction	NN
work_4fnqcubqirfmrir73ujw47kvna	194	31	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	194	32	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	194	33	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	194	34	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	195	1	This	this	DT
work_4fnqcubqirfmrir73ujw47kvna	195	2	effect	effect	NN
work_4fnqcubqirfmrir73ujw47kvna	195	3	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	195	4	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	195	5	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	195	6	could	could	MD
work_4fnqcubqirfmrir73ujw47kvna	195	7	explain	explain	VB
work_4fnqcubqirfmrir73ujw47kvna	195	8	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	195	9	favorable	favorable	JJ
work_4fnqcubqirfmrir73ujw47kvna	195	10	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	195	11	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	195	12	ACE	ACE	NNP
work_4fnqcubqirfmrir73ujw47kvna	195	13	inhibitors	inhibitor	NNS
work_4fnqcubqirfmrir73ujw47kvna	195	14	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	195	15	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	195	16	prognosis	prognosis	NN
work_4fnqcubqirfmrir73ujw47kvna	195	17	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	195	18	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	195	19	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	195	20	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	195	21	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	195	22	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	195	23	whom	whom	WP
work_4fnqcubqirfmrir73ujw47kvna	195	24	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	195	25	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	195	26	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	195	27	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	195	28	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	195	29	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	195	30	important	important	JJ
work_4fnqcubqirfmrir73ujw47kvna	195	31	prognostic	prognostic	JJ
work_4fnqcubqirfmrir73ujw47kvna	195	32	factor	factor	NN
work_4fnqcubqirfmrir73ujw47kvna	195	33	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	196	1	Hence	hence	RB
work_4fnqcubqirfmrir73ujw47kvna	196	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	196	3	ACE	ACE	NNP
work_4fnqcubqirfmrir73ujw47kvna	196	4	inhibitors	inhibitor	NNS
work_4fnqcubqirfmrir73ujw47kvna	196	5	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	196	6	possibly	possibly	RB
work_4fnqcubqirfmrir73ujw47kvna	196	7	angiotensin	angiotensin	VB
work_4fnqcubqirfmrir73ujw47kvna	196	8	II	ii	CD
work_4fnqcubqirfmrir73ujw47kvna	196	9	receptor	receptor	NN
work_4fnqcubqirfmrir73ujw47kvna	196	10	antagonists	antagonist	NNS
work_4fnqcubqirfmrir73ujw47kvna	196	11	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	196	12	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	196	13	particu-	particu-	VBN
work_4fnqcubqirfmrir73ujw47kvna	196	14	larly	larly	RB
work_4fnqcubqirfmrir73ujw47kvna	196	15	efficacious	efficacious	JJ
work_4fnqcubqirfmrir73ujw47kvna	196	16	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	196	17	blunting	blunting	NN
work_4fnqcubqirfmrir73ujw47kvna	196	18	or	or	CC
work_4fnqcubqirfmrir73ujw47kvna	196	19	even	even	RB
work_4fnqcubqirfmrir73ujw47kvna	196	20	inhibiting	inhibit	VBG
work_4fnqcubqirfmrir73ujw47kvna	196	21	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	196	22	untoward	untoward	JJ
work_4fnqcubqirfmrir73ujw47kvna	196	23	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	196	24	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	196	25	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	196	26	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	196	27	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	196	28	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	196	29	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	196	30	cardiovascular	cardiovascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	196	31	disease	disease	NN
work_4fnqcubqirfmrir73ujw47kvna	196	32	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	197	1	Similar	similar	JJ
work_4fnqcubqirfmrir73ujw47kvna	197	2	reduction	reduction	NN
work_4fnqcubqirfmrir73ujw47kvna	197	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	197	4	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	197	5	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	197	6	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	197	7	achieved	achieve	VBN
work_4fnqcubqirfmrir73ujw47kvna	197	8	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	197	9	nitrates	nitrate	NNS
work_4fnqcubqirfmrir73ujw47kvna	197	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	197	11	but	but	CC
work_4fnqcubqirfmrir73ujw47kvna	197	12	these	these	DT
work_4fnqcubqirfmrir73ujw47kvna	197	13	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	197	14	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	197	15	associated	associate	VBN
work_4fnqcubqirfmrir73ujw47kvna	197	16	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	197	17	marked	mark	VBN
work_4fnqcubqirfmrir73ujw47kvna	197	18	activa-	activa-	NNP
work_4fnqcubqirfmrir73ujw47kvna	197	19	tion	tion	NN
work_4fnqcubqirfmrir73ujw47kvna	197	20	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	197	21	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	197	22	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	197	23	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	198	1	Earlier	early	JJR
work_4fnqcubqirfmrir73ujw47kvna	198	2	studies	study	NNS
work_4fnqcubqirfmrir73ujw47kvna	198	3	demonstrated	demonstrate	VBD
work_4fnqcubqirfmrir73ujw47kvna	198	4	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	198	5	intravenous	intravenous	JJ
work_4fnqcubqirfmrir73ujw47kvna	198	6	administration	administration	NN
work_4fnqcubqirfmrir73ujw47kvna	198	7	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	198	8	nitrovasodialators	nitrovasodialators	NNP
work_4fnqcubqirfmrir73ujw47kvna	198	9	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	198	10	associated	associate	VBN
work_4fnqcubqirfmrir73ujw47kvna	198	11	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	198	12	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	198	13	marked	marked	JJ
work_4fnqcubqirfmrir73ujw47kvna	198	14	increase	increase	NN
work_4fnqcubqirfmrir73ujw47kvna	198	15	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	198	16	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	198	17	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	199	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	199	2	healthy	healthy	JJ
work_4fnqcubqirfmrir73ujw47kvna	199	3	subjects	subject	NNS
work_4fnqcubqirfmrir73ujw47kvna	199	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	199	5	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	199	6	acute	acute	JJ
work_4fnqcubqirfmrir73ujw47kvna	199	7	oral	oral	JJ
work_4fnqcubqirfmrir73ujw47kvna	199	8	administration	administration	NN
work_4fnqcubqirfmrir73ujw47kvna	199	9	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	199	10	isosorbide	isosorbide	JJ
work_4fnqcubqirfmrir73ujw47kvna	199	11	dinitrate	dinitrate	NN
work_4fnqcubqirfmrir73ujw47kvna	199	12	causes	cause	VBZ
work_4fnqcubqirfmrir73ujw47kvna	199	13	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	199	14	marked	marked	JJ
work_4fnqcubqirfmrir73ujw47kvna	199	15	increase	increase	NN
work_4fnqcubqirfmrir73ujw47kvna	199	16	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	199	17	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	199	18	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	199	19	Fig	fig	NN
work_4fnqcubqirfmrir73ujw47kvna	199	20	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	200	1	4	4	LS
work_4fnqcubqirfmrir73ujw47kvna	200	2	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	200	3	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	200	4	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	200	5	rate	rate	NN
work_4fnqcubqirfmrir73ujw47kvna	200	6	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	200	7	has	have	VBZ
work_4fnqcubqirfmrir73ujw47kvna	200	8	little	little	JJ
work_4fnqcubqirfmrir73ujw47kvna	200	9	effect	effect	NN
work_4fnqcubqirfmrir73ujw47kvna	200	10	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	200	11	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	200	12	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	200	13	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	201	1	Indeed	indeed	RB
work_4fnqcubqirfmrir73ujw47kvna	201	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	201	3	this	this	DT
work_4fnqcubqirfmrir73ujw47kvna	201	4	effect	effect	NN
work_4fnqcubqirfmrir73ujw47kvna	201	5	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	201	6	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	201	7	nitrates	nitrate	NNS
work_4fnqcubqirfmrir73ujw47kvna	201	8	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	201	9	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	201	10	partially	partially	RB
work_4fnqcubqirfmrir73ujw47kvna	201	11	responsible	responsible	JJ
work_4fnqcubqirfmrir73ujw47kvna	201	12	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	201	13	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	201	14	clinically	clinically	RB
work_4fnqcubqirfmrir73ujw47kvna	201	15	observed	observe	VBN
work_4fnqcubqirfmrir73ujw47kvna	201	16	tolerance	tolerance	NN
work_4fnqcubqirfmrir73ujw47kvna	201	17	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	201	18	or	or	CC
work_4fnqcubqirfmrir73ujw47kvna	201	19	rather	rather	RB
work_4fnqcubqirfmrir73ujw47kvna	201	20	pseudotolerance	pseudotolerance	NN
work_4fnqcubqirfmrir73ujw47kvna	201	21	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	201	22	since	since	IN
work_4fnqcubqirfmrir73ujw47kvna	201	23	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	201	24	baroreflex	baroreflex	NN
work_4fnqcubqirfmrir73ujw47kvna	201	25	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	201	26	mediated	mediate	VBN
work_4fnqcubqirfmrir73ujw47kvna	201	27	News	News	NNP
work_4fnqcubqirfmrir73ujw47kvna	201	28	Physiol	Physiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	201	29	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	202	1	Sci	Sci	NNP
work_4fnqcubqirfmrir73ujw47kvna	202	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	203	1	•	•	NNP
work_4fnqcubqirfmrir73ujw47kvna	203	2	Volume	volume	NN
work_4fnqcubqirfmrir73ujw47kvna	203	3	15	15	CD
work_4fnqcubqirfmrir73ujw47kvna	203	4	•	•	NN
work_4fnqcubqirfmrir73ujw47kvna	203	5	June	June	NNP
work_4fnqcubqirfmrir73ujw47kvna	203	6	2000128	2000128	CD
work_4fnqcubqirfmrir73ujw47kvna	203	7	FIGURE	FIGURE	NNP
work_4fnqcubqirfmrir73ujw47kvna	203	8	3	3	CD
work_4fnqcubqirfmrir73ujw47kvna	203	9	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	204	1	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	204	2	expressed	express	VBD
work_4fnqcubqirfmrir73ujw47kvna	204	3	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	204	4	bursts	burst	NNS
work_4fnqcubqirfmrir73ujw47kvna	204	5	/	/	SYM
work_4fnqcubqirfmrir73ujw47kvna	204	6	min	min	NNP
work_4fnqcubqirfmrir73ujw47kvna	204	7	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	204	8	left	leave	VBN
work_4fnqcubqirfmrir73ujw47kvna	204	9	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	204	10	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	204	11	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	204	12	rate	rate	NN
work_4fnqcubqirfmrir73ujw47kvna	204	13	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	204	14	right	right	UH
work_4fnqcubqirfmrir73ujw47kvna	204	15	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	204	16	before	before	IN
work_4fnqcubqirfmrir73ujw47kvna	204	17	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	204	18	after	after	IN
work_4fnqcubqirfmrir73ujw47kvna	204	19	oral	oral	JJ
work_4fnqcubqirfmrir73ujw47kvna	204	20	nifedipine	nifedipine	NN
work_4fnqcubqirfmrir73ujw47kvna	204	21	[	[	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	204	22	5	5	CD
work_4fnqcubqirfmrir73ujw47kvna	204	23	mg	mg	CD
work_4fnqcubqirfmrir73ujw47kvna	204	24	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	204	25	10	10	CD
work_4fnqcubqirfmrir73ujw47kvna	204	26	mg	mg	NN
work_4fnqcubqirfmrir73ujw47kvna	204	27	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	204	28	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	204	29	GI	GI	NNP
work_4fnqcubqirfmrir73ujw47kvna	204	30	theraputic	theraputic	NN
work_4fnqcubqirfmrir73ujw47kvna	204	31	system	system	NN
work_4fnqcubqirfmrir73ujw47kvna	204	32	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	204	33	GITS	GITS	NNP
work_4fnqcubqirfmrir73ujw47kvna	204	34	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	204	35	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	204	36	60	60	CD
work_4fnqcubqirfmrir73ujw47kvna	204	37	mg	mg	NNP
work_4fnqcubqirfmrir73ujw47kvna	204	38	]	]	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	204	39	or	or	CC
work_4fnqcubqirfmrir73ujw47kvna	204	40	placebo	placebo	NN
work_4fnqcubqirfmrir73ujw47kvna	204	41	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	205	1	bpm	bpm	NNP
work_4fnqcubqirfmrir73ujw47kvna	205	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	205	3	Beats	Beats	NNPS
work_4fnqcubqirfmrir73ujw47kvna	205	4	per	per	IN
work_4fnqcubqirfmrir73ujw47kvna	205	5	minute	minute	NN
work_4fnqcubqirfmrir73ujw47kvna	205	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	206	1	Modified	modify	VBN
work_4fnqcubqirfmrir73ujw47kvna	206	2	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	206	3	Ref	Ref	NNP
work_4fnqcubqirfmrir73ujw47kvna	206	4	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	207	1	14	14	CD
work_4fnqcubqirfmrir73ujw47kvna	207	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	208	1	FIGURE	FIGURE	NNP
work_4fnqcubqirfmrir73ujw47kvna	208	2	4	4	CD
work_4fnqcubqirfmrir73ujw47kvna	208	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	209	1	Change	change	NN
work_4fnqcubqirfmrir73ujw47kvna	209	2	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	209	3	resting	rest	VBG
work_4fnqcubqirfmrir73ujw47kvna	209	4	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	209	5	90	90	CD
work_4fnqcubqirfmrir73ujw47kvna	209	6	minutes	minute	NNS
work_4fnqcubqirfmrir73ujw47kvna	209	7	after	after	IN
work_4fnqcubqirfmrir73ujw47kvna	209	8	oral	oral	JJ
work_4fnqcubqirfmrir73ujw47kvna	209	9	administration	administration	NNP
work_4fnqcubqirfmrir73ujw47kvna	209	10	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	209	11	placebo	placebo	NNP
work_4fnqcubqirfmrir73ujw47kvna	209	12	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	209	13	6.25	6.25	CD
work_4fnqcubqirfmrir73ujw47kvna	209	14	mg	mg	NNP
work_4fnqcubqirfmrir73ujw47kvna	209	15	captopril	captopril	NNP
work_4fnqcubqirfmrir73ujw47kvna	209	16	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	209	17	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	209	18	40	40	CD
work_4fnqcubqirfmrir73ujw47kvna	209	19	mg	mg	NN
work_4fnqcubqirfmrir73ujw47kvna	209	20	isosorbide	isosorbide	JJ
work_4fnqcubqirfmrir73ujw47kvna	209	21	dinitrate	dinitrate	NN
work_4fnqcubqirfmrir73ujw47kvna	209	22	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	209	23	ISDN	ISDN	NNP
work_4fnqcubqirfmrir73ujw47kvna	209	24	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	209	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	210	1	A	a	DT
work_4fnqcubqirfmrir73ujw47kvna	210	2	signifi-	signifi-	NN
work_4fnqcubqirfmrir73ujw47kvna	210	3	ca	can	MD
work_4fnqcubqirfmrir73ujw47kvna	210	4	nt	not	RB
work_4fnqcubqirfmrir73ujw47kvna	210	5	increase	increase	VB
work_4fnqcubqirfmrir73ujw47kvna	210	6	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	210	7	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	210	8	was	be	VBD
work_4fnqcubqirfmrir73ujw47kvna	210	9	observed	observe	VBN
work_4fnqcubqirfmrir73ujw47kvna	210	10	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	210	11	subjects	subject	NNS
work_4fnqcubqirfmrir73ujw47kvna	210	12	who	who	WP
work_4fnqcubqirfmrir73ujw47kvna	210	13	received	receive	VBD
work_4fnqcubqirfmrir73ujw47kvna	210	14	placebo	placebo	NN
work_4fnqcubqirfmrir73ujw47kvna	210	15	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	211	1	Increase	increase	NN
work_4fnqcubqirfmrir73ujw47kvna	211	2	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	211	3	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	211	4	after	after	IN
work_4fnqcubqirfmrir73ujw47kvna	211	5	ISDN	ISDN	NNP
work_4fnqcubqirfmrir73ujw47kvna	211	6	was	be	VBD
work_4fnqcubqirfmrir73ujw47kvna	211	7	more	more	RBR
work_4fnqcubqirfmrir73ujw47kvna	211	8	pronounced	pronounced	JJ
work_4fnqcubqirfmrir73ujw47kvna	211	9	compared	compare	VBN
work_4fnqcubqirfmrir73ujw47kvna	211	10	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	211	11	placebo	placebo	NN
work_4fnqcubqirfmrir73ujw47kvna	211	12	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	212	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	212	2	subjects	subject	NNS
work_4fnqcubqirfmrir73ujw47kvna	212	3	treated	treat	VBN
work_4fnqcubqirfmrir73ujw47kvna	212	4	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	212	5	captopril	captopril	NNP
work_4fnqcubqirfmrir73ujw47kvna	212	6	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	212	7	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	212	8	did	do	VBD
work_4fnqcubqirfmrir73ujw47kvna	212	9	not	not	RB
work_4fnqcubqirfmrir73ujw47kvna	212	10	change	change	VB
work_4fnqcubqirfmrir73ujw47kvna	212	11	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	213	1	*	*	NFP
work_4fnqcubqirfmrir73ujw47kvna	213	2	P	p	NN
work_4fnqcubqirfmrir73ujw47kvna	213	3	<	<	XX
work_4fnqcubqirfmrir73ujw47kvna	213	4	0.05	0.05	CD
work_4fnqcubqirfmrir73ujw47kvna	213	5	vs.	vs.	IN
work_4fnqcubqirfmrir73ujw47kvna	213	6	placebo	placebo	NN
work_4fnqcubqirfmrir73ujw47kvna	213	7	;	;	:
work_4fnqcubqirfmrir73ujw47kvna	213	8	#	#	NNP
work_4fnqcubqirfmrir73ujw47kvna	213	9	P	p	NN
work_4fnqcubqirfmrir73ujw47kvna	213	10	<	<	XX
work_4fnqcubqirfmrir73ujw47kvna	213	11	0.05	0.05	CD
work_4fnqcubqirfmrir73ujw47kvna	213	12	vs.	vs.	IN
work_4fnqcubqirfmrir73ujw47kvna	213	13	ISDN	ISDN	NNP
work_4fnqcubqirfmrir73ujw47kvna	213	14	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	214	1	Modified	modify	VBN
work_4fnqcubqirfmrir73ujw47kvna	214	2	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	214	3	Ref	Ref	NNP
work_4fnqcubqirfmrir73ujw47kvna	214	4	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	215	1	8	8	LS
work_4fnqcubqirfmrir73ujw47kvna	215	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	216	1	Downloaded	download	VBN
work_4fnqcubqirfmrir73ujw47kvna	216	2	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	216	3	journals.physiology.org/journal/physiologyonline	journals.physiology.org/journal/physiologyonline	NN
work_4fnqcubqirfmrir73ujw47kvna	216	4	at	at	IN
work_4fnqcubqirfmrir73ujw47kvna	216	5	Carnegie	Carnegie	NNP
work_4fnqcubqirfmrir73ujw47kvna	216	6	Mellon	Mellon	NNP
work_4fnqcubqirfmrir73ujw47kvna	216	7	Univ	Univ	NNP
work_4fnqcubqirfmrir73ujw47kvna	216	8	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	216	9	128.182.081.034	128.182.081.034	CD
work_4fnqcubqirfmrir73ujw47kvna	216	10	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	216	11	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	216	12	April	April	NNP
work_4fnqcubqirfmrir73ujw47kvna	216	13	5	5	CD
work_4fnqcubqirfmrir73ujw47kvna	216	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	216	15	2021	2021	CD
work_4fnqcubqirfmrir73ujw47kvna	216	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	217	1	News	News	NNP
work_4fnqcubqirfmrir73ujw47kvna	217	2	Physiol	Physiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	217	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	218	1	Sci	Sci	NNP
work_4fnqcubqirfmrir73ujw47kvna	218	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	219	1	•	•	NNP
work_4fnqcubqirfmrir73ujw47kvna	219	2	Volume	volume	NN
work_4fnqcubqirfmrir73ujw47kvna	219	3	15	15	CD
work_4fnqcubqirfmrir73ujw47kvna	219	4	•	•	NN
work_4fnqcubqirfmrir73ujw47kvna	219	5	June	June	NNP
work_4fnqcubqirfmrir73ujw47kvna	219	6	2000	2000	CD
work_4fnqcubqirfmrir73ujw47kvna	219	7	129	129	CD
work_4fnqcubqirfmrir73ujw47kvna	219	8	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	219	9	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	219	10	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	219	11	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	219	12	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	219	13	part	part	NN
work_4fnqcubqirfmrir73ujw47kvna	219	14	blunts	blunt	VBZ
work_4fnqcubqirfmrir73ujw47kvna	219	15	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	219	16	vasodilator	vasodilator	NN
work_4fnqcubqirfmrir73ujw47kvna	219	17	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	219	18	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	219	19	these	these	DT
work_4fnqcubqirfmrir73ujw47kvna	219	20	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	219	21	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	219	22	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	219	23	intact	intact	JJ
work_4fnqcubqirfmrir73ujw47kvna	219	24	organ	organ	NN
work_4fnqcubqirfmrir73ujw47kvna	219	25	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	219	26	8)	8)	CD
work_4fnqcubqirfmrir73ujw47kvna	219	27	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	220	1	Centrally	centrally	RB
work_4fnqcubqirfmrir73ujw47kvna	220	2	acting	act	VBG
work_4fnqcubqirfmrir73ujw47kvna	220	3	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	220	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	220	5	i.e.	i.e.	FW
work_4fnqcubqirfmrir73ujw47kvna	220	6	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	220	7	clonidine	clonidine	NN
work_4fnqcubqirfmrir73ujw47kvna	220	8	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	220	9	α	α	NNP
work_4fnqcubqirfmrir73ujw47kvna	220	10	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	220	11	methyl	methyl	NN
work_4fnqcubqirfmrir73ujw47kvna	220	12	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	220	13	DOPA	DOPA	NNP
work_4fnqcubqirfmrir73ujw47kvna	220	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	220	15	have	have	VBP
work_4fnqcubqirfmrir73ujw47kvna	220	16	been	be	VBN
work_4fnqcubqirfmrir73ujw47kvna	220	17	used	use	VBN
work_4fnqcubqirfmrir73ujw47kvna	220	18	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	220	19	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	220	20	treatment	treatment	NN
work_4fnqcubqirfmrir73ujw47kvna	220	21	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	220	22	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	220	23	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	220	24	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	220	25	long	long	JJ
work_4fnqcubqirfmrir73ujw47kvna	220	26	time	time	NN
work_4fnqcubqirfmrir73ujw47kvna	220	27	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	221	1	It	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	221	2	has	have	VBZ
work_4fnqcubqirfmrir73ujw47kvna	221	3	been	be	VBN
work_4fnqcubqirfmrir73ujw47kvna	221	4	postulated	postulate	VBN
work_4fnqcubqirfmrir73ujw47kvna	221	5	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	221	6	this	this	DT
work_4fnqcubqirfmrir73ujw47kvna	221	7	antihypertensive	antihypertensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	221	8	effect	effect	NN
work_4fnqcubqirfmrir73ujw47kvna	221	9	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	221	10	due	due	JJ
work_4fnqcubqirfmrir73ujw47kvna	221	11	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	221	12	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	221	13	central	central	JJ
work_4fnqcubqirfmrir73ujw47kvna	221	14	inhibitory	inhibitory	JJ
work_4fnqcubqirfmrir73ujw47kvna	221	15	effect	effect	NN
work_4fnqcubqirfmrir73ujw47kvna	221	16	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	221	17	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	221	18	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	221	19	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	222	1	Moxonidine	moxonidine	NN
work_4fnqcubqirfmrir73ujw47kvna	222	2	belongs	belong	VBZ
work_4fnqcubqirfmrir73ujw47kvna	222	3	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	222	4	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	222	5	new	new	JJ
work_4fnqcubqirfmrir73ujw47kvna	222	6	generation	generation	NN
work_4fnqcubqirfmrir73ujw47kvna	222	7	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	222	8	centrally	centrally	RB
work_4fnqcubqirfmrir73ujw47kvna	222	9	acting	act	VBG
work_4fnqcubqirfmrir73ujw47kvna	222	10	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	222	11	that	that	WDT
work_4fnqcubqirfmrir73ujw47kvna	222	12	activate	activate	VBP
work_4fnqcubqirfmrir73ujw47kvna	222	13	I1-imida-	I1-imida-	NNP
work_4fnqcubqirfmrir73ujw47kvna	222	14	zoline	zoline	NN
work_4fnqcubqirfmrir73ujw47kvna	222	15	receptors	receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	222	16	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	222	17	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	222	18	brain	brain	NN
work_4fnqcubqirfmrir73ujw47kvna	222	19	stem	stem	NN
work_4fnqcubqirfmrir73ujw47kvna	222	20	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	223	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	223	2	oral	oral	JJ
work_4fnqcubqirfmrir73ujw47kvna	223	3	administration	administration	NN
work_4fnqcubqirfmrir73ujw47kvna	223	4	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	223	5	moxonidine	moxonidine	NN
work_4fnqcubqirfmrir73ujw47kvna	223	6	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	223	7	healthy	healthy	JJ
work_4fnqcubqirfmrir73ujw47kvna	223	8	volunteers	volunteer	NNS
work_4fnqcubqirfmrir73ujw47kvna	223	9	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	223	10	hypertensive	hypertensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	223	11	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	223	12	leads	lead	VBZ
work_4fnqcubqirfmrir73ujw47kvna	223	13	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	223	14	a	a	DT
work_4fnqcubqirfmrir73ujw47kvna	223	15	significant	significant	JJ
work_4fnqcubqirfmrir73ujw47kvna	223	16	decrease	decrease	NN
work_4fnqcubqirfmrir73ujw47kvna	223	17	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	223	18	systolic	systolic	JJ
work_4fnqcubqirfmrir73ujw47kvna	223	19	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	223	20	diastolic	diastolic	JJ
work_4fnqcubqirfmrir73ujw47kvna	223	21	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	223	22	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	223	23	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	223	24	NE	NE	NNP
work_4fnqcubqirfmrir73ujw47kvna	223	25	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	223	26	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	223	27	MSA	MSA	NNP
work_4fnqcubqirfmrir73ujw47kvna	223	28	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	223	29	15	15	CD
work_4fnqcubqirfmrir73ujw47kvna	223	30	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	223	31	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	224	1	This	this	DT
work_4fnqcubqirfmrir73ujw47kvna	224	2	demonstrates	demonstrate	VBZ
work_4fnqcubqirfmrir73ujw47kvna	224	3	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	224	4	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	224	5	I1-imida-	I1-imida-	NNP
work_4fnqcubqirfmrir73ujw47kvna	224	6	zoline	zoline	NN
work_4fnqcubqirfmrir73ujw47kvna	224	7	receptor	receptor	NN
work_4fnqcubqirfmrir73ujw47kvna	224	8	agonist	agonist	NN
work_4fnqcubqirfmrir73ujw47kvna	224	9	moxonidine	moxonidine	NNP
work_4fnqcubqirfmrir73ujw47kvna	224	10	reduces	reduce	VBZ
work_4fnqcubqirfmrir73ujw47kvna	224	11	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	224	12	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	224	13	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	224	14	untreated	untreated	JJ
work_4fnqcubqirfmrir73ujw47kvna	224	15	hypertensive	hypertensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	224	16	subjects	subject	NNS
work_4fnqcubqirfmrir73ujw47kvna	224	17	through	through	IN
work_4fnqcubqirfmrir73ujw47kvna	224	18	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	224	19	reduction	reduction	NN
work_4fnqcubqirfmrir73ujw47kvna	224	20	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	224	21	central	central	JJ
work_4fnqcubqirfmrir73ujw47kvna	224	22	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	224	23	outflow	outflow	NN
work_4fnqcubqirfmrir73ujw47kvna	224	24	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	224	25	15	15	CD
work_4fnqcubqirfmrir73ujw47kvna	224	26	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	224	27	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	225	1	This	this	DT
work_4fnqcubqirfmrir73ujw47kvna	225	2	effect	effect	NN
work_4fnqcubqirfmrir73ujw47kvna	225	3	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	225	4	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	225	5	beneficial	beneficial	JJ
work_4fnqcubqirfmrir73ujw47kvna	225	6	not	not	RB
work_4fnqcubqirfmrir73ujw47kvna	225	7	only	only	RB
work_4fnqcubqirfmrir73ujw47kvna	225	8	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	225	9	hypertensives	hypertensive	NNS
work_4fnqcubqirfmrir73ujw47kvna	225	10	but	but	CC
work_4fnqcubqirfmrir73ujw47kvna	225	11	also	also	RB
work_4fnqcubqirfmrir73ujw47kvna	225	12	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	225	13	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	225	14	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	225	15	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	225	16	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	225	17	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	226	1	Clinical	clinical	JJ
work_4fnqcubqirfmrir73ujw47kvna	226	2	Implications	implication	NNS
work_4fnqcubqirfmrir73ujw47kvna	226	3	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	226	4	conclusion	conclusion	NN
work_4fnqcubqirfmrir73ujw47kvna	226	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	226	6	it	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	226	7	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	226	8	clear	clear	JJ
work_4fnqcubqirfmrir73ujw47kvna	226	9	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	226	10	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	226	11	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	226	12	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	226	13	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	226	14	important	important	JJ
work_4fnqcubqirfmrir73ujw47kvna	226	15	prognostic	prognostic	JJ
work_4fnqcubqirfmrir73ujw47kvna	226	16	factor	factor	NN
work_4fnqcubqirfmrir73ujw47kvna	226	17	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	226	18	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	226	19	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	226	20	cardiovascular	cardiovascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	226	21	disease	disease	NN
work_4fnqcubqirfmrir73ujw47kvna	226	22	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	226	23	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	226	24	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	226	25	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	226	26	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	226	27	particular	particular	JJ
work_4fnqcubqirfmrir73ujw47kvna	226	28	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	227	1	Its	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	227	2	true	true	JJ
work_4fnqcubqirfmrir73ujw47kvna	227	3	importance	importance	NN
work_4fnqcubqirfmrir73ujw47kvna	227	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	227	5	however	however	RB
work_4fnqcubqirfmrir73ujw47kvna	227	6	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	227	7	has	have	VBZ
work_4fnqcubqirfmrir73ujw47kvna	227	8	been	be	VBN
work_4fnqcubqirfmrir73ujw47kvna	227	9	revealed	reveal	VBN
work_4fnqcubqirfmrir73ujw47kvna	227	10	more	more	RBR
work_4fnqcubqirfmrir73ujw47kvna	227	11	recently	recently	RB
work_4fnqcubqirfmrir73ujw47kvna	227	12	though	though	IN
work_4fnqcubqirfmrir73ujw47kvna	227	13	new	new	JJ
work_4fnqcubqirfmrir73ujw47kvna	227	14	tech-	tech-	JJ
work_4fnqcubqirfmrir73ujw47kvna	227	15	niques	nique	NNS
work_4fnqcubqirfmrir73ujw47kvna	227	16	allowing	allow	VBG
work_4fnqcubqirfmrir73ujw47kvna	227	17	precise	precise	JJ
work_4fnqcubqirfmrir73ujw47kvna	227	18	assessment	assessment	NN
work_4fnqcubqirfmrir73ujw47kvna	227	19	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	227	20	its	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	227	21	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	227	22	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	227	23	its	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	227	24	con-	con-	NN
work_4fnqcubqirfmrir73ujw47kvna	227	25	trol	trol	VBP
work_4fnqcubqirfmrir73ujw47kvna	227	26	over	over	IN
work_4fnqcubqirfmrir73ujw47kvna	227	27	cardiovascular	cardiovascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	227	28	functions	function	NNS
work_4fnqcubqirfmrir73ujw47kvna	227	29	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	227	30	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	227	31	intact	intact	JJ
work_4fnqcubqirfmrir73ujw47kvna	227	32	organism	organism	NN
work_4fnqcubqirfmrir73ujw47kvna	227	33	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	228	1	Recent	recent	JJ
work_4fnqcubqirfmrir73ujw47kvna	228	2	data	datum	NNS
work_4fnqcubqirfmrir73ujw47kvna	228	3	suggest	suggest	VBP
work_4fnqcubqirfmrir73ujw47kvna	228	4	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	228	5	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	228	6	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	228	7	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	228	8	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	228	9	during	during	IN
work_4fnqcubqirfmrir73ujw47kvna	228	10	men-	men-	NN
work_4fnqcubqirfmrir73ujw47kvna	228	11	tal	tal	JJ
work_4fnqcubqirfmrir73ujw47kvna	228	12	stress	stress	NN
work_4fnqcubqirfmrir73ujw47kvna	228	13	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	228	14	precede	precede	VB
work_4fnqcubqirfmrir73ujw47kvna	228	15	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	228	16	increase	increase	NN
work_4fnqcubqirfmrir73ujw47kvna	228	17	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	228	18	resting	rest	VBG
work_4fnqcubqirfmrir73ujw47kvna	228	19	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	228	20	present	present	JJ
work_4fnqcubqirfmrir73ujw47kvna	228	21	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	228	22	early	early	JJ
work_4fnqcubqirfmrir73ujw47kvna	228	23	stages	stage	NNS
work_4fnqcubqirfmrir73ujw47kvna	228	24	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	228	25	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	228	26	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	229	1	These	these	DT
work_4fnqcubqirfmrir73ujw47kvna	229	2	data	datum	NNS
work_4fnqcubqirfmrir73ujw47kvna	229	3	suggest	suggest	VBP
work_4fnqcubqirfmrir73ujw47kvna	229	4	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	229	5	respon-	respon-	NNP
work_4fnqcubqirfmrir73ujw47kvna	229	6	siveness	siveness	NNP
work_4fnqcubqirfmrir73ujw47kvna	229	7	as	as	RB
work_4fnqcubqirfmrir73ujw47kvna	229	8	well	well	RB
work_4fnqcubqirfmrir73ujw47kvna	229	9	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	229	10	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	229	11	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	229	12	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	229	13	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	229	14	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	229	15	play	play	VB
work_4fnqcubqirfmrir73ujw47kvna	229	16	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	229	17	important	important	JJ
work_4fnqcubqirfmrir73ujw47kvna	229	18	role	role	NN
work_4fnqcubqirfmrir73ujw47kvna	229	19	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	229	20	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	229	21	development	development	NN
work_4fnqcubqirfmrir73ujw47kvna	229	22	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	229	23	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	229	24	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	230	1	Hence	hence	RB
work_4fnqcubqirfmrir73ujw47kvna	230	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	230	3	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	230	4	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	230	5	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	230	6	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	230	7	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	230	8	this	this	DT
work_4fnqcubqirfmrir73ujw47kvna	230	9	important	important	JJ
work_4fnqcubqirfmrir73ujw47kvna	230	10	regulatory	regulatory	JJ
work_4fnqcubqirfmrir73ujw47kvna	230	11	system	system	NN
work_4fnqcubqirfmrir73ujw47kvna	230	12	should	should	MD
work_4fnqcubqirfmrir73ujw47kvna	230	13	be	be	VB
work_4fnqcubqirfmrir73ujw47kvna	230	14	more	more	RBR
work_4fnqcubqirfmrir73ujw47kvna	230	15	thoroughly	thoroughly	RB
work_4fnqcubqirfmrir73ujw47kvna	230	16	investigated	investigate	VBN
work_4fnqcubqirfmrir73ujw47kvna	230	17	since	since	IN
work_4fnqcubqirfmrir73ujw47kvna	230	18	this	this	DT
work_4fnqcubqirfmrir73ujw47kvna	230	19	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	230	20	have	have	VB
work_4fnqcubqirfmrir73ujw47kvna	230	21	important	important	JJ
work_4fnqcubqirfmrir73ujw47kvna	230	22	impli-	impli-	JJ
work_4fnqcubqirfmrir73ujw47kvna	230	23	cations	cation	NNS
work_4fnqcubqirfmrir73ujw47kvna	230	24	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	230	25	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	230	26	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	230	27	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	230	28	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	230	29	prognosis	prognosis	NN
work_4fnqcubqirfmrir73ujw47kvna	230	30	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	230	31	these	these	DT
work_4fnqcubqirfmrir73ujw47kvna	230	32	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	230	33	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	231	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	231	2	regard	regard	NN
work_4fnqcubqirfmrir73ujw47kvna	231	3	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	231	4	calcium	calcium	NN
work_4fnqcubqirfmrir73ujw47kvna	231	5	antagonists	antagonist	NNS
work_4fnqcubqirfmrir73ujw47kvna	231	6	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	231	7	it	-PRON-	PRP
work_4fnqcubqirfmrir73ujw47kvna	231	8	appears	appear	VBZ
work_4fnqcubqirfmrir73ujw47kvna	231	9	that	that	IN
work_4fnqcubqirfmrir73ujw47kvna	231	10	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	231	11	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	231	12	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	231	13	cal-	cal-	NNP
work_4fnqcubqirfmrir73ujw47kvna	231	14	cium	cium	NN
work_4fnqcubqirfmrir73ujw47kvna	231	15	antagonists	antagonist	NNS
work_4fnqcubqirfmrir73ujw47kvna	231	16	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	231	17	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	231	18	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	231	19	depend	depend	VBP
work_4fnqcubqirfmrir73ujw47kvna	231	20	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	231	21	pharmacokinet-	pharmacokinet-	NN
work_4fnqcubqirfmrir73ujw47kvna	231	22	ics	ics	NN
work_4fnqcubqirfmrir73ujw47kvna	231	23	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	231	24	these	these	DT
work_4fnqcubqirfmrir73ujw47kvna	231	25	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	231	26	as	as	RB
work_4fnqcubqirfmrir73ujw47kvna	231	27	well	well	RB
work_4fnqcubqirfmrir73ujw47kvna	231	28	as	as	IN
work_4fnqcubqirfmrir73ujw47kvna	231	29	their	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	231	30	genuine	genuine	JJ
work_4fnqcubqirfmrir73ujw47kvna	231	31	pharmacological	pharmacological	JJ
work_4fnqcubqirfmrir73ujw47kvna	231	32	properties	property	NNS
work_4fnqcubqirfmrir73ujw47kvna	231	33	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	232	1	Activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	232	2	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	232	3	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	232	4	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	232	5	is	be	VBZ
work_4fnqcubqirfmrir73ujw47kvna	232	6	most	most	RBS
work_4fnqcubqirfmrir73ujw47kvna	232	7	pronounced	pronounce	VBN
work_4fnqcubqirfmrir73ujw47kvna	232	8	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	232	9	short	short	JJ
work_4fnqcubqirfmrir73ujw47kvna	232	10	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	232	11	acting	act	VBG
work_4fnqcubqirfmrir73ujw47kvna	232	12	dihydropyridines	dihydropyridine	NNS
work_4fnqcubqirfmrir73ujw47kvna	232	13	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	232	14	less	less	RBR
work_4fnqcubqirfmrir73ujw47kvna	232	15	so	so	RB
work_4fnqcubqirfmrir73ujw47kvna	232	16	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	232	17	long	long	RB
work_4fnqcubqirfmrir73ujw47kvna	232	18	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	232	19	acting	act	VBG
work_4fnqcubqirfmrir73ujw47kvna	232	20	preparations	preparation	NNS
work_4fnqcubqirfmrir73ujw47kvna	232	21	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	232	22	these	these	DT
work_4fnqcubqirfmrir73ujw47kvna	232	23	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	232	24	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	233	1	These	these	DT
work_4fnqcubqirfmrir73ujw47kvna	233	2	properties	property	NNS
work_4fnqcubqirfmrir73ujw47kvna	233	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	233	4	certain	certain	JJ
work_4fnqcubqirfmrir73ujw47kvna	233	5	cal-	cal-	NN
work_4fnqcubqirfmrir73ujw47kvna	233	6	cium	cium	NN
work_4fnqcubqirfmrir73ujw47kvna	233	7	antagonists	antagonist	NNS
work_4fnqcubqirfmrir73ujw47kvna	233	8	deserve	deserve	VBP
work_4fnqcubqirfmrir73ujw47kvna	233	9	further	further	JJ
work_4fnqcubqirfmrir73ujw47kvna	233	10	investigation	investigation	NN
work_4fnqcubqirfmrir73ujw47kvna	233	11	to	to	TO
work_4fnqcubqirfmrir73ujw47kvna	233	12	elucidate	elucidate	VB
work_4fnqcubqirfmrir73ujw47kvna	233	13	their	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	233	14	clinical	clinical	JJ
work_4fnqcubqirfmrir73ujw47kvna	233	15	implications	implication	NNS
work_4fnqcubqirfmrir73ujw47kvna	233	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	234	1	ACE	ACE	NNP
work_4fnqcubqirfmrir73ujw47kvna	234	2	inhibitors	inhibitor	NNS
work_4fnqcubqirfmrir73ujw47kvna	234	3	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	234	4	besides	besides	IN
work_4fnqcubqirfmrir73ujw47kvna	234	5	their	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	234	6	favor-	favor-	NN
work_4fnqcubqirfmrir73ujw47kvna	234	7	able	able	JJ
work_4fnqcubqirfmrir73ujw47kvna	234	8	influence	influence	NN
work_4fnqcubqirfmrir73ujw47kvna	234	9	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	234	10	hemodynamics	hemodynamic	NNS
work_4fnqcubqirfmrir73ujw47kvna	234	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	234	12	seem	seem	VBP
work_4fnqcubqirfmrir73ujw47kvna	234	13	to	to	TO
work_4fnqcubqirfmrir73ujw47kvna	234	14	lower	low	JJR
work_4fnqcubqirfmrir73ujw47kvna	234	15	SNS	sns	NN
work_4fnqcubqirfmrir73ujw47kvna	234	16	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	234	17	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	234	18	an	an	DT
work_4fnqcubqirfmrir73ujw47kvna	234	19	effect	effect	NN
work_4fnqcubqirfmrir73ujw47kvna	234	20	that	that	WDT
work_4fnqcubqirfmrir73ujw47kvna	234	21	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	234	22	contribute	contribute	VB
work_4fnqcubqirfmrir73ujw47kvna	234	23	to	to	IN
work_4fnqcubqirfmrir73ujw47kvna	234	24	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	234	25	beneficial	beneficial	JJ
work_4fnqcubqirfmrir73ujw47kvna	234	26	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	234	27	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	234	28	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	234	29	prognosis	prognosis	NN
work_4fnqcubqirfmrir73ujw47kvna	234	30	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	234	31	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	234	32	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	234	33	impaired	impaired	JJ
work_4fnqcubqirfmrir73ujw47kvna	234	34	left	left	JJ
work_4fnqcubqirfmrir73ujw47kvna	234	35	ventricular	ventricular	JJ
work_4fnqcubqirfmrir73ujw47kvna	234	36	function	function	NN
work_4fnqcubqirfmrir73ujw47kvna	234	37	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	235	1	Assessment	assessment	NN
work_4fnqcubqirfmrir73ujw47kvna	235	2	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	235	3	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	235	4	influence	influence	NN
work_4fnqcubqirfmrir73ujw47kvna	235	5	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	235	6	pharmacotherapy	pharmacotherapy	NN
work_4fnqcubqirfmrir73ujw47kvna	235	7	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	235	8	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	235	9	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	235	10	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	235	11	sensitive	sensitive	JJ
work_4fnqcubqirfmrir73ujw47kvna	235	12	techniques	technique	NNS
work_4fnqcubqirfmrir73ujw47kvna	235	13	may	may	MD
work_4fnqcubqirfmrir73ujw47kvna	235	14	allow	allow	VB
work_4fnqcubqirfmrir73ujw47kvna	235	15	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	235	16	tailoring	tailoring	NN
work_4fnqcubqirfmrir73ujw47kvna	235	17	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	235	18	drug	drug	NN
work_4fnqcubqirfmrir73ujw47kvna	235	19	treat-	treat-	JJ
work_4fnqcubqirfmrir73ujw47kvna	235	20	ment	ment	NN
work_4fnqcubqirfmrir73ujw47kvna	235	21	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	235	22	different	different	JJ
work_4fnqcubqirfmrir73ujw47kvna	235	23	patient	patient	NN
work_4fnqcubqirfmrir73ujw47kvna	235	24	populations	population	NNS
work_4fnqcubqirfmrir73ujw47kvna	235	25	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	235	26	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	235	27	future	future	NN
work_4fnqcubqirfmrir73ujw47kvna	235	28	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	236	1	Georg	Georg	NNP
work_4fnqcubqirfmrir73ujw47kvna	236	2	Noll	Noll	NNP
work_4fnqcubqirfmrir73ujw47kvna	236	3	was	be	VBD
work_4fnqcubqirfmrir73ujw47kvna	236	4	awarded	award	VBN
work_4fnqcubqirfmrir73ujw47kvna	236	5	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	236	6	Pfizer	Pfizer	NNP
work_4fnqcubqirfmrir73ujw47kvna	236	7	Research	Research	NNP
work_4fnqcubqirfmrir73ujw47kvna	236	8	Prize	Prize	NNP
work_4fnqcubqirfmrir73ujw47kvna	236	9	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	236	10	clinical	clinical	JJ
work_4fnqcubqirfmrir73ujw47kvna	236	11	cardiovas-	cardiovas-	NN
work_4fnqcubqirfmrir73ujw47kvna	236	12	cular	cular	JJ
work_4fnqcubqirfmrir73ujw47kvna	236	13	research	research	NN
work_4fnqcubqirfmrir73ujw47kvna	236	14	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	236	15	1998	1998	CD
work_4fnqcubqirfmrir73ujw47kvna	236	16	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	236	17	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	236	18	work	work	NN
work_4fnqcubqirfmrir73ujw47kvna	236	19	reviewed	review	VBN
work_4fnqcubqirfmrir73ujw47kvna	236	20	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	236	21	this	this	DT
work_4fnqcubqirfmrir73ujw47kvna	236	22	article	article	NN
work_4fnqcubqirfmrir73ujw47kvna	236	23	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	237	1	References	reference	NNS
work_4fnqcubqirfmrir73ujw47kvna	237	2	1	1	CD
work_4fnqcubqirfmrir73ujw47kvna	237	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	238	1	Anderson	Anderson	NNP
work_4fnqcubqirfmrir73ujw47kvna	238	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	238	3	E.	E.	NNP
work_4fnqcubqirfmrir73ujw47kvna	238	4	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	238	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	238	6	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	238	7	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	238	8	Sinkey	Sinkey	NNP
work_4fnqcubqirfmrir73ujw47kvna	238	9	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	238	10	W.	W.	NNP
work_4fnqcubqirfmrir73ujw47kvna	238	11	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	238	12	Lawton	Lawton	NNP
work_4fnqcubqirfmrir73ujw47kvna	238	13	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	238	14	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	238	15	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	238	16	L.	L.	NNP
work_4fnqcubqirfmrir73ujw47kvna	238	17	Mark	Mark	NNP
work_4fnqcubqirfmrir73ujw47kvna	238	18	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	239	1	Elevated	elevated	JJ
work_4fnqcubqirfmrir73ujw47kvna	239	2	SNA	SNA	NNP
work_4fnqcubqirfmrir73ujw47kvna	239	3	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	239	4	borderline	borderline	NN
work_4fnqcubqirfmrir73ujw47kvna	239	5	hypertensive	hypertensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	239	6	humans	human	NNS
work_4fnqcubqirfmrir73ujw47kvna	239	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	240	1	Evidence	evidence	NN
work_4fnqcubqirfmrir73ujw47kvna	240	2	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	240	3	direct	direct	JJ
work_4fnqcubqirfmrir73ujw47kvna	240	4	intraneural	intraneural	JJ
work_4fnqcubqirfmrir73ujw47kvna	240	5	recordings	recording	NNS
work_4fnqcubqirfmrir73ujw47kvna	240	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	241	1	Hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	241	2	14	14	CD
work_4fnqcubqirfmrir73ujw47kvna	241	3	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	241	4	177–183	177–183	CD
work_4fnqcubqirfmrir73ujw47kvna	241	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	241	6	1989	1989	CD
work_4fnqcubqirfmrir73ujw47kvna	241	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	242	1	2	2	LS
work_4fnqcubqirfmrir73ujw47kvna	242	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	243	1	Cohn	Cohn	NNP
work_4fnqcubqirfmrir73ujw47kvna	243	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	243	3	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	243	4	N.	N.	NNP
work_4fnqcubqirfmrir73ujw47kvna	243	5	Plasma	Plasma	NNP
work_4fnqcubqirfmrir73ujw47kvna	243	6	norepinephrine	norepinephrine	NN
work_4fnqcubqirfmrir73ujw47kvna	243	7	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	243	8	mortality	mortality	NN
work_4fnqcubqirfmrir73ujw47kvna	243	9	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	244	1	Clin	Clin	NNP
work_4fnqcubqirfmrir73ujw47kvna	244	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	245	1	Cardiol	Cardiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	245	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	246	1	18	18	CD
work_4fnqcubqirfmrir73ujw47kvna	246	2	Suppl	Suppl	NNP
work_4fnqcubqirfmrir73ujw47kvna	246	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	247	1	1	1	CD
work_4fnqcubqirfmrir73ujw47kvna	247	2	:	:	SYM
work_4fnqcubqirfmrir73ujw47kvna	247	3	19–12	19–12	CD
work_4fnqcubqirfmrir73ujw47kvna	247	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	247	5	1995	1995	CD
work_4fnqcubqirfmrir73ujw47kvna	247	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	248	1	3	3	LS
work_4fnqcubqirfmrir73ujw47kvna	248	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	249	1	Delius	Delius	NNP
work_4fnqcubqirfmrir73ujw47kvna	249	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	249	3	W.	W.	NNP
work_4fnqcubqirfmrir73ujw47kvna	249	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	249	5	K.	K.	NNP
work_4fnqcubqirfmrir73ujw47kvna	249	6	E.	E.	NNP
work_4fnqcubqirfmrir73ujw47kvna	249	7	Hagbarth	Hagbarth	NNP
work_4fnqcubqirfmrir73ujw47kvna	249	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	249	9	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	249	10	Hongell	Hongell	NNP
work_4fnqcubqirfmrir73ujw47kvna	249	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	249	12	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	249	13	B.	B.	NNP
work_4fnqcubqirfmrir73ujw47kvna	249	14	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	249	15	Wallin	Wallin	NNP
work_4fnqcubqirfmrir73ujw47kvna	249	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	250	1	General	general	JJ
work_4fnqcubqirfmrir73ujw47kvna	250	2	charac-	charac-	JJ
work_4fnqcubqirfmrir73ujw47kvna	250	3	teristics	teristic	NNS
work_4fnqcubqirfmrir73ujw47kvna	250	4	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	250	5	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	250	6	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	250	7	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	250	8	human	human	JJ
work_4fnqcubqirfmrir73ujw47kvna	250	9	muscle	muscle	NN
work_4fnqcubqirfmrir73ujw47kvna	250	10	nerves	nerve	NNS
work_4fnqcubqirfmrir73ujw47kvna	250	11	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	251	1	Acta	Acta	NNP
work_4fnqcubqirfmrir73ujw47kvna	251	2	Physiol	Physiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	251	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	252	1	Scand	scand	NN
work_4fnqcubqirfmrir73ujw47kvna	252	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	253	1	84	84	CD
work_4fnqcubqirfmrir73ujw47kvna	253	2	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	253	3	65–81	65–81	CD
work_4fnqcubqirfmrir73ujw47kvna	253	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	253	5	1972	1972	CD
work_4fnqcubqirfmrir73ujw47kvna	253	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	254	1	4	4	LS
work_4fnqcubqirfmrir73ujw47kvna	254	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	255	1	Ferguson	Ferguson	NNP
work_4fnqcubqirfmrir73ujw47kvna	255	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	255	3	D.	D.	NNP
work_4fnqcubqirfmrir73ujw47kvna	255	4	W.	W.	NNP
work_4fnqcubqirfmrir73ujw47kvna	255	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	255	6	W.	W.	NNP
work_4fnqcubqirfmrir73ujw47kvna	255	7	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	255	8	Berg	Berg	NNP
work_4fnqcubqirfmrir73ujw47kvna	255	9	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	255	10	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	255	11	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	255	12	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	255	13	Sanders	Sanders	NNP
work_4fnqcubqirfmrir73ujw47kvna	255	14	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	256	1	Clinical	clinical	JJ
work_4fnqcubqirfmrir73ujw47kvna	256	2	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	256	3	hemodynamic	hemodynamic	JJ
work_4fnqcubqirfmrir73ujw47kvna	256	4	correlates	correlate	NNS
work_4fnqcubqirfmrir73ujw47kvna	256	5	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	256	6	SNA	SNA	NNP
work_4fnqcubqirfmrir73ujw47kvna	256	7	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	256	8	normal	normal	JJ
work_4fnqcubqirfmrir73ujw47kvna	256	9	humans	human	NNS
work_4fnqcubqirfmrir73ujw47kvna	256	10	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	256	11	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	256	12	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	256	13	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	256	14	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	256	15	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	256	16	evi-	evi-	NN
work_4fnqcubqirfmrir73ujw47kvna	256	17	dence	dence	NN
work_4fnqcubqirfmrir73ujw47kvna	256	18	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	256	19	direct	direct	JJ
work_4fnqcubqirfmrir73ujw47kvna	256	20	microneurographic	microneurographic	JJ
work_4fnqcubqirfmrir73ujw47kvna	256	21	recordings	recording	NNS
work_4fnqcubqirfmrir73ujw47kvna	256	22	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	257	1	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	258	1	Am	Am	NNP
work_4fnqcubqirfmrir73ujw47kvna	258	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	259	1	Coll	coll	NN
work_4fnqcubqirfmrir73ujw47kvna	259	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	260	1	Cardiol	Cardiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	260	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	261	1	16	16	CD
work_4fnqcubqirfmrir73ujw47kvna	261	2	:	:	SYM
work_4fnqcubqirfmrir73ujw47kvna	261	3	1125–1134	1125–1134	CD
work_4fnqcubqirfmrir73ujw47kvna	261	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	261	5	1990	1990	CD
work_4fnqcubqirfmrir73ujw47kvna	261	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	262	1	5	5	CD
work_4fnqcubqirfmrir73ujw47kvna	262	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	263	1	Kleiger	Kleiger	NNP
work_4fnqcubqirfmrir73ujw47kvna	263	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	263	3	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	263	4	E.	E.	NNP
work_4fnqcubqirfmrir73ujw47kvna	263	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	263	6	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	263	7	P.	P.	NNP
work_4fnqcubqirfmrir73ujw47kvna	263	8	Miller	Miller	NNP
work_4fnqcubqirfmrir73ujw47kvna	263	9	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	263	10	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	263	11	T.	T.	NNP
work_4fnqcubqirfmrir73ujw47kvna	263	12	Bigger	big	JJR
work_4fnqcubqirfmrir73ujw47kvna	263	13	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	263	14	Jr.	Jr.	NNP
work_4fnqcubqirfmrir73ujw47kvna	263	15	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	263	16	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	263	17	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	263	18	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	263	19	Moss	Moss	NNP
work_4fnqcubqirfmrir73ujw47kvna	263	20	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	264	1	Decreased	decrease	VBN
work_4fnqcubqirfmrir73ujw47kvna	264	2	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	264	3	rate	rate	NN
work_4fnqcubqirfmrir73ujw47kvna	264	4	variability	variability	NN
work_4fnqcubqirfmrir73ujw47kvna	264	5	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	264	6	its	-PRON-	PRP$
work_4fnqcubqirfmrir73ujw47kvna	264	7	association	association	NN
work_4fnqcubqirfmrir73ujw47kvna	264	8	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	264	9	increased	increase	VBN
work_4fnqcubqirfmrir73ujw47kvna	264	10	mortality	mortality	NN
work_4fnqcubqirfmrir73ujw47kvna	264	11	after	after	IN
work_4fnqcubqirfmrir73ujw47kvna	264	12	acute	acute	JJ
work_4fnqcubqirfmrir73ujw47kvna	264	13	myocardial	myocardial	JJ
work_4fnqcubqirfmrir73ujw47kvna	264	14	infarction	infarction	NN
work_4fnqcubqirfmrir73ujw47kvna	264	15	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	265	1	Am	Am	NNP
work_4fnqcubqirfmrir73ujw47kvna	265	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	266	1	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	266	2	Cardiol	Cardiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	266	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	267	1	59	59	CD
work_4fnqcubqirfmrir73ujw47kvna	267	2	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	267	3	256–262	256–262	CD
work_4fnqcubqirfmrir73ujw47kvna	267	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	267	5	1987	1987	CD
work_4fnqcubqirfmrir73ujw47kvna	267	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	268	1	6	6	CD
work_4fnqcubqirfmrir73ujw47kvna	268	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	269	1	Leimbach	Leimbach	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	269	3	W.	W.	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	4	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	269	6	B.	B.	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	7	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	8	Wallin	Wallin	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	9	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	269	10	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	11	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	12	Victor	Victor	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	13	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	269	14	P.	P.	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	15	E.	E.	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	16	Aylward	Aylward	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	17	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	269	18	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	19	Sundlof	Sundlof	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	20	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	269	21	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	269	22	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	23	L.	L.	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	24	Mark	Mark	NNP
work_4fnqcubqirfmrir73ujw47kvna	269	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	270	1	Direct	direct	JJ
work_4fnqcubqirfmrir73ujw47kvna	270	2	evidence	evidence	NN
work_4fnqcubqirfmrir73ujw47kvna	270	3	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	270	4	intraneural	intraneural	JJ
work_4fnqcubqirfmrir73ujw47kvna	270	5	recordings	recording	NNS
work_4fnqcubqirfmrir73ujw47kvna	270	6	for	for	IN
work_4fnqcubqirfmrir73ujw47kvna	270	7	increased	increased	JJ
work_4fnqcubqirfmrir73ujw47kvna	270	8	cen-	cen-	NN
work_4fnqcubqirfmrir73ujw47kvna	270	9	tral	tral	JJ
work_4fnqcubqirfmrir73ujw47kvna	270	10	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	270	11	outflow	outflow	NN
work_4fnqcubqirfmrir73ujw47kvna	270	12	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	270	13	patients	patient	NNS
work_4fnqcubqirfmrir73ujw47kvna	270	14	with	with	IN
work_4fnqcubqirfmrir73ujw47kvna	270	15	heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	270	16	failure	failure	NN
work_4fnqcubqirfmrir73ujw47kvna	270	17	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	271	1	Circulation	circulation	NN
work_4fnqcubqirfmrir73ujw47kvna	271	2	73	73	CD
work_4fnqcubqirfmrir73ujw47kvna	271	3	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	271	4	913–919	913–919	CD
work_4fnqcubqirfmrir73ujw47kvna	271	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	271	6	1986	1986	CD
work_4fnqcubqirfmrir73ujw47kvna	271	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	272	1	7	7	LS
work_4fnqcubqirfmrir73ujw47kvna	272	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	273	1	Noll	Noll	NNP
work_4fnqcubqirfmrir73ujw47kvna	273	2	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	273	3	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	273	4	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	273	5	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	273	6	Wenzel	Wenzel	NNP
work_4fnqcubqirfmrir73ujw47kvna	273	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	273	8	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	273	9	Binggeli	Binggeli	NNP
work_4fnqcubqirfmrir73ujw47kvna	273	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	273	11	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	273	12	Corti	Corti	NNP
work_4fnqcubqirfmrir73ujw47kvna	273	13	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	273	14	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	273	15	T.	T.	NNP
work_4fnqcubqirfmrir73ujw47kvna	273	16	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	273	17	Lüscher	Lüscher	NNP
work_4fnqcubqirfmrir73ujw47kvna	273	18	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	274	1	Role	role	NN
work_4fnqcubqirfmrir73ujw47kvna	274	2	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	274	3	sym-	sym-	JJ
work_4fnqcubqirfmrir73ujw47kvna	274	4	pathetic	pathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	274	5	nervous	nervous	JJ
work_4fnqcubqirfmrir73ujw47kvna	274	6	system	system	NN
work_4fnqcubqirfmrir73ujw47kvna	274	7	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	274	8	hypertension	hypertension	NN
work_4fnqcubqirfmrir73ujw47kvna	274	9	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	274	10	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	274	11	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	274	12	cardiovascular	cardiovascular	JJ
work_4fnqcubqirfmrir73ujw47kvna	274	13	drugs	drug	NNS
work_4fnqcubqirfmrir73ujw47kvna	274	14	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	275	1	Eur	Eur	NNP
work_4fnqcubqirfmrir73ujw47kvna	275	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	276	1	Heart	heart	NN
work_4fnqcubqirfmrir73ujw47kvna	276	2	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	277	1	19	19	CD
work_4fnqcubqirfmrir73ujw47kvna	277	2	Suppl	Suppl	NNP
work_4fnqcubqirfmrir73ujw47kvna	277	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	278	1	F	F	NNP
work_4fnqcubqirfmrir73ujw47kvna	278	2	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	278	3	F32–F38	F32–F38	NNP
work_4fnqcubqirfmrir73ujw47kvna	278	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	278	5	1998	1998	CD
work_4fnqcubqirfmrir73ujw47kvna	278	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	279	1	8	8	LS
work_4fnqcubqirfmrir73ujw47kvna	279	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	280	1	Noll	Noll	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	280	3	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	280	5	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	6	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	7	Wenzel	Wenzel	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	280	9	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	10	de	de	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	11	Marchi	Marchi	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	12	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	280	13	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	14	Shaw	Shaw	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	15	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	280	16	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	280	17	T.	T.	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	18	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	19	Lüscher	Lüscher	NNP
work_4fnqcubqirfmrir73ujw47kvna	280	20	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	281	1	Differen-	Differen-	NNP
work_4fnqcubqirfmrir73ujw47kvna	281	2	tial	tial	JJ
work_4fnqcubqirfmrir73ujw47kvna	281	3	effects	effect	NNS
work_4fnqcubqirfmrir73ujw47kvna	281	4	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	281	5	captopril	captopril	NNP
work_4fnqcubqirfmrir73ujw47kvna	281	6	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	281	7	nitrates	nitrates	NNP
work_4fnqcubqirfmrir73ujw47kvna	281	8	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	281	9	muscle	muscle	NN
work_4fnqcubqirfmrir73ujw47kvna	281	10	SNA	SNA	NNP
work_4fnqcubqirfmrir73ujw47kvna	281	11	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	281	12	volunteers	volunteer	NNS
work_4fnqcubqirfmrir73ujw47kvna	281	13	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	282	1	Circula-	circula-	IN
work_4fnqcubqirfmrir73ujw47kvna	282	2	tion	tion	NN
work_4fnqcubqirfmrir73ujw47kvna	282	3	95	95	CD
work_4fnqcubqirfmrir73ujw47kvna	282	4	:	:	SYM
work_4fnqcubqirfmrir73ujw47kvna	282	5	2286–2292	2286–2292	CD
work_4fnqcubqirfmrir73ujw47kvna	282	6	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	282	7	1997	1997	CD
work_4fnqcubqirfmrir73ujw47kvna	282	8	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	283	1	9	9	CD
work_4fnqcubqirfmrir73ujw47kvna	283	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	284	1	Noll	Noll	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	284	3	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	284	5	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	6	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	7	Wenzel	Wenzel	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	284	9	M.	M.	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	10	Schneider	Schneider	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	284	12	V.	V.	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	13	Oesch	Oesch	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	284	15	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	16	Binggeli	Binggeli	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	17	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	284	18	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	19	Shaw	Shaw	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	20	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	284	21	P.	P.	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	22	Weidmann	Weidmann	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	23	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	284	24	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	284	25	T.	T.	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	26	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	27	Luscher	Luscher	NNP
work_4fnqcubqirfmrir73ujw47kvna	284	28	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	285	1	Increased	increase	VBN
work_4fnqcubqirfmrir73ujw47kvna	285	2	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	285	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	285	4	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	285	5	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	285	6	endothelin	endothelin	NN
work_4fnqcubqirfmrir73ujw47kvna	285	7	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	285	8	mental	mental	JJ
work_4fnqcubqirfmrir73ujw47kvna	285	9	stress	stress	NN
work_4fnqcubqirfmrir73ujw47kvna	285	10	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	285	11	normotensive	normotensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	285	12	offspring	offspring	NN
work_4fnqcubqirfmrir73ujw47kvna	285	13	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	285	14	hypertensive	hypertensive	JJ
work_4fnqcubqirfmrir73ujw47kvna	285	15	parents	parent	NNS
work_4fnqcubqirfmrir73ujw47kvna	285	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	286	1	Circu-	Circu-	NNP
work_4fnqcubqirfmrir73ujw47kvna	286	2	lation	lation	NN
work_4fnqcubqirfmrir73ujw47kvna	286	3	93	93	CD
work_4fnqcubqirfmrir73ujw47kvna	286	4	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	286	5	866–869	866–869	CD
work_4fnqcubqirfmrir73ujw47kvna	286	6	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	286	7	1996	1996	CD
work_4fnqcubqirfmrir73ujw47kvna	286	8	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	287	1	10	10	CD
work_4fnqcubqirfmrir73ujw47kvna	287	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	288	1	Noll	Noll	NNP
work_4fnqcubqirfmrir73ujw47kvna	288	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	288	3	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	288	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	288	5	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	288	6	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	288	7	Wenzel	Wenzel	NNP
work_4fnqcubqirfmrir73ujw47kvna	288	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	288	9	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	288	10	Shaw	Shaw	NNP
work_4fnqcubqirfmrir73ujw47kvna	288	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	288	12	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	288	13	T.	T.	NNP
work_4fnqcubqirfmrir73ujw47kvna	288	14	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	288	15	Lüscher	Lüscher	NNP
work_4fnqcubqirfmrir73ujw47kvna	288	16	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	289	1	Calcium	calcium	NN
work_4fnqcubqirfmrir73ujw47kvna	289	2	antagonists	antagonist	NNS
work_4fnqcubqirfmrir73ujw47kvna	289	3	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	289	4	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	289	5	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	289	6	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	289	7	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	289	8	are	be	VBP
work_4fnqcubqirfmrir73ujw47kvna	289	9	there	there	EX
work_4fnqcubqirfmrir73ujw47kvna	289	10	differences	difference	NNS
work_4fnqcubqirfmrir73ujw47kvna	289	11	between	between	IN
work_4fnqcubqirfmrir73ujw47kvna	289	12	classes	class	NNS
work_4fnqcubqirfmrir73ujw47kvna	289	13	?	?	.
work_4fnqcubqirfmrir73ujw47kvna	290	1	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	290	2	Hypertens	Hypertens	NNP
work_4fnqcubqirfmrir73ujw47kvna	290	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	291	1	16	16	CD
work_4fnqcubqirfmrir73ujw47kvna	291	2	Suppl	Suppl	NNP
work_4fnqcubqirfmrir73ujw47kvna	291	3	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	292	1	1	1	LS
work_4fnqcubqirfmrir73ujw47kvna	292	2	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	292	3	S17–S24	s17–s24	XX
work_4fnqcubqirfmrir73ujw47kvna	292	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	292	5	1998	1998	CD
work_4fnqcubqirfmrir73ujw47kvna	292	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	293	1	11	11	CD
work_4fnqcubqirfmrir73ujw47kvna	293	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	294	1	Shepherd	Shepherd	NNP
work_4fnqcubqirfmrir73ujw47kvna	294	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	294	3	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	294	4	T.	T.	NNP
work_4fnqcubqirfmrir73ujw47kvna	294	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	294	6	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	294	7	P.	P.	NNP
work_4fnqcubqirfmrir73ujw47kvna	294	8	M.	M.	NNP
work_4fnqcubqirfmrir73ujw47kvna	294	9	Vanhoutte	Vanhoutte	NNP
work_4fnqcubqirfmrir73ujw47kvna	294	10	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	295	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	295	2	Human	Human	NNP
work_4fnqcubqirfmrir73ujw47kvna	295	3	Cardiovascular	Cardiovascular	NNP
work_4fnqcubqirfmrir73ujw47kvna	295	4	System	System	NNP
work_4fnqcubqirfmrir73ujw47kvna	295	5	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	296	1	New	New	NNP
work_4fnqcubqirfmrir73ujw47kvna	296	2	York	York	NNP
work_4fnqcubqirfmrir73ujw47kvna	296	3	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	296	4	Raven	Raven	NNP
work_4fnqcubqirfmrir73ujw47kvna	296	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	296	6	1979	1979	CD
work_4fnqcubqirfmrir73ujw47kvna	296	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	297	1	12	12	CD
work_4fnqcubqirfmrir73ujw47kvna	297	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	298	1	Vanhoutte	Vanhoutte	NNP
work_4fnqcubqirfmrir73ujw47kvna	298	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	298	3	P.	P.	NNP
work_4fnqcubqirfmrir73ujw47kvna	298	4	M.	M.	NNP
work_4fnqcubqirfmrir73ujw47kvna	298	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	298	6	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	298	7	T.	T.	NNP
work_4fnqcubqirfmrir73ujw47kvna	298	8	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	298	9	Lüscher	Lüscher	NNP
work_4fnqcubqirfmrir73ujw47kvna	298	10	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	299	1	Peripheral	peripheral	JJ
work_4fnqcubqirfmrir73ujw47kvna	299	2	mechanisms	mechanism	NNS
work_4fnqcubqirfmrir73ujw47kvna	299	3	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	299	4	cardiovas-	cardiovas-	JJ
work_4fnqcubqirfmrir73ujw47kvna	299	5	cular	cular	JJ
work_4fnqcubqirfmrir73ujw47kvna	299	6	regulation	regulation	NN
work_4fnqcubqirfmrir73ujw47kvna	299	7	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	299	8	transmitters	transmitter	NNS
work_4fnqcubqirfmrir73ujw47kvna	299	9	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	299	10	receptors	receptor	NNS
work_4fnqcubqirfmrir73ujw47kvna	299	11	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	299	12	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	299	13	endothelium	endothelium	NN
work_4fnqcubqirfmrir73ujw47kvna	299	14	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	300	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	300	2	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	300	3	Handbook	Handbook	NNP
work_4fnqcubqirfmrir73ujw47kvna	300	4	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	300	5	Hypertension	Hypertension	NNP
work_4fnqcubqirfmrir73ujw47kvna	300	6	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	300	7	Vol	Vol	NNP
work_4fnqcubqirfmrir73ujw47kvna	300	8	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	301	1	8	8	LS
work_4fnqcubqirfmrir73ujw47kvna	301	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	301	3	Physiology	Physiology	NNP
work_4fnqcubqirfmrir73ujw47kvna	301	4	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	301	5	Pathophysiology	Pathophysiology	NNP
work_4fnqcubqirfmrir73ujw47kvna	301	6	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	301	7	Hyperten-	Hyperten-	NNP
work_4fnqcubqirfmrir73ujw47kvna	301	8	sion	sion	NN
work_4fnqcubqirfmrir73ujw47kvna	301	9	—	—	:
work_4fnqcubqirfmrir73ujw47kvna	301	10	Regulatory	Regulatory	NNP
work_4fnqcubqirfmrir73ujw47kvna	301	11	Mechanisms	Mechanisms	NNPS
work_4fnqcubqirfmrir73ujw47kvna	301	12	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	301	13	edited	edit	VBN
work_4fnqcubqirfmrir73ujw47kvna	301	14	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	301	15	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	301	16	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	301	17	Tarazini	Tarazini	NNP
work_4fnqcubqirfmrir73ujw47kvna	301	18	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	301	19	A.	A.	NNP
work_4fnqcubqirfmrir73ujw47kvna	301	20	Zanchetti	Zanchetti	NNP
work_4fnqcubqirfmrir73ujw47kvna	301	21	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	302	1	Amsterdam	Amsterdam	NNP
work_4fnqcubqirfmrir73ujw47kvna	302	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	302	3	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	302	4	Netherlands	Netherlands	NNP
work_4fnqcubqirfmrir73ujw47kvna	302	5	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	302	6	Elsevier	Elsevier	NNP
work_4fnqcubqirfmrir73ujw47kvna	302	7	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	302	8	1986	1986	CD
work_4fnqcubqirfmrir73ujw47kvna	302	9	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	302	10	p.	p.	NN
work_4fnqcubqirfmrir73ujw47kvna	302	11	96–123	96–123	CD
work_4fnqcubqirfmrir73ujw47kvna	302	12	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	303	1	13	13	CD
work_4fnqcubqirfmrir73ujw47kvna	303	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	304	1	Wallin	Wallin	NNP
work_4fnqcubqirfmrir73ujw47kvna	304	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	304	3	B.	B.	NNP
work_4fnqcubqirfmrir73ujw47kvna	304	4	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	304	5	Intraneural	Intraneural	NNP
work_4fnqcubqirfmrir73ujw47kvna	304	6	recordings	recording	NNS
work_4fnqcubqirfmrir73ujw47kvna	304	7	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	304	8	normal	normal	JJ
work_4fnqcubqirfmrir73ujw47kvna	304	9	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	304	10	abnormal	abnormal	JJ
work_4fnqcubqirfmrir73ujw47kvna	304	11	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	304	12	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	304	13	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	304	14	man	man	NN
work_4fnqcubqirfmrir73ujw47kvna	304	15	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	305	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	305	2	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	305	3	Autonomic	Autonomic	NNP
work_4fnqcubqirfmrir73ujw47kvna	305	4	Failure	Failure	NNP
work_4fnqcubqirfmrir73ujw47kvna	305	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	305	6	edited	edit	VBN
work_4fnqcubqirfmrir73ujw47kvna	305	7	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	305	8	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	305	9	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	305	10	Bannister	Bannister	NNP
work_4fnqcubqirfmrir73ujw47kvna	305	11	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	306	1	Oxford	Oxford	NNP
work_4fnqcubqirfmrir73ujw47kvna	306	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	306	3	UK	UK	NNP
work_4fnqcubqirfmrir73ujw47kvna	306	4	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	306	5	Oxford	Oxford	NNP
work_4fnqcubqirfmrir73ujw47kvna	306	6	University	University	NNP
work_4fnqcubqirfmrir73ujw47kvna	306	7	Press	Press	NNP
work_4fnqcubqirfmrir73ujw47kvna	306	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	306	9	1988	1988	CD
work_4fnqcubqirfmrir73ujw47kvna	306	10	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	306	11	p.	p.	NN
work_4fnqcubqirfmrir73ujw47kvna	306	12	177–195	177–195	CD
work_4fnqcubqirfmrir73ujw47kvna	306	13	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	307	1	14	14	CD
work_4fnqcubqirfmrir73ujw47kvna	307	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	308	1	Wenzel	Wenzel	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	308	3	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	4	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	308	6	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	7	Allegranza	Allegranza	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	308	9	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	10	Binggeli	Binggeli	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	308	12	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	13	Shaw	Shaw	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	308	15	P.	P.	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	16	Weidmann	Weidmann	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	17	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	308	18	T.	T.	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	19	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	20	Lüscher	Lüscher	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	21	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	308	22	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	308	23	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	24	Noll	Noll	NNP
work_4fnqcubqirfmrir73ujw47kvna	308	25	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	309	1	Differential	differential	JJ
work_4fnqcubqirfmrir73ujw47kvna	309	2	activation	activation	NN
work_4fnqcubqirfmrir73ujw47kvna	309	3	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	309	4	cardiac	cardiac	NN
work_4fnqcubqirfmrir73ujw47kvna	309	5	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	309	6	peripheral	peripheral	JJ
work_4fnqcubqirfmrir73ujw47kvna	309	7	SNS	SNS	NNP
work_4fnqcubqirfmrir73ujw47kvna	309	8	by	by	IN
work_4fnqcubqirfmrir73ujw47kvna	309	9	nifedipine	nifedipine	NN
work_4fnqcubqirfmrir73ujw47kvna	309	10	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	309	11	role	role	NN
work_4fnqcubqirfmrir73ujw47kvna	309	12	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	309	13	pharmacokinetics	pharmacokinetic	NNS
work_4fnqcubqirfmrir73ujw47kvna	309	14	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	310	1	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	311	1	Am	Am	NNP
work_4fnqcubqirfmrir73ujw47kvna	311	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	312	1	Coll	coll	NN
work_4fnqcubqirfmrir73ujw47kvna	312	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	313	1	Cardiol	Cardiol	NNP
work_4fnqcubqirfmrir73ujw47kvna	313	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	314	1	29	29	CD
work_4fnqcubqirfmrir73ujw47kvna	314	2	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	314	3	1607–1614	1607–1614	CD
work_4fnqcubqirfmrir73ujw47kvna	314	4	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	314	5	1997	1997	CD
work_4fnqcubqirfmrir73ujw47kvna	314	6	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	315	1	15	15	CD
work_4fnqcubqirfmrir73ujw47kvna	315	2	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	316	1	Wenzel	Wenzel	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	2	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	316	3	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	4	R.	R.	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	316	6	L.	L.	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	7	Spieker	Spieker	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	8	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	316	9	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	10	Qui	Qui	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	11	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	316	12	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	13	Shaw	Shaw	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	14	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	316	15	T.	T.	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	16	F.	F.	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	17	Lüscher	Lüscher	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	18	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	316	19	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	316	20	G.	G.	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	21	Noll	Noll	NNP
work_4fnqcubqirfmrir73ujw47kvna	316	22	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	317	1	The	the	DT
work_4fnqcubqirfmrir73ujw47kvna	317	2	I1-imidazoline	i1-imidazoline	NN
work_4fnqcubqirfmrir73ujw47kvna	317	3	receptor	receptor	NN
work_4fnqcubqirfmrir73ujw47kvna	317	4	agonist	agonist	NN
work_4fnqcubqirfmrir73ujw47kvna	317	5	moxonidine	moxonidine	NN
work_4fnqcubqirfmrir73ujw47kvna	317	6	decreases	decrease	VBZ
work_4fnqcubqirfmrir73ujw47kvna	317	7	sympathetic	sympathetic	JJ
work_4fnqcubqirfmrir73ujw47kvna	317	8	nerve	nerve	NN
work_4fnqcubqirfmrir73ujw47kvna	317	9	activity	activity	NN
work_4fnqcubqirfmrir73ujw47kvna	317	10	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	317	11	blood	blood	NN
work_4fnqcubqirfmrir73ujw47kvna	317	12	pressure	pressure	NN
work_4fnqcubqirfmrir73ujw47kvna	317	13	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	317	14	hypertensives	hypertensive	NNS
work_4fnqcubqirfmrir73ujw47kvna	317	15	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	318	1	Hypertension	Hypertension	NNP
work_4fnqcubqirfmrir73ujw47kvna	318	2	32	32	CD
work_4fnqcubqirfmrir73ujw47kvna	318	3	:	:	SYM
work_4fnqcubqirfmrir73ujw47kvna	318	4	1022–1027	1022–1027	CD
work_4fnqcubqirfmrir73ujw47kvna	318	5	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	318	6	1998	1998	CD
work_4fnqcubqirfmrir73ujw47kvna	318	7	.	.	.
work_4fnqcubqirfmrir73ujw47kvna	319	1	In	in	IN
work_4fnqcubqirfmrir73ujw47kvna	319	2	Forthcoming	forthcoming	JJ
work_4fnqcubqirfmrir73ujw47kvna	319	3	Issue	issue	NN
work_4fnqcubqirfmrir73ujw47kvna	319	4	Toward	toward	IN
work_4fnqcubqirfmrir73ujw47kvna	319	5	Understanding	understand	VBG
work_4fnqcubqirfmrir73ujw47kvna	319	6	the	the	DT
work_4fnqcubqirfmrir73ujw47kvna	319	7	Role	Role	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	8	of	of	IN
work_4fnqcubqirfmrir73ujw47kvna	319	9	Methylation	Methylation	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	10	in	in	IN
work_4fnqcubqirfmrir73ujw47kvna	319	11	Aldosterone	Aldosterone	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	12	-	-	HYPH
work_4fnqcubqirfmrir73ujw47kvna	319	13	Sensitive	Sensitive	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	14	Na+	Na+	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	15	Transport	Transport	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	16	James	James	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	17	D.	D.	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	18	Stockand	Stockand	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	19	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	319	20	Robert	Robert	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	21	S.	S.	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	22	Edinger	Edinger	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	23	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	319	24	Douglas	Douglas	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	25	C.	C.	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	26	Eaton	Eaton	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	27	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	319	28	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	319	29	John	John	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	30	P.	P.	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	31	Johnson	Johnson	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	32	Ca2	Ca2	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	33	+	+	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	34	-Activated	-Activated	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	35	Cl	Cl	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	36	–	–	:
work_4fnqcubqirfmrir73ujw47kvna	319	37	Channels	channels	NN
work_4fnqcubqirfmrir73ujw47kvna	319	38	:	:	:
work_4fnqcubqirfmrir73ujw47kvna	319	39	A	a	DT
work_4fnqcubqirfmrir73ujw47kvna	319	40	Newly	newly	RB
work_4fnqcubqirfmrir73ujw47kvna	319	41	Emerging	Emerging	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	42	Anion	Anion	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	43	Transport	Transport	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	44	Family	Family	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	45	Catherine	Catherine	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	46	M.	M.	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	47	Fuller	Fuller	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	48	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	319	49	Dale	Dale	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	50	J.	J.	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	51	Benos	Benos	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	52	Angiotensin	Angiotensin	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	53	II	II	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	54	Receptor	Receptor	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	55	Physiology	Physiology	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	56	Using	use	VBG
work_4fnqcubqirfmrir73ujw47kvna	319	57	Gene	Gene	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	58	Targeting	Targeting	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	59	Michael	Michael	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	60	I.	I.	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	61	Oliverio	Oliverio	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	62	and	and	CC
work_4fnqcubqirfmrir73ujw47kvna	319	63	Thomas	Thomas	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	64	M.	M.	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	65	Coffman	Coffman	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	66	Downloaded	download	VBD
work_4fnqcubqirfmrir73ujw47kvna	319	67	from	from	IN
work_4fnqcubqirfmrir73ujw47kvna	319	68	journals.physiology.org/journal/physiologyonline	journals.physiology.org/journal/physiologyonline	NN
work_4fnqcubqirfmrir73ujw47kvna	319	69	at	at	IN
work_4fnqcubqirfmrir73ujw47kvna	319	70	Carnegie	Carnegie	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	71	Mellon	Mellon	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	72	Univ	Univ	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	73	(	(	-LRB-
work_4fnqcubqirfmrir73ujw47kvna	319	74	128.182.081.034	128.182.081.034	CD
work_4fnqcubqirfmrir73ujw47kvna	319	75	)	)	-RRB-
work_4fnqcubqirfmrir73ujw47kvna	319	76	on	on	IN
work_4fnqcubqirfmrir73ujw47kvna	319	77	April	April	NNP
work_4fnqcubqirfmrir73ujw47kvna	319	78	5	5	CD
work_4fnqcubqirfmrir73ujw47kvna	319	79	,	,	,
work_4fnqcubqirfmrir73ujw47kvna	319	80	2021	2021	CD
work_4fnqcubqirfmrir73ujw47kvna	319	81	.	.	.